Compounds > fibrinogen
Page last updated: 2024-08-26

fibrinogen and Cardiovascular Diseases

fibrinogen has been researched along with Cardiovascular Diseases in 817 studies

Research

Studies (817)

TimeframeStudies, this research(%)All Research%
pre-199042 (5.14)18.7374
1990's225 (27.54)18.2507
2000's312 (38.19)29.6817
2010's204 (24.97)24.3611
2020's34 (4.16)2.80

Authors

AuthorsStudies
Aivazoglou Carneiro, JD; Cominato, L; Damiani, D; Ferraro, AA; Franco, RR; Frascino, AV; Steinmetz, L; Ybarra, M1
Giannobile, WV; Johnston, J; Majzoub, J; Sugai, JV; Wang, HL; Wang, IC1
Cao, Q; Chen, M; Fang, L; Gao, H; Gao, X; Guleng, B; Li, M; Liang, J; Liu, Z; Miao, Y; Qian, J; Ran, Z; Shen, J; Wang, Y; Wu, K; Wu, W; Yang, H; Zhang, H1
Kowalcze, K; Krysiak, R; Okopień, B6
Basiak, M; Krysiak, R; Okopień, B; Szkróbka, W1
Harlow, SD; Karvonen-Gutierrez, CA; Lange-Maia, BS; Leis, AM; McConnell, DS; Sanders, WM; Ylitalo, KR1
Erasmus, RT; Hill, J; Kengne, AP; Lopes, T; Mchiza, ZJ; Peer, N; Zemlin, AE1
Amini, A; Arabzadeh, E; Avazpour, S; Shirvani, H1
Ariëns, RAS; Undas, A; Ząbczyk, M1
Basiak, M; Krysiak, R; Machnik, G; Okopień, B; Szkróbka, W1
Cai, S; Hernández-Wolters, B; Lan, X; Li, G; Prabahar, K; Yin, Y1
Johnson, CY; Lawson, CC; Rich-Edwards, JW; Schernhammer, ES; Tanz, LJ; Vetter, C1
He, L; Hu, Q; Lavie, CJ; Liu, J; Tabung, FK; Xu, J; Zhang, Y1
Gao, Y; Han, M; Li, T; Li, X; Liu, Y; Wang, L; Wang, X; Wu, D; Xu, Y; Zhu, Y1
Ajjan, R; Kyriakakis, N; Lynch, J; Murray, RD; Orme, SM; Oxley, N; Pechlivani, N; Phoenix, F; Seejore, K1
Aguilar-Ferrándiz, ME; Carmona, R; Del Moral, ML; Martínez-Ramírez, MJ; Molina, F; Rus, A1
Berglund, L; Champagne, CM; Dennis, BH; Elmer, PJ; Ershow, AG; Ginsberg, HN; Holleran, SF; Karmally, W; Kris-Etherton, PM; Lefevre, M; Pearson, TA; Ramakrishnan, R; Stewart, PW; Tracy, RP1
Gogos, C; Lagadinou, M; Marangos, M; Salomou, EE; Velissaris, D; Zareifopoulos, N1
Houttu, N; Koivuniemi, E; Laitinen, K; Mokkala, K; Nielsen, HB; Sørensen, N1
Cheng, L; Guan, H; He, M; Hu, C; Huang, K; Ji, Q; Ke, Z; Keerman, M; Leng, L; Liu, B; Meng, K; Peng, Y; Wang, X; Wu, T; Zeng, Q; Zhu, R1
Huang, F; Huang, N; Li, J; Lin, T; Mao, H; Qiu, Y; Xia, X; Yang, X; Yu, J1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Li, M; Luo, E; Qin, Y; Tang, C; Wang, D; Yan, G1
Bahadori, H; Mohammadtaghizadeh, M; Rezaeeyan, H; Saki, N; Zadeh, FJ1
de Maat, MPM; Ferreira, M; Pieters, M; Ricci, C1
Hamer, M; Malan, L; von Känel, R; Wentzel, A1
Andersson Överström, E; Cameron, VA; Frampton, CMA; Kleffmann, T; Lassé, M; Lewis, LK; Pemberton, CJ; Pilbrow, AP; Poppe, KK; Prickett, TCR; Richards, AM; Troughton, RW; von Zychlinski, A1
Horigome, H; Kikuchi, T; Lin, L1
Bliden, KP; Cho, A; Gurbel, PA; Jerjian, C; Levy, JH; Rapista, N; Tantry, US; Walia, N1
Demakakos, P; Hamer, M; Yates, T1
Arnold, N; Beutel, M; Binder, H; Blankenberg, S; Espinola-Klein, C; Gori, T; Lackner, KJ; Münzel, T; Pfeiffer, N; Prochaska, JH; Schnabel, RB; Schulz, A; Wild, PS; Zeller, T1
Bind, MA; Coull, BA; Schwartz, JD; VanderWeele, TJ1
Burke, DL; Jackson, D; Kirkham, J; Price, M; Riley, RD; Salanti, G; White, IR1
Carvalho, FA; Guedes, AF; Moreira, C; Nogueira, JB; Santos, NC1
Eddy, P; Kingsley, M; Wertheim, EH; Wright, BJ1
Abreu, S; Agostinis-Sobrinho, C; Lopes, L; Moreira, C; Mota, J; Oliveira-Santos, J; Ruiz, JR; Santos, R1
Murtagh, EM; Rowe, DA; Stephens, JW; Thomas, NE; Williams, R1
Kieliszek, M; Lipinski, B1
Arnold, N; Beutel, M; Blettner, M; Hermanns, MI; Lackner, KJ; Laubert-Reh, D; Münzel, T; Panova-Noeva, M; Pfeiffer, N; Prochaska, JH; Schulz, A; Spronk, HM; Ten Cate, H; Wild, PS1
Krysiak, R; Okopień, B; Szkróbka, W1
Baci, D; Bearzi, C; Chirivì, M; Costantini, M; Gargioli, C; Maiullari, F; Maiullari, S; Marei, HE; Milan, M; Pace, V; Rainer, A; Rizzi, R; Seliktar, D1
Chung, YD; Gopinathan, P; Huang, PC; Lee, GB; Li, KH; Lin, HY; Ma, HP; Shiesh, SC; Sinha, A1
Arnold, N; Beutel, ME; Binder, H; Blankenberg, S; Eggebrecht, L; Göbel, S; Jünger, C; Lackner, KJ; Laubert-Reh, D; Münzel, T; Pfeiffer, N; Prochaska, JH; Schulz, A; Spronk, HM; Ten Cate, H; Wild, PS1
Banach, M; Katsiki, N; Kengne, AP; Mazidi, M; Mikhailidis, DP1
Azadbakht, L; Larijani, B; Mozaffari, H; Namazi, N; Surkan, PJ1
Chung, YD; Gopinathan, P; Huang, PC; Lee, GB; Li, KH; Ma, HP; Sarangadharan, I; Shiesh, SC; Sinha, A; Tai, TY; Wang, YL1
Jaffee, SR; Milaniak, I1
Krysiak, R; Marek, B; Okopień, B1
Atiq, F; Bano, A; Chaker, L; de Maat, MPM; Franco, OH; Kavousi, M; Leebeek, FWG; Mattace-Raso, FUS; Peeters, RP1
Persil-Ozkan, O; Yigit, E; Yigit, Z1
Bednarska-Czerwińska, A; Kowalcze, K; Krysiak, R; Okopień, B1
Balagopal, PB; Farrell, DH; George, D; Hossain, J; Komakula, V; Lovely, R; Ramsey, JP1
Ariëns, RA; Jerling, JC; Kotze, RC; Kruger, A; Pieters, M1
Bacci, S; De Cosmo, S; Pacilli, A; Trischitta, V1
Gialernios, T; Karpanou, E; Kyvelou, SM; Stefanadis, C; Tzamou, V; Vyssoulis, G1
Bennett, JM; Klein, LC; Rodrigues, IM1
Goodman, E; Pietras, SA1
Cohen, AK; Muennig, P; Palmer, A; Zhu, W1
Antlanger, M; Gilbertson, JA; Gremmel, T; Haidinger, M; Hawkins, PN; Hecking, M; Hörl, WH; Kain, R; Kopecky, C; Mascherbauer, J; Pfaffenberger, S; Rowczenio, D; Säemann, MD; Weichhart, T; Werzowa, J1
Narges, Z; Omran Simin, F; Omrani Vahid, F; Parisa, Y; Sajad, A1
Cordovil, I; Figueredo, CM; Fischer, RG; Vidal, F1
Alis, R; Alonso, R; Bautista, D; Laiz, B; Pérez, R; Romagnoli, M; Vayá, A1
Koenig, W; Lowe, GD; Peters, SA; Rumley, A; Tunstall-Pedoe, H; Woodward, M1
Ajello, L; Assennato, P; Caruso, M; Castellano, F; Iacona, R; La Franca, E; Mancuso, D; Novo, S; Sansone, A1
Ahmadi-Abhari, S; Khaw, KT; Luben, RN; Wareham, NJ1
Dzingalasevic, G; Ivanisevic, J; Mandic-Radic, S; Miljkovic, M; Prostran, M; Stefanovic, A; Stojanov, M1
Batty, GD; Tabassum, F1
Birmingham, W; Bosch, JA; Bowen, KS; Carlisle, M; Heaney, J; Light, KC; O'Hartaigh, B; Smith, TW; Uchino, BN1
Arbustini, E; D'Armini, AM; Narula, N1
Bandinelli, S; Basu, S; Baumert, J; Becker, DM; Becker, LC; Bevan, S; Bis, JC; Boerwinkle, E; Boomsma, DI; Buckley, BM; Campbell, H; Chambers, JC; Chasman, D; Chen, MH; Clarke, R; Cucca, F; Curb, JD; Danesh, J; Davies, G; de Geus, EJ; Deary, IJ; Dehghan, A; Dichgans, M; Eaton, CB; Erdmann, J; Eriksson, JG; Eriksson, P; Ferrucci, L; Folkersen, L; Folsom, AR; Fornage, M; Franco, OH; Franco-Cereceda, A; Franzosi, MG; Gieger, C; Goel, A; Grant, PJ; Green, D; Gross, M; Grotevendt, A; Guo, X; Hamsten, A; Haritunians, T; Harris, SE; Hayward, C; Hofman, A; Homuth, G; Hopewell, JC; Hottenga, JJ; Huang, J; Huffman, JE; Ikram, MA; Illig, T; Jacobs, D; Johnson, AD; Jukema, JW; Kathiresan, S; Kocher, T; Koenig, W; Kolcic, I; Kooner, JS; Lahti, J; Liewald, DC; Liu, S; Lopez, LM; Lowe, GD; Lumley, T; Mälarstig, A; Markus, HS; McArdle, WL; McKnight, B; Mehra, R; Morange, PE; Mosley, TH; Naitza, S; Navarro, P; Nelson, CP; O'Donnell, CJ; Oudot-Mellakh, T; Palotie, A; Peters, A; Polasek, O; Psaty, BM; Pulanic, D; Räikkönen, K; Redline, S; Reilly, MP; Reiner, AP; Ridker, PM; Rivadeneira, F; Rose, LM; Rothwell, PM; Rotter, JI; Rudan, I; Rudnicka, AR; Rumley, A; Sabater-Lleal, M; Saleheen, D; Samani, NJ; Sanna, S; Sattar, N; Schlessinger, D; Schunkert, H; Seedorf, U; Sennblad, B; Seshadri, S; Shin, SY; Silveira, A; Smith, NL; Song, J; Soranzo, N; Spector, TD; Starr, JM; Steri, M; Stott, DJ; Strachan, DP; Strawbridge, RJ; Sudlow, CL; Swords Jenny, N; Tanaka, T; Tang, W; Tarasov, KV; Taylor, KD; Teichert, M; Teumer, A; Tofler, GH; Tracy, RP; Tregouet, D; Trompet, S; Uitterlinden, AG; van Dongen, J; Völzke, H; Wallace, R; Wallaschofski, H; Watkins, H; Widen, E; Wild, SH; Willemsen, G; Williams, FM; Wilson, JF; Witteman, JC; Wright, AF; Yanek, LR; Yao, J; Zemunik, T1
Donaldson, GC; Garcha, DS; George, SN; Hurst, JR; Kowlessar, BS; Mackay, AJ; Patel, AR; Singh, R; Wedzicha, JA1
Catena, C; Colussi, G; Fedrizzi, S; Sechi, LA1
Adeyanju, MM; Odufuwa, KT; Osilesi, O; Salau, BA1
Chalmers, J; Hamet, P; Harrap, S; Hillis, G; Li, Q; Lowe, G; Marre, M; Patel, A; Poulter, N; Rumley, A; Woodward, M1
Farid, E; Megahed, H; Saleh, N; Samir, N1
Bruinse, HW; Franx, A; Koenen, SV; Koster, MP; Peeters, LL; Post Uiterweer, ED; Scholtens, LC; van Rijn, BB; Veerbeek, JH1
Bathon, JM; Beaulieu, AD; Carlson, TH; Codding, CE; Delles, C; Giles, JT; Lee, JS; McInnes, IB; Salmon, JE; Sattar, N; Thompson, L1
Barbieri, F; Bruzzese, D; Capalbo, D; Di Mase, R; Esposito, A; Mattace Raso, G; Meli, R; Salerno, M1
Azuma, M; Chin, K; Hamada, S; Handa, T; Harada, Y; Hitomi, T; Mishima, M; Murase, K; Oga, T; Tanizawa, K; Toyama, Y; Yoshimura, C1
Estébanez-De Miguel, E; Hidalgo-García, C; Lucha-López, AC; Lucha-López, MO; Salavera-Bordás, C; Tricás-Moreno, JM; Vidal-Peracho, C1
Akcali, C; Buyukcelik, B; Inaloz, S; Kirtak, N1
Amin, RS; Calvin, AD; Davison, D; Shamsuzzaman, A; Somers, VK1
Arturi, F; Fiorentino, TV; Perticone, F; Perticone, M; Sciacqua, A; Sesti, G; Succurro, E1
Abdalla, AA; Casserly, LF; Cronin, CJ; Donigiewicz, U; Hannigan, A; Nguyen, HT; Stack, AG; Weiland, A1
Ruszkowska-Ciastek, B; Sokup, A; Walentowicz-Sadłecka, M1
Aguilar-Sosa, E; Anaya-Gómez, F; Galván-Plata, ME; Isordia-Salas, I; Leaños-Miranda, A; Majluf-Cruz, A; Santiago-Germán, D1
Aryan, Z; Esteghamati, A; Nakhjavani, M1
Ariëns, RA; Boshuizen, H; de Lange, Z; Greeff, M; Pieters, M; Schutte, AE; Schutte, R1
Bolton, CE; Calverley, PM; Cockcroft, JR; Fuld, J; Gale, NS; Lomas, DA; MacNee, W; McEniery, CM; Miller, BE; Mohan, D; Polkey, MI; Shale, DJ; Tal-Singer, R; Wilkinson, IB1
Ariëns, R; Bridge, KI; Philippou, H1
Basu, S; Cushman, M; Delaney, JA; Folsom, AR; O'Donnell, CJ; Palmer, CD; Redline, S; Reiner, AP; Rich, SS; Smith, NL; Tang, W; Tracy, RP; Weng, LC; Yang, Q; Young, T1
Kozinski, M; Krintus, M; Kubica, J; Sypniewska, G1
Chasman, DI; Elias, JA; Loscalzo, J; Ridker, PM; Rose, L1
Anderson, CD; Anderson, SG; Cruickshank, JK; Heald, AH; Hutchings, DC; Sanders, TA1
Achuthan, S; Ahluwalia, J; Bhalla, A; Chandurkar, N; Malhotra, S; Pareek, A; Shafiq, N1
Baryshnikova, E; Laddomada, T; Nano, G; Ranucci, M; Trimarchi, S1
Badeĭnikova, KK; Didigova, RT; Mamedov, MN; Mazaev, AP; Toguzova, ZA1
Lowe, G; Rumley, A2
Hamer, M; Malan, L; Malan, NT; van der Westhuizen, FH; von Känel, R1
Barešić, A; Narančić, NS; Petranović, MZ; Salihović, MP; Škarić-Jurić, T; Tomas, Ž1
Ågren, A; Antovic, A; Jörneskog, G; Lins, PE; Tehrani, S; Wallén, H1
Alba, A; Cámara, R; Giménez, C; Hernández-Mijares, A; Rubio, O; Sarnago, A; Vayá, A1
Appelhans, B; Bruehl, S; Burns, JW; Dugan, SA; Janssen, I; Kravitz, HM; Matthews, KA; Quartana, PJ1
Hamer, M; Huisman, HW; Malan, L; Malan, NT; Reimann, M; Schutte, AE; von Känel, R1
Lu, L; Mackay, DF; Newby, DE; Pell, JP1
Araujo, JA; Gornbein, J; Middlekauff, HR; Ramanathan, G; Yin, F1
Al Rifai, M; Alonso, A; Astor, BC; Ballantyne, CM; Chen, LY; Halushka, MK; Hoogeveen, RC; Maruthur, N; Parrinello, CM; Schneider, AL; Selvin, E; Soliman, EZ1
Losada, M; Manresa, N; Mulero, J; Zafrilla, P1
Hamer, M; Smith, L; Stamatakis, E1
de Lange, Z; Nienaber-Rousseau, C; Pieters, M1
Hernández-Romero, D; Lip, GY; Marco, P; Marín, F; Orenes-Piñero, E; Pineda, J; Roldán, V; Sogorb, F; Tello-Montoliu, A; Valdés, M1
Brite, J; Dowd, JB; McCrillis, AM; Reales, D; Romo, ML; Schooling, CM1
Bolao, F; Fuster, D; Muga, R; Rivas, I; Sanvisens, A; Tor, J; Zuluaga, P1
Bootzin, R; Carroll, JE; Irwin, MR; Melendez, G; Nicassio, P; Olmstead, R; Sadakane, R; Seeman, TE1
Jackowska, M; Steptoe, A1
Collinson, P; Gaze, D; Hamer, M; Lazzarino, AI; Lowe, G; Rumley, A; Steptoe, A2
Feldbrin, Z; Luckish, A; Shargorodsky, M1
Bansal, SS; Haschka, D; Kiechl, S; Mayr, M; Pechlaner, R; Santer, P; Weger, S; Weiss, G; Willeit, J1
Hansen, ÅM; Holtermann, A; Korshøj, M; Krustrup, P; Ravn, MH1
Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W1
de Borst, GJ; Moll, FL; Roest, M; Teraa, M; Verhaar, MC; Wisman, PP1
Eisele, L; Erbel, R; Fuks, K; Hertel, S; Hoffmann, B; Jakobs, H; Jöckel, KH; Moebus, S; Möhlenkamp, S; Nonnemacher, M; Viehmann, A1
Dunbar, DR; Hayes, PC; Le Bihan, T; Lockman, KA; Manning, JR; Martin, SF; Morley, SD; Nelson, LJ; Plevris, JN; Rogers, SM; Treskes, P; Yeung, EN1
Lahera, V; López-Farré, AJ; Melander, O; Modrego, J; Santos-Sancho, JM; Zamorano-León, JJ1
Bagir, GS; Bakiner, OS; Bozkirli, E; Cavlak, G; Ertorer, ME; Serinsoz, H1
Devi, CS; Dhamodharan, D; Mohanasrinivasan, V; Naine, SJ1
Akalin, N; Akay, H; Erturk, K; Harmankaya, O; Kaptanogullari, H; Kocoglu, H; Okuturlar, Y1
Bhat, A; Dakna, M; Jankowski, V; Klein, J; Koeck, T; Mischak, H; Mullen, W; Nkuipou-Kenfack, E; Pich, A; Rudolph, KL; Schanstra, JP; Schumacher, B; Vlahou, A; Zürbig, P1
Amore, C; Beume, R; Dell'Elba, G; Di Santo, A; Evangelista, V; Martelli, N; Piccoli, A; Tenor, H; Totani, L1
Baer, DJ; Stote, KS; Taylor, PR; Tracy, RP1
El Husseiny, M; El-Masry, S; Fathy, M; Hafez, M; Hassan, M; Hassan, N; Musa, N; Tareef, M1
Baker, G; Lüdicke, F; Magnette, J; Weitkunat, R1
Byun, YS; Cho, SW; Goh, CW; Kim, BG; Kim, BO; Kwon, HM; Lee, BK; Rhee, KJ1
Dabass, A; Holguin, F; Marsh, GM; Rager, J; Sharma, RK; Talbott, EO; Venkat, A1
Beilin, LJ; Burke, V; Hodgson, JM; Mori, TA; Puddey, IB; Zilkens, RR1
Barany, P; Bergman, P; Hällqvist, J; Heimbürger, O; Lindholm, B; Missailidis, C; Qureshi, AR; Stenvinkel, P1
Engin-Üstün, Y; Göçmen, AY; Kiyak Çağlayan, E; Polat, MF; Sari, N1
Arnaoutoglou, E; Gartzonika, K; Koulouras, V; Kouvelos, G; Matsagkas, M; Milionis, H; Papa, N1
Appiah, D; Cushman, M; Folsom, AR; Heckbert, SR; Psaty, BM1
Carvalho, FA; Guedes, AF; Lousada, N; Malho, I; Santos, NC; Sargento, L1
Adamovski, M; Bernal, RT; da Silva, NN; Debortoli, G; Gonçalves, Mde C; Mastroeni, MF; Mastroeni, SS; Rondó, PH; Veugelers, PJ1
Ang, L; Behnamfar, O; Lin, F; Mahmud, E; Patel, M; Reeves, R1
Declerck, PJ; Gils, A; Jern, C; Jood, K; Lundberg, L; Nilsson, S; Pedersen, A; Redfors, P1
Gao, HL; Ley, CM; Liao, X; Ni, Q; Robinson, N1
Barger, SD; Cribbet, MR; Muldoon, MF1
Agusti, A; Halpin, D; Martinez, FJ; Roche, N; Singh, D; Wedzicha, JA1
Deanfield, JE; Ellins, EA; Halcox, JP; Rees, DA; Steptoe, A1
Lowe, GD; Peters, SA; Rumley, A; Tunstall-Pedoe, HD; Woodward, M1
Deeks, SG; Ganz, P; Hsue, PY; Hur, S; Li, D; Ma, Y; Scherzer, R; Sinha, A1
Cao, Y; Ding, X; Gamariel, RR; Kong, Y; Li, ZY; Liu, TD; Liu, XD; Ming, X; Wang, CH; Xie, ZL; Zhao, Q1
Acien, AN; Al Rifai, M; Barr, GR; Benjamin, EJ; Bhatnagar, A; Blaha, MJ; DeFilippis, AP; Hall, ME; Jones, MR; Keith, R; Magid, HS; McEvoy, JW; Robertson, RM; Rodriguez, CJ1
Ajjan, R; Kearney, K; Smith, K; Tomlinson, D1
Cho, L; Hazen, SL; Hoogwerf, BJ; Lauer, MS; Oliveira, LP; Shishehbor, MH; Sprecher, DL; Wolski, K1
Altberg, G; Arbel, Y; Justo, D; Kinori, M; Melamed, S; Rogowski, O; Shapira, I; Shirom, A1
Bennett, PC; Lane, DA; Lip, GY1
Kruger, SH; Nienaber, C; Pieters, M; Stonehouse, W; Vorster, HH1
Burke, GL; Jacobs, DR; Jenny, NS; Jiang, R; Nettleton, JA; Schulze, MB1
Heuch, I; Jacobsen, BK; Jenssen, T; Jørgensen, L1
Thomas, NE; Williams, DR1
Arocha-Piñango, CL; Campos, G; Diez-Ewald, M; Fernández, V; Rivero, F; Ryder, E; Torres-Guerra, E1
Ang, L; Bromberg-Marin, G; Clopton, P; Idrees, Z; Keramati, S; Khalid, A; Mahmud, E; Palakodeti, V; Tran, P; Tsimikas, S; Zafar, N1
Cornell, E; Knowler, WC; Krakoff, J; Le, DS; Miles, R; Savage, PJ; Tracy, RP1
Berliner, S; Justo, D; Melamed, S; Rogowski, O; Saar, N; Shapira, I; Shirom, A; Steinvil, A; Toker, S1
Bertrand, M; Blann, A; Ceconi, C; Cokkinos, D; Deckers, JW; Ferrari, R; Fox, KM; Kluft, C; Parrinello, G; Remme, WJ; Simoons, ML1
Andreotti, F; Becker, RC; Chan, MY1
Aragoncillo, I; de Vinuesa, SG; Goicoechea, M; Gómez-Campderá, F; Luño, J; Mosse, A; Verdalles, U1
Coppola, G; Corrado, E; Muratori, I; Novo, G; Novo, S; Rizzo, M1
Cheng, J; Li, Y; Qin, LP; Sun, JY; Wang, W; Wu, ZS; Zhao, D1
Hamer, M; Molloy, GJ; Stamatakis, E1
de Kraker, AT; Kenemans, P; Kroeks, MV; Smolders, RG; van der Mooren, MJ1
Abreu-Gonzalez, P; Dominguez-Rodriguez, A1
Hirokawa, K; Kayaba, K; Tsutsumi, A2
Gnyp, W; Grela, W; Koszowski, B; Sobczak, A; Szołtysek-Bołdys, I; Zielińska-Danch, W1
Siasos, G; Stefanadis, C; Tousoulis, D1
Dogru, T; Ercin, CN; Erdem, G; Sonmez, A; Tapan, S; Tasci, I1
Albert, MA; Buring, J; Morris, A; Pare, G; Ridker, PM; Rose, L; Zee, RY1
Benjamin, EJ; D'Agostino, RB; Hayes, L; Jacques, P; Joseph, J; Levy, D; Pencina, MJ; Selhub, J; Tofler, GH; Vasan, RS; Wang, TJ1
Lowe, GD; Rumley, A; Tunstall-Pedoe, H; Welsh, P; Woodward, M1
Deary, IJ; Gow, AJ; Luciano, M; Marioni, RE; Starr, JM1
Alexeeff, SE; Litonjua, AA; Mittleman, MA; Poon, A; Schwartz, J; Sparrow, D; Vokonas, PS; Wilker, EH1
Krysiak, R; Okopien, B; Pruski, M1
Black, MA; Blumenstein, M; Cooney, J; Cooper, GJ; McCowan, LM; McMaster, MT; North, RA; Prakash, R; Wu, S1
Bouskela, E; Kraemer-Aguiar, LG; Lima, LM; Wiernsperger, N1
Lowe, GD; Rumley, A; Tunstall-Pedoe, H; Woodward, M2
Al-Barjas, HS; Ariëns, RA; Chappell, L; Parry, DJ; Rashid, T; Scott, DJ1
Bingol, B; Biri, A; Gunenc, Z; Güner, H; Tiras, B; Yilmaz, M1
Bröcker-Preuss, M; Dragano, N; Erbel, R; Hoffmann, B; Jöckel, KH; Mann, K; Memmesheimer, M; Moebus, S; Möhlenkamp, S; Schmermund, A; Stang, A1
Buja, A; Coin, A; Crepaldi, G; Enzi, G; Frigo, AC; Maggi, S; Manzato, E; Mastrangelo, G; Perissinotto, E; Scafato, E; Sergi, G1
Berdeli, A; Cetinkalp, S; Erdogan, M; Karadeniz, M; Ozgen, AG; Saygili, F; Tamsel, S; Yilmaz, C1
Dean, WL; Lominadze, D; Roberts, AM; Tyagi, SC1
Catena, C; Cavarape, A; Colussi, G; De Marchi, S; Dotto, L; Novehllo, M; Sechi, LA1
Ebbesson, SO; Eilat-Adar, S; Fabsitz, RR; Howard, BV; Mete, M; Nobmann, ED; Xu, J1
Engström, G; Hedblad, B; Li, C1
Aggermann, T; Binder, S; Frantal, S; Haas, P; Krugluger, W; Oberkanins, C; Pühringer, H; Steindl, K1
Ferdinand, KC; Morris, A1
Awodu, OA; Famodu, AA1
Panagiotakos, DB; Vardavas, CI1
Aulchenko, YS; Basu, S; Baumert, J; Bis, JC; Boerwinkle, E; Chen, MH; Couper, DJ; de Maat, M; Dehghan, A; Eyhermendy, S; Folsom, AR; Gieger, C; Hofman, A; Illig, T; Johnson, AD; Kathiresan, S; Kavousi, M; Koenig, W; Kolz, M; Larson, MG; Lowe, GD; Lumley, T; Massaro, JM; McArdle, WL; McKnight, B; O'Donnell, CJ; Pankow, JS; Peters, A; Psaty, BM; Rivadeneira, F; Rudnicka, AR; Smith, NL; Strachan, DP; Tang, W; Taylor, KD; Tofler, GH; Uitterlinden, AG; van Duijn, CM; Volcik, KA; Witteman, JC; Yang, Q1
Bielinski, SJ; Carlson, CS; Fornage, M; Gross, MD; Jacobs, DR; Jenny, NS; Lange, LA; Nickerson, DA; Reiner, AP; Tracy, RP; Walston, J; Williams, OD1
Ashton, DW; Charlton-Menys, V; Durrington, PN; Humphries, SE; Kwok, S; Lowe, GD; McElduff, P; Wood, D1
Carty, CL; Cushman, M; Heagerty, P; Heckbert, SR; Jarvik, GP; Lange, LA; Reiner, AP; Tracy, RP1
Baune, BT; Berger, K; Ellert, U; Neuhauser, H1
Chang, MH; Dowling, NF; Fan, AZ; Fang, J; Hayes, D; House, M; Mokdad, AH; Ned, R; Yesupriya, A1
Chae, CU; Crawford, SL; Everson-Rose, SA; Matthews, KA; Sowers, MF; Sternfeld, B; Sutton-Tyrrell, K1
Bittner, V1
Astegiano, M; Berrutti, M; Castelli, A; Fadda, M; Fagoonee, S; Leone, N; Luigiano, C; Oliaro, E; Pellicano, R; Repici, A; Rizzetto, M; Saracco, G; Smedile, A1
Cushman, M; Diez-Roux, AV; Ranjit, N; Roy, B; Seeman, T; Shea, S1
Aiello, AE; Kaplan, GA1
Chang, HH; Chang, PY; Hsu, LA; Hu, CF; Ko, YL; Lin, JF; Teng, MS; Wu, S1
Dajak, M; Ignjatović, S; Jovicić, S; Kangrga, R; Majkić-Singh, N1
Abregu, AV; Bazán, MC; Del R Carrizo, T; Díaz, EI; Fonio, MC; Prado, MM; Velarde, MS1
Lowe, GD2
D'Agostino, RB; Farrell, DH; Kazmierczak, SC; Lovely, RS; Massaro, JM; O'Donnell, CJ1
Boehlen, F; de Moerloose, P; Neerman-Arbez, M1
Chung, WS; Ihm, SH; Kim, DB; Kim, HY; Kim, JH; Lee, JM; Park, CS; Seung, KB; Yoo, KD1
Anzaldi, M; Catanzaro, S; Fiore, V; Neri, S; Sciacchitano, S; Signorelli, SS; Simili, M1
Gluszko, P; Kwasny-Krochin, B; Undas, A1
de Oliveira, C; Hamer, M; Watt, R1
Adeghe, JE; Ekeh, CC; Ogefere, HO; Omokaro, EU; Omoregie, R1
Batty, GD; Hamer, M; Kivimaki, M; Lowe, GD; Stamatakis, E1
Carey, H; Carter, T; Dailey, C; Elliott, M; Morel-Kopp, MC; Schenck, K; Taylor, B; Tofler, G; Villata, L; Ward, C; Woodward, M1
Genco, RJ; Van Dyke, TE1
Bernlochner, I; Braun, S; Jaitner, J; Kastrati, A; Mehilli, J; Morath, T; Schömig, A; Sibbing, D; Stegherr, J; Steinhubl, S; von Beckerath, N1
Delaney, JA; Folsom, AR; Green, D; Ho, LA; Jacobs, DR; Johnson, AD; Keating, BJ; Lange, EM; Lange, LA; Li, Y; O'Donnell, CJ; Palmer, C; Redline, S; Reiner, AP; Smith, NL; Tang, W; Taylor, HA; Taylor, KC; Tofler, G; Tracy, RP; Wassel, CL; Wilson, JG; Yang, Q1
Chen, YH; Fu, X; Liang, XL; Liang, YZ; Shi, W1
Buggage, R; Chakravarthy, U; Evans, C; Fletcher, A; Mitchell, P; Piault, E; Pleil, A; Wong, TY; Zlateva, G1
Alexander, KS; Farrell, DH; Madden, TE1
Aita, CA; Fortes, PC; Marcondes, LB; Mendes, JG; Pecoits-Filho, R; Riella, MC; Sesiuk, K1
Daskalaki, M; Kotrotsou, A; Makris, TK; Mourouzis, I; Papadopoulos, DP; Papazachou, U; Sanidas, E; Thomopoulos, C1
Dhangana, R; Murphy, TP; Pencina, MJ; Zafar, AM1
Allin, KH; Jensen, GB; Jensen, MT; Marott, JL; Nordestgaard, BG1
Batty, GD; Calvin, CM; Deary, IJ; Lowe, GD1
Liu, ZH; Luo, Q; McEvoy, RD; Wang, Y; Zhang, HL; Zhao, Q; Zhao, ZH1
Anuurad, E; Berglund, L; Enkhmaa, B; Gungor, Z; Kim, K; Pearson, TA; Tracy, RP; Zhang, W1
Koptonashvili, L; Ormotsadze, G; Parkosadze, G; Ratiani, L; Sanikidze, T; Sulaqvelidze, M1
Cherny, SS; Cheung, BM; Lam, KS; Lam, TH; Leung, RY; Ong, KL; Sham, PC; Tso, AW1
de Maat, MP; Hoekstra, T; Jerling, JC; Kruger, A; Pieters, M1
Choo, J; Curb, JD; El-Saed, A; Evans, RW; Fujiyoshi, A; Hassen, LJ; Kadota, A; Kadowaki, T; Kuller, LH; Lee, S; Masaki, K; Miura, K; Sekikawa, A; Seto, TB; Shin, C; Sutton-Tyrrell, K; Ueshima, H; Willcox, BJ1
Borges, MA; Carvalho, MG; Fernandes, AP; Kazmi, RS; Lwaleed, BA; Rosário, PW; Soares, AL; Sousa, MO1
Conti, E; Favaretto, E; Frascaro, M; Legnani, C; Palareti, G; Sartori, M1
Gao, W; Guo, L; Hang, J; Li, Z; Xu, W; Zhao, Y1
Berkman, LF; Buring, JE; Clark, CR; Coull, B; Ridker, PM1
Acevedo-Flores, M; Adubato, S; Allison, K; Baig, M; Barr, E; Belanger, R; Bettica, L; Borkowsky, W; Borne, C; Burchett, S; Burey, M; Cagwin, E; Chambers, C; Chen, J; Cintron, A; Cooper, N; Dieudonne, A; DiMeglio, LA; Dooley, L; Garvie, P; Geffner, ME; Gobs, E; Grant, M; Harris, L; Hazra, R; Himic, L; Hunter, S; Jacobson, DL; Kammerer, B; Karthas, N; Knapp, K; Malee, K; McFarland, E; McFarland, EJ; Mendez, AJ; Messenger, N; Miller, TI; Navarro, S; Nichols, S; Norris, K; Nozyce, M; Olivera, V; Patel, K; Patton, D; Puga, A; Purswani, M; Rios, H; Scott, G; Shearer, W; Siberry, GK; Silio, M; Sirois, P; Spector, S; Van Dyke, RB; Watson, D; Willen, E; Wiznia, A; Worrell, CJ; Yogev, R1
Koenen, KC; Kubzansky, LD; Slopen, N1
Best, LG; Devereux, RB; Howard, BV; Karas, MG; Kizer, JR; Lee, ET; Roman, MJ; Umans, JG; Whisnant, JP; Wiebers, DO1
Ahmadi Dehrashid, K; Ahmadi, S; Gharibi, F; Sheikholeslami Vatani, D1
de Almeida, JP; Saldanha, C1
Freitas-Santos, T; Lopes de Almeida, JP; Saldanha, C1
Aso, T; Honjo, H; Mizunuma, H; Terauchi, M1
Babicz, K; Malinowska, J; Olas, B; Oleszek, W; Stochmal, A1
Baena-Díez, JM; Félix-Redondo, FJ; Fernández-Bergés, D; Grau, M; Tormo, MÁ1
Alonso-Villaverde Grote, C; Bleda Fernández, D; Fernández Pérez, C; Muñoz Lloret, A; Peña Sendra, E; Pérez Santos, JM; Rodríguez Cristóbal, JJ; Travé Mercadé, P1
Berkman, LF; Buring, JE; Clark, CR; Coull, B; Huisingh, CE; Ommerborn, MJ; Ridker, PM1
Basaria, S; Bhasin, S; Davda, MN; Singh, R; Travison, TG; Ulloor, J1
Arheart, K; Clark, JD; Fleming, LE; Lee, DJ; Serdar, B; Wilkinson, JD1
Brailly-Tabard, S; Canonico, M; Carcaillon, L; Gaussem, P; Guiochon-Mantel, A; Rouaud, O; Ryan, J; Scarabin, PY; Setiao, J1
Batty, GD; Czernichow, S; Hamer, M; Kengne, AP; Stamatakis, E1
Malinowska, J; Olas, B; Oleszek, W; Stochmal, A1
Arbel, Y; Birati, EY; Canaani M D, J; Shapira, I; Topilsky, Y; Wirguin, M1
de Maat, MP; Deckers, JW; Leebeek, FW; van Domburg, RT; van Loon, JE1
Luo, B; Ma, S; Wang, B; Zhang, S; Zhou, J2
Barnett, AG; Bønaa, KH; Hopstock, LA; Mannsverk, J; Njølstad, I; Wilsgaard, T1
Fialka-Moser, V; Giurgea, A; Gschwandtner, M; Hammer, A; Koppensteiner, R; Schlager, O; Schuhfried, O; Steiner, S1
Breza, J; Goncalves, FM; Ziaran, S1
Adamo, EB; Alibrandi, A; Altavilla, D; Atteritano, M; Bitto, A; Caccamo, D; Currò, M; D'Anna, R; Ferlazzo, N; Ientile, R; Marini, H; Polito, F; Squadrito, F1
Assori, IN; Ellenga-Mbolla, B; Fuele, SM; Gombet, T; Ibara, JR; Longo-Mbenza, B; Mokondjimobe, E; Nsenga, JN; Vangu, DN1
Amouyel, P; Assmann, G; Bakker, SJ; Barr, EL; Barrett-Connor, E; Benjamin, EJ; Björkelund, C; Brenner, H; Brunner, E; Butterworth, AS; Caslake, M; Clarke, R; Cooper, JA; Cremer, P; Cushman, M; D'Agostino, RB; Dagenais, GR; Danesh, J; Dankner, R; Davey-Smith, G; Deeg, D; Dekker, JM; Di Angelantonio, E; Engström, G; Folsom, AR; Ford, I; Fowkes, FG; Gallacher, J; Gao, P; Gaziano, JM; Giampaoli, S; Gillum, RF; Gudnason, V; Hofman, A; Howard, BV; Ingelsson, E; Iso, H; Jørgensen, T; Kaptoge, S; Kauhanen, J; Khaw, KT; Kiechl, S; Kitamura, A; Kiyohara, Y; Koenig, W; Kromhout, D; Kuller, LH; Lawlor, DA; Lowe, GD; Meade, TW; Nissinen, A; Nordestgaard, BG; Onat, A; Packard, CJ; Panagiotakos, DB; Pennells, L; Pepys, MB; Psaty, BM; Ridker, PM; Rodriguez, B; Rosengren, A; Salomaa, V; Salonen, JT; Sarwar, N; Sattar, N; Shaffer, JA; Shea, S; Stehouwer, CD; Strandberg, TE; Thompson, A; Thompson, SG; Tipping, RW; Tosetto, A; Walker, M; Wareham, NJ; Wassertheil-Smoller, S; Wennberg, P; Westendorp, RG; Whincup, PH; White, IR; Wilhelmsen, L; Wood, AM; Woodward, M1
da Silva, AM; Fayh, AP; Friedman, R; Lopes, AL; Reischak-Oliveira, A1
Countryman, AJ; Llabre, MM; McCalla, JR; Penedo, FJ; Saab, PG; Schneiderman, N1
MacNee, W1
Chan, C; Green, D; Jenny, NS; Klein, O; Liu, K; Okwuosa, TM; Schreiner, P1
Boehm, BO; Bosch, JA; Carroll, D; Fischer, JE; Grammer, TB; Hemming, K; Kleber, ME; Loerbroks, A; März, W; O Hartaigh, B; Pilz, S; Thomas, GN1
Danesh, J; Kaptoge, S; Thompson, SG1
Stulnig, TM1
Ammirati, E; Maseri, A1
Weinrauch, LA1
Goodman, E; Oreskovic, NM1
Cloetens, L; Herzig, KH; Johansson-Persson, A; Karhu, T; Onning, G; Ulmius, M1
Mertens, I; Van Gaal, LF1
Anaya, F; Andrés, A; Arias, M; Campistol, JM; Capdevila, L; del Castillo, D; Escuín, F; Gil Vernet, JM; González Molina, M; Grinyo, JM; Lampreave, I; Marcén, R; Morales, JM; Oppenheimer, F; Pallardó, L; Valdés, F1
Cienfuegos, JA; de Irala, J; Diez-Caballero, A; Frühbeck, G; Gil, MJ; Gómez-Ambrosi, J; Orbe, J; Páramo, JA; Salvador, J1
Greenwell, H1
Covas, MI; Elosua, R; Marrugat, J; Nascetti, S; Pena, A; Senti, M1
Cort, N; Haustein, H; Haustein, KO; Krause, J; Rasmussen, T1
Bal Dit Sollier, C; Drouet, L1
Biondi, B; Fazio, S; Lombardi, G; Nuzzo, V; Palmieri, EA; Pulcrano, M; Rossi, R; Tauchmanovà, L1
Hendriks, HF; Kluft, C; Sierksma, A; van der Gaag, MS1
Bukowska, H; Johansson, ML; Naruszewicz, M; Zapolska-Downar, D1
Gilardini, L; Guzzaloni, G; Invitti, C; Morabito, F; Viberti, G1
Bleyer, AJ; Crump, C; Fried, LF; Furberg, CD; Manolio, TA; Psaty, BM; Shlipak, MG; Tracy, RP1
Espinosa, RA1
Ambler, G; Head, J; Royston, P1
Klatsky, AL1
Ashton, EL; Liew, D; Magliano, DJ; McNeil, JJ; Sundararajan, V1
Ebano, V; Fruscella, M; Imperato, F; Marziani, R; Mossa, B; Perniola, G1
Shivakumar, K1
Best, L; Celentano, A; de Simone, G; Devereux, RB; Fabsitz, RR; Howard, BV; Lewis, MR; Palmieri, V; Robbins, DC; Roman, MJ1
Koenig, W2
Bhopal, R; Fischbacher, C1
Collins, P; Dann, S; Davies, JS; Evans, LM; Goodfellow, J; Lane, HA; Lewis, J; Scanlon, MF; Smith, JC1
Bazzano, LA; He, J; Muntner, P; Vupputuri, S; Whelton, PK1
Tracy, RP2
Grebe, OC; Hoffmeister, A; Höher, M; Hombach, V; Kestler, HA; Kochs, M; Koenig, W; Nusser, T; Wöhrle, J1
Ducobu, J; Ledent, T; Lefebvre, P1
Lip, GY; Marín, F; Roldán, V1
Alexy, T; Gaál, V; Horváth, B; Juricskay, I; Késmárky, G; Koltai, K; Márton, Z; Nagy, F; Pálfi, A; Szapáry, L; Szóts, M; Tóth, K1
Becker, A; Bouter, LM; Heine, RJ; Stehouwer, CD; van der Does, FE; van Hinsbergh, VW1
Bonanno, G; Buemi, M; Cutrupi, S; Fatuzzo, P; Malatino, LS; Mallamaci, F; Nicocia, G; Parlongo, S; Rapisarda, F; Seminara, G; Stancanelli, B; Tripepi, G; Zoccali, C1
De Maat, MP; Huisman, MV; Kluft, C; Meinders, AE; Princen, HM; Van De Ree, MA1
Jousilahti, P; Palosuo, T; Rasi, V; Salomaa, V; Vahtera, E1
Duarte, N; Hoy, W; Maguire, G; McDonald, S; Wang, XL1
LOSNER, S; VOLK, BW; WILENSKY, ND1
Barba, J; Beloqui, O; Benito, A; Colina, I; Diez, J; Irimia, P; Martínez-Vila, E; Monreal, I; Orbe, J; Páramo, JA; Zubieta, JL1
CRASTNOPOL, P; LOSNER, S; VOLK, BW1
HOLGER-MADSEN, T1
GILLUM, GN; GORENSTEIN, I; GRAHAM, WK; HAMILTON, A; STEINBERG, MS1
KOZLOVA, VN; SANDLER, RI1
KISELEVA, EN; PETROVA, TR1
STEINMANN, B1
Kamath, S; Lip, GY1
Alfredsson, LS; de Faire, UH; Fransson, EI; Knutsson, A; Westerholm, PJ1
Balk, EM; Goudas, LC; Jordan, HS; Karas, RH; Kim, LU; Kupelnick, B; Lau, J1
Dimsdale, JE; von Känel, R1
Carrillo, E; Lanes, R; Palacios, A; Paoli, M; Villaroel, O1
Barbier, S; Godin, M; Le Roy, F; Passos, EM1
Chrysohoou, C; Panagiotakos, DB; Papaioannou, I; Pitsavos, C; Skoumas, J; Stefanadis, C; Toutouza, M; Toutouzas, PK1
Engström, G; Hedblad, B; Janzon, L; Lind, P; Lindgärde, F; Stavenow, L; Tydén, P1
Joshipura, KJ; Merchant, AT; Rimm, EB; Wand, HC1
Chrysohoou, C; Masoura, C; Panagiotakos, DB; Pitsavos, C; Skoumas, J; Stefanadis, C; Toutouzas, P1
Afzali, B; Bakri, RS; Bharma-Ariza, P; Covic, A; Crook, MA; Dalton, N; Goldsmith, DJ; Park, WH; Sriharan, M; Sriskantharan, R; Wierzbicki, AS1
Döring, A; Fröhlich, M; Koenig, W; Löwel, H1
von Eckardstein, A1
Brönstrup, A; Burger, M; Mensink, G; Pietrzik, K; Thierfelder, W1
Alfredsson, L; Theorell, T; Westerlund, H1
Auchincloss, H; Baid-Agrawal, S; Cosimi, AB; Delmonico, FL; Farrell, M; Pascual, M; Shih, V; Tolkoff-Rubin, NE; Williams, WW1
Fisher, M; Kirk, A; MacIntyre, P; Mutrie, N1
Fujii, C; Naito, M; Sakakibara, H1
Engström, G; Hedblad, B; Janzon, L; Jonsson, S; Lind, P; Lindgärde, F; Stavenow, L1
de Maat, MP; Tak, HS; van der Beek, MT; Verschuur, M; Visser, LG1
Farrell, DH1
Bernhardt, O; Gesch, D; John, U; Kocher, T; Luedemann, J; Robinson, DM; Schwahn, C; Völzke, H1
Andrades Corrales, A; Juan Babot, O; Peña Sendra, E; Rodríguez Cristóbal, JJ; Tibau Llardén, N; Villaverde Grote, CA1
Parish, JM; Somers, VK1
Bainton, D; Ben-Shlomo, Y; Lowe, GD; Rumley, A; Rumley, C; Sweetnam, PM; Yarnell, JW1
Jung, EM; Kiesewetter, H; Koscielny, J; Latza, R; Mrowietz, C1
Ben Abdallah, T; Ben Maiz, H; Feki, H; Feki, M; Fellah, H; Kaabachi, N; Lacour, B; Massy, ZA; Mebazaa, A; Souissi, M1
Baroselli, S; Colussi, GL; Sechi, L1
Bartholomew, JR; Gupta, R; Gurm, H1
Antoniades, C; Brown, M; Chrysohoou, C; Panagiotakos, DB; Pitsavos, C; Skoumas, J; Stefanadis, C1
Ahrén, B; Björk, J; Cavallin-Ståhl, E; Erfurth, EM; Garwicz, S; Link, K; Moëll, C; Thilén, U1
Borzì, V; Caschetto, S; Cassibba, N; Celotta, G; Costa, MP; Di Pino, L; Digrandi, D; Libertini, C; Marchese, G; Pennisi, G; Sciacchitano, S; Signorelli, SS; Torrisi, B1
Fielding, R; Ho, SY; Janus, ED; Lam, TH1
Chrysohoou, C; Kavouras, S; Panagiotakos, DB; Pitsavos, C; Stefanadis, C1
Chinchilli, VM; Duan, Y; Folsom, AR; Heiss, G; Liao, D; Lin, HM; Salomaa, V1
Cooper, JA; Humphries, SE; Ireland, H; Miller, GJ; Webb, KE1
Al-Wakeel, JS; Alam, AA; Chaudhary, AR; Mitwalli, AH; Zebaid, MA1
Durrington, PN; Kwok, S; Laing, I; Mackness, B; Mackness, MI; McElduff, P; Morgan, J; Prais, H; Sci, FM; Selby, PL; Yates, AP1
Littler, WA; Shah, SU; White, A; White, S1
Lowe, GD; Mackie, IJ; Rumley, A1
Wilson, PW1
Cavallini, C; Doggen, CJ; Mannucci, PM; Martini, CH; Rosendaal, FR1
Dragsted, LO; Finné Nielsen, IL; Grønbaek, M; Hansen, AS; Marckmann, P; Nielsen, SE1
Bargero, G; Biggeri, A; Bruno, G; Cavallo-Perin, P; Ferrero, S; Merletti, F; Pagano, G1
Cases, A1
Best, LG; Howard, BV; Lee, ET; Maccluer, JW; North, KE; Palmieri, V; Tracy, RP1
Oliveira, GH1
Bergeron, J; Corneau, L; Lemieux, S; Nadeau, A; Piché, ME; Weisnagel, SJ1
de Maat, MP1
Balagopal, P; Bayne, E; George, D; Gidding, S; Patton, N; Roberts, WL; Yarandi, H1
Adamo, EB; Altavilla, D; Bitto, A; Buemi, M; Cancellieri, F; Corrado, F; Crisafulli, A; Cucinotta, D; D'Anna, R; Frisina, N; Marini, H; Marini, R; Romeo, A; Squadrito, F; Squadrito, G1
Bingham, S; Day, NE; Khaw, KT; Luben, RN; Sinha, S; Wareham, NJ; Welch, A1
Cherry, L; Divecha, H; Lowe, GD; Rumley, A; Sattar, N; Sturrock, R1
Benavides Márquez, F; Flor Serra, F; Peña Sendra, E; Rodríguez Cristóbal, JJ; Travé Mercadé, P; Villaverde Grote, C1
Couper, DJ; Hubbard, LD; Klein, BE; Klein, R; Larsen, EK; Mitchell, P; Sharrett, AR; Siscovick, DS; Wong, TY1
Lennon, L; Lowe, GD; Rumley, A; Shaper, AG; Wannamethee, SG; Whincup, PH1
Choumerianou, D; Chrysohoou, C; Dedoussis, GV; Panagiotakos, DB; Pitsavos, C; Skoumas, J; Stefanadis, C1
Ariëns, RA; Dunn, EJ; Grant, PJ1
Farmer, A; Glasziou, P; Neil, A; Wendland, E1
Ijzerman, RG1
Kobus, G; Małyszko, J; Myśyliwiec, M1
Bakhru, A; Erlinger, TP1
Berthier-Schaad, Y; Coresh, J; Fallin, MD; Fink, NE; Klag, MJ; Liu, Y; Smith, MW; Tracy, RP1
Panagiotakos, DB; Papageorgiou, C; Pitsavos, C; Soldatos, C; Stefanadis, C; Tsetsekou, E1
Athyros, VG; Elisaf, M; Mikhailidis, DP1
Fischer, JE; Frey, K; Hanebuth, D; Herrmann-Lingen, C; Kudielka, BM; Preckel, D; von Känel, R1
Pulanić, D; Rudan, I1
D'Agostino, RB; Levy, D; Lipinska, I; Massaro, J; Mittleman, M; Muller, JE; Sutherland, P; Tofler, GH1
Einecke, D1
Coppola, G; Corrado, E; Lo Coco, L; Muratori, I; Novo, S; Tantillo, R; Vitale, G1
Bonura, F; Corrado, E; Muratori, I; Novo, S; Rizzo, M; Tantillo, R; Vitale, G1
Clays, E; De Backer, G; De Bacquer, D; Delanghe, J1
Ameratunga, R; Baldi, JC; French, JK; Hammett, CJ; Prapavessis, H; Schoenbeck, U; Stewart, RA; Varo, N; White, HD2
Barboutis, K; Kirmizis, D; Koutoupa, E; Pangalou, M; Protopappa, M; Rozi, P; Tsiandoulas, A1
Kurl, S; Laaksonen, D; Laukkanen, JA; Niskanen, L; Nyyssönen, K; Salonen, JT; Sivenius, J1
Anandan, CL; Fowkes, FG; Lee, AJ; Lowe, GD; Powell, JT; Rumley, A; Smith, FB; Tzoulaki, I1
Langer, C; Rudack, C; Rust, S; Stoll, W; Walter, M1
Minematsu, K; Nagatsuka, K; Ogata, T; Yamamura, O; Yasaka, M1
Barzilay, JI; Cushman, M; Forsberg, C; Heckbert, SR; Newman, AB1
Fujii, C; Kondo, T; Sakakibara, H; Tamakoshi, K; Toyoshima, H; Yatsuya, H1
Day, IN; Ebrahim, S; Lawlor, DA; Smith, GD; Timpson, N1
Buring, JE; Lee, IM; Mora, S; Ridker, PM1
Festa, A; Haffner, SM; Tracy, RP; Wagenknecht, LE; Williams, K1
Camargo, AL; Gabriel, SB; Hirschhorn, JN; Kathiresan, S; Larson, MG; O'Donnell, CJ; Tofler, GH; Yang, Q1
Smith, GD1
Marie, B; Maumus, S; Siest, G; Vincent-Viry, M; Visvikis-Siest, S1
Boerwinkle, E; Carlson, CS; Carty, CL; Fornage, M; Jaquish, CE; Lewis, CE; Nickerson, DA; Reiner, AP; Rice, K; Rieder, MJ; Siscovick, DS; Smith, JD; Tracy, RP; Wan, JY; Williams, OD1
Cienfuegos, JA; Frühbeck, G; Gil, MJ; Gómez-Ambrosi, J; Pastor, C; Rotellar, F; Salvador, J; Silva, C1
Gullu, S; Gursoy, A; Kamel, N; Ozduman Cin, M1
Franks, PW1
Klein, LC; Rodrigues, IM1
Buring, JE; Mora, S; Ridker, PM; Rifai, N1
Eggebrecht, H; Erbel, R; Fahy, M; Hartmann, M; Louwerenburg, HW; Mintz, GS; Neumann, T; Stoel, MG; van der Palen, J; Verhorst, PM; von Birgelen, C; Wieneke, H1
Abia, R; Bermúdez, B; López, S; Muriana, FJ; Pacheco, YM; Villar, J1
Feher, G; Juricskay, I; Kesmarky, G; Koltai, K; Szapary, L; Toth, K1
Garfunkel, AA1
Bovy, A; Hall, R; Herbers, K; Kleemann, R; Kooistra, T; Rein, D; Schijlen, E; Sonnewald, U; Verschuren, L1
Alkonyi, B; Czopf, L; Feher, G; Kenyeres, P; Kesmarky, G; Koltai, K; Papp, E; Solyom, A; Toth, K1
Cheng, Y; Dunker, AK; LeGall, T; Oldfield, CJ; Uversky, VN1
Aktürk, M; Altinova, AE; Arslan, M; Ayvaz, G; Bukan, N; Cakir, N; Törüner, FB1
Dzekova, P; Gelev, S; Koloska, V; Polenakovic, M; Selim, G; Sikole, A; Stefanovski, K; Stojceva-Taneva, O; Zafirovska, K1
Leichtle, A; Teupser, D; Thiery, J1
Beloqui, O; Montero, I; Orbe, J; Páramo, JA; Rodríguez, JA; Roncal, C1
Beishuizen, ED; Huisman, MV; Misra, A; Ray, A; Tamsma, JT1
Abad, S; Cachofeiro, V; de Vinuesa, SG; Goicoechea, M; Gómez-Campderá, F; Lahera, V; Luño, J; Vega, A1
Bickel, C; Blankenberg, S; Espinola-Klein, C; Lackner, KJ; Lubos, E; Messow, CM; Münzel, T; Rupprecht, HJ; Schnabel, R; Sinning, JM; Tiret, L1
Danesh, J; Lewington, S; Thompson, SG; White, I; Wood, AM1
Ganotakis, ES; Gazi, IF; Jagroop, IA; Mikhailidis, DP; Nair, DR; Papadakis, JA1
Engström, G; Hedblad, B; Janzon, L; Lindgärde, F1
Letonturier, P1
Carrasco, P; Corella, D; Santaolaria, M; Simó, M; Vayá, A1
Hirsch, CH; Jenny, NS; Kuller, LH; Psaty, BM; Tracy, RP; Yanez, ND1
Diez-Roux, AV; Heiss, G; Kaufman, JS; Pollitt, RA; Rose, KM; Zeng, D1
Abrahamsen, B; Bladbjerg, EM; Brixen, K; Christensen, K; de Maat, MP; Jespersen, J; Kristensen, SR; Langdahl, B; Madsen, JS; Rejnmark, L; Tofteng, CL1
Kim, PY; Lipson, SM; Nesheim, ME; Stewart, RJ1
Britton, J; Venn, A1
Ladányi, E; Mácsai, E; Madácsy, L; Széll, J; Treszl, A; Vásárhelyi, B1
Abensur, H; Aveles, P; Barberato, SH; Bignelli, AT; Pecoits-Filho, R1
Cushman, M; Jenny, NS; Katz, R; Psaty, BM; Reiner, AP; Schwartz, SM; Zakai, NA1
Brosnan, JF; Norris, LA; Sheppard, BL1
Caringella, M; Coviello, M; De Pergola, G; Di Roma, P; Giorgino, R; Pannacciulli, N; Quaranta, M; Scarangella, A; Venneri, MT1
Best, J; McDermott, R; O'Dea, K; Rowley, K; Taylor, M; Wang, Z1
Bianchi, C; Caricato, F; Civitelli, A; Del Prato, S; Miccoli, R; Pancani, F; Pellegrini, G; Penno, G; Piaggesi, A1
Abebe, A; Alhassan, S; Grandjean, PW; Mestek, ML; Plaisance, EP; Taylor, JK1
Mahato, B; Muennig, P; Sohler, N1
Peluffo, G; Radi, R1
Kakafika, AI; Liberopoulos, EN; Mikhailidis, DP1
Adamo, EB; Altavilla, D; Atteritano, M; Bitto, A; Bonaiuto, M; Cancellieri, F; Cannata, ML; Corrado, F; D'Anna, R; Frisina, A; Frisina, N; Gaudio, A; Lubrano, C; Marini, H; Mazzaferro, S; Minutoli, L; Polito, F; Squadrito, F1
Stolarska, I; Szamotulska, K; Szostak-Wegierek, D1
Danesh, J; Kaptoge, S; Lewington, S; Lowe, GD; Thompson, SG; White, IR; Wood, AM1
Dean, WL; Lominadze, D; Roberts, AM; Tyagi, N; Tyagi, SC1
Aznaouridis, K; Bratsas, A; Pietri, P; Stefanadi, E; Stefanadis, C; Tousoulis, D; Vasiliadou, C; Vlachopoulos, C; Vyssoulis, G; Xaplanteris, P1
Beauregard, C; Potter, BJ; Serri, O1
Carter, AM; Cymbalista, CM; Grant, PJ; Spector, TD1
Davis, J; Davison, G; Duly, E; Murphy, M; Nevill, A; Trinick, T1
Asselin, G; Cunnane, SC; Dodin, S; Forest, JC; Jacques, H; Lamarche, B; Légaré, F; Lemay, A; Marc, I; Mâsse, B; Tremblay-Mercier, J1
Haidar, A; Saad, F; Shabsigh, R; Yassin, A1
Broman, KW; Fallin, MD; Jee, SH; Mathias, RA; Roy-Gagnon, MH; Wilson, AF1
Ozgen, AG; Saraç, F; Tüzün, M; Yilmaz, C1
Pieters, M; Vorster, HH1
MEYERS, L1
Araneta, MR; Lindsay, SP; Macera, CA; Marshall, SJ; Reis, JP; Wingard, DL1
Barzilay, JI; Chaves, PH; Domitrovich, PP; Gottdiener, JS; Heckbert, SR; Stein, PK; Traber, J1
Bibbins-Domingo, K; Ix, JH; Lin, F; Shlipak, MG; Whooley, MA1
Buryachkovskaya, LI; Kadinskaya, MI; Khaspekova, SG; Mazurov, AV; Shvartsman, AL; Sirotkina, OV; Sivachenko, EB; Taraskina, AE; Uchitel', IA; Vavilova, TV; Zabotina, AM; Zueva, EE1
Albert, MA1
Carlson, CS; Carty, CL; Cushman, M; Durda, JP; Hindorff, LA; Jenny, NS; Jones, D; Lange, LA; Nickerson, D; Reiner, AP; Rice, K; Tracy, RP; Walston, J1
Doggen, CJ; Rosendaal, FR; van der Bom, JG; van der Krabben, MD1
Arbel, Y; Berliner, S; Justo, D; Rogowski, O; Shapira, I; Steinvil, A1
Borazan, A; Demircan, N; Ilikhan, S; Kadayifci, S; Kuvandik, G; Ozer, C; Pocan, B; Tekin, IO; Ucar, E1
Suarez, EC1
Kumari, M; Lowe, G; Power, C; Rumley, A; Strachan, DP; Tabassum, F1
Bertolini, L; Day, CP; Franchini, M; Lippi, G; Muggeo, M; Rodella, S; Targher, G; Zoppini, G1
Lowe, G; Rumley, A; Welsh, P; Woodward, M1
Eriksen, BO; Jenssen, T; Kronborg, J; Njølstad, I; Solbu, M; Toft, I1
Elsayed, EF; Griffith, JL; Levey, AS; Salem, DN; Sarnak, MJ; Tighiouart, H; Weiner, DE1
Demmer, RT; Desvarieux, M; Jacobs, DR; Kocher, T; Schwahn, C; Völzke, H1
Dyr, JE; Vorlová, Z1
Pourrat, JP; Rumeau, M1
Chakrabarti, R; Mann, JI; Meade, TW; Simpson, HC; Stirling, Y; Woolf, L1
Fuller, JH1
Amiral, J; Fareed, J; Walenga, JM1
Atanasov, K; Dzhurdzhev, A1
Cucuianu, MP; Missits, I; Olinic, N; Roman, S1
den Ottolander, GJ; Jonker, JJ1
Caimi, G; Catania, A; Francavilla, G; La Bruzzo, S; Romano, A; Sarno, A1
Ferrari, S; Galetta, F; Giannasi, G1
Breimer, L1
Cappucci, G; Celentano, E; Di Minno, G; Fusilli, S; Giordano, M; Grandone, E; Grilli, M; Margaglione, M; Simone, P; Vecchione, G1
Foley, A; Khaw, KT; Meade, TW; Plummer, M; Woodhouse, PR1
Weitz, J1
Bulpitt, CJ1
Eri, LM; Urdal, P1
Brown, JH; McNamee, PT; Murphy, BG; Yong, A1
Assmann, G; Heinrich, J1
Basdevant, A; Conard, J; Degrelle, H; Denis, C; Guyene, TT; Ochsenbein, E; Thomas, JL1
Evans, MC; Grey, AB; Reid, IR; Stapleton, JP1
McCarty, MF2
Bozzoli, C; D'Atena, T; Legnani, C; Massarelli, G; Mazzuca, A; Miniero, R; Muscari, A; Palareti, G; Puddu, GM; Toscano, V1
Fogari, R; Marasi, G; Vanasia, A; Villa, G; Zoppi, A1
Argimón, JM; Castells, A; Domenech, P; Espínola, A; Fiol, C; Pintó, X; Val, A1
Bjønnes, CH; Borch-Iohnsen, B; Bugge, KH; Neslein, IL; Oshaug, A1
Gariepy, J; Giral, P; Levenson, J; Razavian, M; Simon, A1
Bovill, EG; Fried, LP; Heiss, G; Lee, M; Polak, JF; Psaty, BM; Savage, PJ; Tracy, RP; Yanez, D1
Lip, GY1
Khaw, KT; Woodhouse, P1
Hospers, J; Laterveer, R; Nieuwenhuizen, W; van Poppel, G1
Humphries, SE1
Folsom, AR1
Mannucci, PM1
Ernst, E; Resch, KL3
Nieuwenhuizen, W1
Fowkes, FG1
Bosch, JG; Reiber, JH; Rosendaal, FR; Sosef, MN; van Oostayen, J; Visser, T1
Meade, TW3
Bovill, EG; Cornell, ES; Cushman, M; Howard, PR; Tracy, RP1
Barnard, HC; Jerling, JC; Kruger, A; Oosthuizen, W; Silvis, N; Smuts, CM; Venter, CS; Vorster, HH1
Ross-Murphy, SB; Scrutton, MC1
Ekstrum, JK; Folsom, AR; Johnson, KM; Lando, HA; McGovern, PG; Solberg, LI1
Agewall, S; Fagerberg, B; Suurküla, M; Tengborn, L; Wikstrand, J1
Bonithon-Kopp, C; Guillanneuf, MT; Guize, L; Kirzin, JM; Levenson, J; Malmejac, A; Scarabin, PY1
Kendall, MJ; Rajman, I1
Barker, DJ; Martyn, CN1
Chappell, RJ; Feyzi, JM; Love, RR; Newcomb, PA; Wiebe, DA1
de la Serna, G1
Ells, K; Fowkes, FG; Horrobin, DF; Leng, GC; Lowe, GD; Morse-Fisher, N; Smith, FB1
Hafner, JM; Rosenson, RS; Tangney, CC1
Dotevall, A; Johansson, S; Wilhelmsen, L1
Avellone, G; Bompiani, G; Cordova, R; De Simone, R; Di Garbo, V; Raneli, G1
Collet, JP; Mirshahi, SS; Soria, C; Soria, J; Vannier, JP; Vasse, M1
Judkiewicz, L1
Ernst, E12
Duguid, JK; Hay, CR; Jenkins, JA; Maggs, PB; Rugman, FP1
Avellone, G; Bompiani, G; Cordova, R; Cucinella, G; De Simone, R; Di Garbo, V; Raneli, G1
Calabrese, S; Cattin, L; Da Col, PG; Fiotti, N; Giansante, C1
Bartoli, E; Ceriello, A; Falleti, E; Giacomello, R; Gonano, F; Lizzio, S; Motz, E; Pirisi, M; Stel, G1
Barker, DJ3
Cambus, JP; Corberand, JX; Fillola, G; Laharrague, PF1
Angelico, F; Giampaoli, S; Menotti, A; Morisi, G; Sotis, G; Urbinati, G1
Ubachs, HM; van der Salm, P; van Wersch, JW1
Dubrey, SW; Ireland, H; Lane, DA; Leslie, RD; Noble, MI; O'Connor, B; O'Donnell, M; Reaveley, DR; Seed, M1
Cigolini, M; de Sandre, G; Muggeo, M; Seidell, JC; Targher, G1
Glueck, CJ; Glueck, HI; Speirs, J; Stroop, D; Tracy, T1
Anand, A1
Davis, CE; Folsom, AR; Shahar, E; Wu, KK1
Machin, SJ; Mackie, IJ1
Flack, JM; Folsom, AR; Hilner, JE; Howard, BV; Liu, K; Qamhieh, HT; Tracy, RP1
Bartoli, E; Ceriello, A; De Stasio, G; Falleti, E; Giacomello, R; Gonano, F; Lizzio, S; Motz, E; Taboga, C1
Asplund, K; Dahlén, GH; Johnson, O; Slunga, L1
Barker, DJ; Fall, CH1
Baeza, J; Cocho, P; Sanchez-Bayle, M; Vila, S1
Astedt, B; Lecander, I; Lindoff, C; Martinsson, G; Petersson, F1
Berg, JE; Hovi, K; Høstmark, AT; Lystad, E; Vellar, OD1
Bao, W; Berenson, GS; Srinivasan, SR1
Petch, MC1
Baele, G; Braeckman, L; De Backer, G; De Bacquer, D; De Boever, E; Rosseneu, M1
Gillies, S; Goubet, S; Gould, MM; Haines, AP; Mohamed-Ali, V; Yudkin, JS1
Barrett-Connor, E; Bodin-Dunn, L; Greendale, GA; Haile, R; Ingles, S1
Asada, R; Kario, K; Kobayashi, H; Matsuo, M; Matsuo, T1
Castiglioni, C; Criqui, M; Longoni, A; Violi, F1
Aoshima, K; Asakura, H; Hashimoto, T; Jokaji, H; Kumabashiri, I; Matsuda, T; Morishita, E; Saito, M; Uotani, C; Yamazaki, M1
Cushman, M; Fried, LP; Heiss, G; Lee, M; Polak, JF; Psaty, BM; Savage, PJ; Tracy, RP; Yanez, D1
Ando, R; Chida, Y; Doi, M; Ida, T; Marumo, F; Nakamura, Y; Ootsuka, S; Shinoda, T; Tomura, S; Tsuchiya, S; Yanagi, H1
Chin, K; Kita, H; Kuno, K; Mishima, M; Noguchi, T; Ohi, M; Otsuka, N; Tsuboi, T1
McCormick, A; Rosenson, RS; Uretz, EF1
Belanger, AJ; D'Agostino, RB; Kannel, WB; Sibershatz, H; Tofler, GT1
Rosito, GB; Tofler, GH1
Burchfiel, CM; Curb, JD; Fujimoto, W; Huang, B; Lu, GY; Rodriguez, BL; Sharp, DS; Yano, K1
Biesenbach, G; Zazgornik, J1
Cremer, P; Kienast, J; Nagel, D; Seidel, D; van de Loo, JC1
Blümchen, G; Brestrich, M; Claus, J1
Juhan-Vage, I1
Ishizaki, M; Nakagawa, H; Noborisaka, Y; Tabata, M; Tsuritani, I; Yamada, Y1
Fowkes, FG; Housley, E; Lee, AJ; Lowe, GD; Riemersma, RA1
Allikmets, K; Parik, T; Teesalu, R1
Abbate, R; Gensini, GF; Micheli, S; Prisco, D1
Fagerström, KO; Lundgren, H; Nilsson, P; Nilsson-Ehle, P; Söderström, M1
Braeckman, L; De Backer, G; De Bacquer, D; Rosseneu, M1
Feskens, EJ; Kalmijn, S; Kromhout, D; Launer, LJ1
Aznar, J; Dalmau, J; Labios, M; Martínez, M; Vayá, A1
Brandis, S; Caneti, M; Creter, D; Ferrara, M; Goldbourt, U; Hart, J; Katz, M; Marom, R; Rudnicki, C; Salman, H; Yaari, S; Zahavi, I1
Green, FR; Irish, AB1
Levy, D; Lipinska, I; Matheney, TH; Mittleman, MA; Muller, JE; Sutherland, PA; Tofler, GH; Welty, FK; Wilson, PW1
Carreras, LO; Colorio, CC; Falcón, CR1
LaCava, J; Pearson, TA; Weil, HF1
Barry, P; FitzGerald, GA1
Breimer, LH; Ganotakis, ES; Mikhailidis, DP1
Bild, D; Fried, L; Mittelmark, M; O'Leary, DH; Rutan, G; Siscovick, DS1
Chan, JC; Chow, CC; Cockram, CS; Ko, GT; Li, JK; So, WY; Tsang, LW; Yeung, VT1
Fuller, JH; Goodfellow, K; Greaves, M; Malia, RG; Mattock, M; Stephenson, JM; Stevens, LK1
Carmassi, F; De Negri, F; Morale, M1
Barker, DJ; Bolla, M; Fall, C; Henry, JA; Humphries, SE; Osmond, C1
Dinesen, B; Eliasson, M; Evrin, PE; Lindahl, B; Røder, ME1
Deckert, T; Gram, J; Jensen, T; Jespersen, J; Kluft, C; Myrup, B1
Carter, AM; Grant, PJ; Ossei-Gerning, N; Wilson, IJ1
Bell, WR1
Kannel, WB2
Boberg, M; Kilander, L; Lithell, H; Nyman, H1
Fischer, HG; Fröhlich, M; Hoffmeister, A; Hombach, V; Koenig, W; Russ, S; Sund, M1
Jäger, K; Labs, KH; Marbet, GA; Tsakiris, DA; Tschopl, M1
Luque Martín, JS; Mérida de la Torre, FJ; Morell Ocaña, M; Ortiz García, C; Rojano Martín, JC; Sánchez Luque, JJ1
Eckfeldt, JH; Evans, GW; Folsom, AR; Pankow, JS; Province, MA; Williams, RR1
Ernst, E; Koenig, W1
Bots, ML; de Jong, PT; de Maat, MP; Grobbee, DE; Haverkate, F; Hofman, A; Kluft, C; van der Bom, JG1
Irish, A1
Leeder, SR; Mitchell, P; Smith, W; Wang, JJ1
Artigao, LM; Divisón, JA; García Gosálvez, F; López Abril, J; Naharro, F; Puras, A; Rodríguez Paños, B; Sanchís, C1
Arveiler, D; Curran, JM; Evans, A; Green, FR; Humphries, SE; Luc, G; Ruidavets, JB1
Rosenson, RS; Tangney, CC1
Kronenberg, F1
Aw, TC; Choo, M; Hughes, K; Kuperan, P; Ong, CN1
Blair, SN; Blix, G; Haddock, BL; Hopp, HP; Mason, JJ1
Alexander, KC; Badenhorst, PN; Coetzee, MJ; van Wyk, V1
Berg, K1
Sjögren, B1
Carmellini, M; Coppelli, A; Di Cianni, G; Giannarelli, R; Innocenti, M; Lencioni, C; Lorenzetti, M; Marchetti, P; Marselli, L; Mosca, F; Navalesi, R; Paleologo, G; Rindi, P; Rizzo, G1
Humphries, SE; Montgomery, HE; Sumeray, MS1
de Leiva, A1
Assmann, G; Erren, M; Heinrich, J; Junker, R; Schulte, H1
Aillaud, MF; Amouyel, P; Arveiler, D; Evans, A; Ferrières, J; Juhan-Vague, I; Luc, G; Scarabin, PY1
Mosca, LJ; Rosenson, RS; Tangney, CC1
Kario, K1
Helminen, A; Rankinen, T; Rauramaa, R; Väisänen, S1
Chinchilli, VM; Costa, LA; Demers, LM; Harvey, HA; Kopreski, MS; Lipton, A; Santen, RJ1
Herrlinger, S; Metzger, T; Pruy, A; Wanner, C; Zimmermann, J1
Andersen, LF; Gram, J; Jespersen, J; Skouby, SO1
Abendroth, D; Hepp, KD; Land, W; Landgraf, R; Mellinghoff, AC; Reininger, AJ1
Jensen-Urstad, K; Jensen-Urstad, M; Johansson, J1
Yudkin, JS1
Balkau, B; Cacès, E; Eschwège, E; Mennen, LI; Vol, S1
Byrne, DJ; Ganotakis, ES; Jagroop, IA; Mikhailidis, DP; Spyropoulos, KA; Winder, AF1
Donati, MB; Iacoviello, L1
Binz, JG; Brown, HR; Gaskill, BA; Lancaster, ME; Lenhard, JM; Lightfoot, RM; Paulik, MA; Sundseth, SS; Weiel, JE1
Titus, K1
Anwaar, I; Gottsäter, A; Lind, P; Lindgärde, F; Mattiasson, I1
Vinokur, VA1
Arnold, AM; Ettinger, W; Fried, L; Meilahn, E; Savage, P; Tracy, RP1
Mercer, JB; Osterud, B; Tveita, T1
Blöndal, T; Franzon, M; Gudmundsson, TV; Lúdvíksdóttir, D; Säwe, U1
Cadarso, C; de la Serna, G1
Biro, A; Boaz, M; Fainaru, M; Green, M; Katzir, Z; Matas, Z; Smetana, S1
Harjai, KJ1
Giuseppe, P; Luigi, D; Pia, CM; Salvatore, S; Sarina, C; Signorelli, SS1
Halvorsen, S1
Agher, R; Amiral, J; Bourgeat, P; Guize, L; Kirzin, JM; Scarabin, PY; Vissac, AM1
Vorster, HH2
Coppola, L; Cozzolino, D; De Lucia, D; Gentile, S; Masi, S; Salvatore, T; Sasso, FC; Torella, R1
Adshead, FJ; Carey, IM; Cook, DG; Howarth, D; Miller, G; Papacosta, O; Walker, M; Whincup, PH1
Burnett, L; Cumming, RG; Goodrich, ME; Koutts, J; Mitchell, P1
Björkander, I; Forslund, L; Håkan Wallén, N; Held, C; Hjemdahl, P; Rehnqvist, N; Wiman, B1
Rauramaa, R; Väisänen, SB1
Anderssen, T; Brox, J; Eliassen, LT; Elvevoll, EO; Engstad, CS; Halvorsen, H; Høgmo, P; Kvernmo, H; Lia, K; Lund, T; Olsen, JO; Olsen, RL; Osterud, B; Vognild, E1
Dorn, JP; Falkner, KL; Genco, RJ; Sempos, CT; Trevisan, M; Wu, T1
Blix, G; Haddock, BL; Marshak, HP; Mason, JJ1
Agius, RM; Cohen, GR; Elton, RA; Fowkes, FG; Lee, AJ; Lee, RJ; Prescott, GJ1
Byzova, TV; Plow, EF1
Agerholm-Larsen, L; Astrup, A; Hansen, AS; Haulrik, N; Manders, M; Raben, A1
Dominiczak, MH2
Bønaa, KH; Hansen, JB; Nilsen, H; Nordøy, A; Sandset, PM1
Law, CM; Lucas, A; Morley, R1
Berglund, L; Deckelbaum, R; Isasi, CR; Shea, S; Starc, TJ; Tracy, RP1
Alessi, MC; Gourmelin, Y; Gouvernet, J; Grimaux, M; Juhan-Vague, I; Morange, PE; Renucci, JF1
Bengtsson, BA1
De Geus, EJ; Houtman, IL; Riese, H; Van Doornen, LJ1
Bell, DS1
D'Agostino, RB; Lipinska, I; Massaro, JM; Matheney, TH; Muller, JE; Silbershatz, H; Stec, JJ; Sutherland, P; Tofler, GH; Wilson, PF1
Catena, C; De Marchi, S; Sechi, LA; Zingaro, L1
de Maat, MP; Kluft, C; Pijl, H; Princen, HM1
Cushman, M; Lewis, MR; Sakkinen, PA; Tracy, RP; Wahl, P1
Shamsuzzaman, AS; Somers, VK1
Bush, AJ; Gross, MD; Kritchevsky, SB; Pahor, M1
Darko, D; Kirk, G; McLaren, M; Sands, RH; Seed, M1
Ishida, M; Komori, K; Kume, M; Matsumoto, T; Ohta, S; Onohara, T; Sugimachi, K; Takeuchi, K1
Hedley, AJ; Janus, ED; Lam, KS; Lam, TH; Liu, LJ1
Buckley, L; Costantino, JP; Cushman, M; Krag, DN; Roberts, JD; Song, K; Tracy, RP1
Burke, GL; Cushman, M; Geffken, DF; Polak, JF; Sakkinen, PA; Tracy, RP1
Gupta, HL; Jain, A; Narayan, S1
Eriksson, KF; Hedblad, B; Janzon, L; Lind, P; Lindgärde, F; Stavenow, L1
Li, W; Steiner, M1
Atkinson, RW; Cappuccio, FP; Chitolie, A; Cook, DG; Humphries, SE; Nakandakare, ER; Sagnella, GA; Wicks, PD1
Bonaduce, D; Colao, A; Cuocolo, A; di Somma, C; Lombardi, G; Pivonello, R; Salvatore, M; Spinelli, L; Tedesco, N1
Pallaud, C; Sass, C; Siest, G; Visvikis, S; Zannad, F2
Su, CT1
Castillo, O; Cuevas, A; Leighton, F; Marshall, G; Martínez, C; Mezzano, D; Mizón, C; Muñoz, B; Panes, O; Pereira, J; Pérez, DD; Rozowski, J; San Martín, A1
Capell, HA; Creran, D; Lowe, GD; McEntegart, A; Rumley, A; Woodward, M1
Schwartz, J1
Geiss, HC; Parhofer, KG; Schwandt, P1
D'Agostino, RB; Feng, D; Larson, MG; Levy, D; Lindpaintner, K; Lipinska, I; Mittleman, M; Muller, JE; O'Donnell, CJ; Sutherland, PA; Tofler, GH1
McMillan, D; Sattar, N1
Böke, E; Erbaş, T; Güvener, M; Güvener, N; Paşaoğlu, I; Tütüncü, NB; Tütüncü, T; Yilmaz, M1
Broekmans, WM; Klöpping-Ketelaars, WA; Kluft, C; Kok, FJ; van den Berg, H; van Poppel, G1
Halonen, P; Kareinen, A; Laakso, M; Lehto, S; Viitanen, L1
Eliasson, B; Hjalmarson, A; Kruse, E; Landfeldt, B1
Montgomery, HE1
Bryman, I; Landin-Wilhelmsen, K; Wilhelmsen, L1
Bobak, M; Fobker, M; Hense, HW; Junker, R; Kuch, B; Marmot, M; von Eckardstein, A1
Bell, CR; Jagroop, IA; Khan, MA; Mikhailidis, DP; Miller, MA; Morgan, RJ; Sullivan, ME; Thompson, CS1
Mosca, L; Rosenson, RS; Staffileno, BA; Tangney, CC1
Colas, JL; Montalescot, G; Tribouilloy, C1
Benedetta Donati, M; Iacoviello, L; Vischetti, M; Zito, F1
Genovese, S; Parillo, M; Rivellese, AA1
Brzósko, S; Hryszko, T; Małyszko, J; Małyszko, JS; Myśliwiec, M1
Kruger, HS; Venter, CS; Vorster, HH1
Golec, DB1
Basanova, AV; Baskova, IP; Zavalova, LL1
Brun, JF; Dumortier, M; Mercier, J; Pérez-Martin, A; Pierrisnard, E; Raynaud, E1
Rossouw, JE1
Byrne, DJ; Jagroop, IA; Mikhailidis, DP; Milton, NG; Montgomery, HE; Thomas, M; Winder, AF1
Brandenburg, SL; Felder, KK; Lindenfeld, J; Manco-Johnson, M; Nelson-Wong, E; Regensteiner, JG; Reusch, JE1
Ascari, E; Ferrari, R; Galeazzi, G; Portera, C; Raddino, R; Sarasso, L; Scarabelli, TM; Visioli, O1
King, DE; Mainous, AG; Pearson, W; Steyer, TE1
Bratt, G; Bylund, H; Koppel, K; Sandström, E; Schulman, S1
Lewandrowski, EL; Lewandrowski, KB; Lipinska, I; McDonald, JC; Mendelson, JH; Ridker, PM; Sholar, MB; Siegel, AJ; Tofler, GH1
D'Souza, SE; Tsakadze, NL; Zhao, Z1
Byrne, DJ; Ginsburg, J; Jagroop, IA; Kwong, P; Mikhailidis, DP; Prelevic, GM1
Di Napoli, M; Papa, F1
Dintenfass, L; Lake, B1
Dintenfass, L; Zador, I1
Andersen, P1
Cajthamlová, H; Dyr, JE; Fortová, H; Suttnar, J1
Adewuyi, JO; Mufunda, J; Sigola, LB1
Kiss, JE; Kuller, LH; Matthews, KA; Meilahn, EN1
Belanger, AJ; D'Agostino, RB; Kannel, WB1
Conlan, MG; Davis, CE; Folsom, AR; Wu, KK1
Bovill, EG; Fried, LP; Heiss, G; Lee, MH; Polak, JF; Psaty, BM; Savage, PJ; Tracy, RP1
Dotevall, A; Eriksson, H; Rosengren, A; Welin, L; Wilhelmsen, L1
Ellis, D; Orchard, TJ; Stuhldreher, WL1
Haaland, A; Nordby, G; Os, I1
Davies, JA; Hughes, R; Johnston, D; Prentice, CR; Primrose, JN1
Bovill, EG; Tracy, RP1
Miller, GJ1
Meilahn, EN1
Ernst, E; Matrai, A; Paulsen, HF; Resch, KL1
Betteridge, DJ; Jay, RH; Rampling, MW1
Barker, DJ; Meade, TW; Osmond, C1
Anadere, I; Walitza, E; Witte, S1
Crawford, V; Stout, RW1
Cooper, J; Howarth, DJ; Meade, TW; Miller, GJ; Stirling, Y1
Bossini, S; Maffetti, G; Tani, M1
Conlan, MG; Davis, CE; Folsom, AR; Sorlie, PD; Szklo, M; Wu, KK1
Hollnagel, H; Kristensen, TS; Møller, L1
Brown, AJ; Roberts, DC1
Jespersen, J; Kristensen, TS; Møller, LF1
Hultin, MB1
Hawiger, J1
Eliasson, M; Hägg, E; Lundblad, D1
Armani, U; Cella, A; Del Nero, E; Gastaldi, S; Piana, A1
Miles, LA; Plow, EF1
Landin, K; Smith, U; Tengborn, L1
Cook, NS; Ubben, D1
Rosengren, A; Teger-Nilsson, AC; Tsipogianni, A; Wedel, H; Welin, L; Wilhelmsen, L1
Bjerkedal, T; Flaten, H; Høstmark, AT; Kierulf, P; Lystad, E; Osland, A; Trygg, K1
Belanger, AJ; D'Agostino, RB; Gagnon, DR; Kannel, WB; Wilson, PW1
Finch, A; Folsom, AR; Iso, H; Komachi, Y; Munger, RG; Sato, S; Shimamoto, T; Terao, A; Wu, KK1
Bruckert, E; Caen, JC; Carvalho Sousa, J; Soria, C; Soria, J; Tobelem, G1
Craveri, A; di Bella, M; Paganardi, L; Ranieri, R; Tornaghi, G1
Borch-Johnsen, K; Deckert, T; Jensen, T; Valdorf-Hansen, F1
Haines, AP; Imeson, JD; Meade, TW1
Castelli, WP; D'Agostino, RB; Kannel, WB; Wolf, PA1
Acca, MR; Balestrieri, AA; Cambuli, AB; Mameli, G; Mamusa, AM; Marassi, PP; Marongiu, F; Mulas, G; Tronci, MB1
Cornell, CJ; Edwards, RL; Forcier, RJ; Forman, WB; Headley, E; Henderson, WG; Moritz, TE; O'Donnell, JF; Rickles, FR; Zacharski, LR1
Seviour, PW1
Ernst, E; Matrai, A1
Chakrabarti, R; Evans, JF; Fearnley, GR1
Davis, HL; Davis, NL1
Kuller, L1
Dintenfass, L; Forbes, CD; Milton, GW; Stewart, JH1
Baillet, J; Baillet, M; Blanc, J; Jaulmes, B; Maurice, P; Terrier, E; Zaky, Y1
Kushner, S1
Ivannikov, MN; Pavlov, IuA; Radzivil, GG; Solov'ev, GM1
Baklaja-Jevremović, R; Bosnjaković, V; Dordević, BS; Nastić, D1
Pinkus, SSh1
Kennedy, JH1

Reviews

142 review(s) available for fibrinogen and Cardiovascular Diseases

ArticleYear
Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice.
    Cardiovascular research, 2023, 03-17, Volume: 119, Issue:1

    Topics: Brain Ischemia; Cardiovascular Diseases; Fibrin; Fibrinogen; Humans; Hypertension; Prospective Studies; Stroke; Thrombosis

2023
Effects of Transdermal 17β-Estradiol + Norethisterone Acetate on Cardiovascular Disease Risk Factors in Postmenopausal Women: A Meta-analysis of Data From Randomized, Controlled Trials.
    Clinical therapeutics, 2023, Volume: 45, Issue:11

    Topics: Administration, Cutaneous; Blood Glucose; Body Weight; Cardiovascular Diseases; Cholesterol, LDL; Estradiol; Factor VII; Female; Fibrinogen; Heart Disease Risk Factors; Humans; Insulin; Lipoprotein(a); Norethindrone Acetate; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors

2023
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
The role of exogenous Fibrinogen in cardiac surgery: stop bleeding or induce cardiovascular disease.
    Molecular biology reports, 2020, Volume: 47, Issue:10

    Topics: Blood Loss, Surgical; Cardiac Surgical Procedures; Cardiovascular Diseases; Fibrinogen; Humans; Postoperative Complications

2020
Associations between the effort-reward imbalance model of workplace stress and indices of cardiovascular health: A systematic review and meta-analysis.
    Neuroscience and biobehavioral reviews, 2017, Volume: 83

    Topics: Blood Pressure; Cardiovascular Diseases; Carotid Intima-Media Thickness; Fibrinogen; Heart Rate; Humans; Occupational Stress; Reward

2017
Pathophysiological significance of protein hydrophobic interactions: An emerging hypothesis.
    Medical hypotheses, 2018, Volume: 110

    Topics: Animals; Arthritis; Cardiovascular Diseases; Diabetes Mellitus; Fibrin; Fibrinogen; Fibrinolysis; Humans; Hydrophobic and Hydrophilic Interactions; Kidney Diseases; Lung Diseases; Models, Biological; Neoplasms; Nervous System Diseases; Polymerization; Protein Interaction Domains and Motifs; Serum Albumin, Human; Solubility; Thrombosis

2018
Childhood socioeconomic status and inflammation: A systematic review and meta-analysis.
    Brain, behavior, and immunity, 2019, Volume: 78

    Topics: Adolescent; Adult; Adverse Childhood Experiences; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Child; Chronic Disease; Female; Fibrinogen; Humans; Income; Inflammation; Interleukin-6; Longitudinal Studies; Male; Risk Factors; Social Class; Socioeconomic Factors; Stress, Psychological

2019
Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease.
    Circulation, 2013, Sep-17, Volume: 128, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Black People; Cardiovascular Diseases; Coronary Artery Disease; Female; Fibrinogen; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Hispanic or Latino; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Factors; Stroke; Venous Thromboembolism; White People; Young Adult

2013
Clot properties and cardiovascular disease.
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:5

    Topics: Arterial Occlusive Diseases; Blood Coagulation; Cardiovascular Agents; Cardiovascular Diseases; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Porosity; Venous Thrombosis

2014
Critical appraisal of inflammatory markers in cardiovascular risk stratification.
    Critical reviews in clinical laboratory sciences, 2014, Volume: 51, Issue:5

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Growth Differentiation Factor 15; Humans; Inflammation

2014
The relevance of coagulation in cardiovascular disease: what do the biomarkers tell us?
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:5

    Topics: Biomarkers; Blood Coagulation; Blood Coagulation Factors; Blood Proteins; Cardiovascular Diseases; Fibrinogen; Humans; Inflammation; Platelet Activation; Prospective Studies; Risk Factors

2014
Pharmacologic androgen deprivation and cardiovascular disease risk factors: a systematic review.
    European journal of clinical investigation, 2015, Volume: 45, Issue:5

    Topics: Adiposity; Androgen Antagonists; Antineoplastic Agents, Hormonal; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Dyslipidemias; Fibrinogen; Humans; Hypertension; Insulin Resistance; Male; Prostatic Neoplasms; Risk Factors; Triglycerides

2015
Fibrinolytic Actinokinase--A Short Review.
    Cardiovascular & hematological agents in medicinal chemistry, 2015, Volume: 13, Issue:2

    Topics: Actinomyces; Cardiovascular Diseases; Fibrinogen; Fibrinolysis; Humans; Streptokinase

2015
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.
    Cardiovascular diabetology, 2017, 03-09, Volume: 16, Issue:1

    Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Thrombosis

2017
Inflammatory factors, physical activity, and physical fitness in young people.
    Scandinavian journal of medicine & science in sports, 2008, Volume: 18, Issue:5

    Topics: Adolescent; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Child; Child, Preschool; Chronic Disease; Energy Metabolism; Exercise; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Motor Activity; Obesity; Oxygen Consumption; Physical Fitness; Young Adult

2008
Hypercoagulable states in cardiovascular disease.
    Circulation, 2008, Nov-25, Volume: 118, Issue:22

    Topics: Blood Coagulation Factors; Cardiovascular Diseases; Disease Susceptibility; Fibrinogen; Fibrinolysis; Humans; Polymorphism, Single Nucleotide; Prothrombin; Risk Factors; Thromboembolism; Thrombophilia; Thromboplastin; Thrombosis

2008
Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease.
    Acta physiologica (Oxford, England), 2010, Volume: 198, Issue:1

    Topics: Animals; Blood Viscosity; Cardiovascular Diseases; Erythrocyte Aggregation; Fibrinogen; Humans; Microcirculation

2010
The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.
    Advances in clinical pathology : the official journal of Adriatic Society of Pathology, 2003, Volume: 7, Issue:1

    Topics: Biomarkers; Cardiovascular Diseases; Epidemiologic Studies; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Oxidative Stress; Risk Factors; Seroepidemiologic Studies

2003
The causal relationship between passive smoking and inflammation on the development of cardiovascular disease: a review of the evidence.
    Inflammation & allergy drug targets, 2009, Volume: 8, Issue:5

    Topics: Animals; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Inflammation; Nicotiana; Oxidative Stress; Risk Factors; Thrombosis; Tobacco Smoke Pollution

2009
Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts.
    Circulation. Cardiovascular genetics, 2009, Volume: 2, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Genetic Loci; Genome-Wide Association Study; Humans; Male; Middle Aged; Pedigree; Polymorphism, Single Nucleotide; White People; Young Adult

2009
Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics.
    Biodemography and social biology, 2009, Volume: 55, Issue:2

    Topics: Biomarkers; Biometry; C-Reactive Protein; Cardiovascular Diseases; Cardiovascular System; Endothelium, Vascular; Fibrinogen; Humans; Income; Inflammation; Interleukin-6; Michigan; Oxidative Stress; Risk Factors; Social Class; Stress, Psychological; Tissue Adhesions; United States

2009
Fibrinogen and the risk of thrombosis.
    Seminars in thrombosis and hemostasis, 2010, Volume: 36, Issue:1

    Topics: Atherosclerosis; Cardiovascular Diseases; Fibrinogen; Genome-Wide Association Study; Humans; Polymorphism, Genetic; Risk; Thromboembolism; Thrombosis

2010
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis.
    BMC ophthalmology, 2010, Dec-13, Volume: 10

    Topics: Aging; Cardiovascular Diseases; Cataract Extraction; Diabetes Complications; Evidence-Based Medicine; Eye Color; Fibrinogen; Genetic Predisposition to Disease; Humans; Macular Degeneration; Obesity; Odds Ratio; Racial Groups; Risk; Risk Factors; Sex Factors; Smoking

2010
Childhood adversity and immune and inflammatory biomarkers associated with cardiovascular risk in youth: a systematic review.
    Brain, behavior, and immunity, 2012, Volume: 26, Issue:2

    Topics: Adolescent; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Child; Child, Preschool; Cytokines; Fibrinogen; Humans; Immunity; Inflammation; Killer Cells, Natural; Life Change Events; Risk Factors; Stress, Psychological

2012
Erythrocyte as a link between basic and clinical research.
    Clinical hemorheology and microcirculation, 2011, Volume: 49, Issue:1-4

    Topics: Cardiovascular Diseases; Cross-Sectional Studies; Erythrocyte Aggregation; Female; Fibrinogen; Glaucoma; Hematology; Humans; Hypercholesterolemia; Hypertension, Pregnancy-Induced; Kidney Diseases; Longitudinal Studies; Male; Multicenter Studies as Topic; Nitric Oxide; Pregnancy; Research

2011
Fibrinogen and future cardiovascular disease in people with diabetes: aetiological associations and risk prediction using individual participant data from nine community-based prospective cohort studies.
    Diabetes & vascular disease research, 2013, Volume: 10, Issue:2

    Topics: Adult; Aged; Area Under Curve; Cardiovascular Diseases; Cause of Death; Cohort Studies; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; United Kingdom

2013
Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.
    Annals of medicine, 2013, Volume: 45, Issue:3

    Topics: Adiponectin; Aging; Airway Remodeling; Biomarkers; C-Reactive Protein; Cachexia; Cardiovascular Diseases; CD40 Ligand; Chemokines, CC; Cytokines; Desmosine; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Isodesmosine; Lung Neoplasms; Matrix Metalloproteinases; Natriuretic Peptide, Brain; Osteoprotegerin; Pulmonary Disease, Chronic Obstructive; Pulmonary Surfactant-Associated Protein D; Serum Amyloid A Protein; Severity of Illness Index; Telomere; Uteroglobin

2013
Obesity, haemostasis and the fibrinolytic system.
    Obesity reviews : an official journal of the International Association for the Study of Obesity, 2002, Volume: 3, Issue:2

    Topics: Blood Coagulation Factors; Body Constitution; Cardiovascular Diseases; Factor VII; Factor VIII; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin Resistance; Obesity; Plasminogen Activator Inhibitor 1; von Willebrand Factor; Weight Loss

2002
[Prevention of cardiovascular risk in renal transplantation. Consensus document].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2002, Volume: 22 Suppl 4

    Topics: Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Diabetes Complications; Diet; Exercise; Fibrinogen; Homocysteine; Humans; Kidney Transplantation; Obesity; Risk Factors; Smoking

2002
[Fibrinogen: factor and marker of cardiovascular risk].
    Journal des maladies vasculaires, 2002, Volume: 27, Issue:3

    Topics: Alternative Splicing; Amino Acid Sequence; Biomarkers; Cardiovascular Diseases; Fibrinogen; Hemorrhage; Humans; Inflammation; Risk Factors; Sequence Alignment; Thrombosis

2002
[Fibrinogen: cardiovascular risk factor].
    Investigacion clinica, 2002, Volume: 43, Issue:4

    Topics: Arteriosclerosis; Cardiovascular Diseases; Fibrinogen; Humans; Risk Factors; Thrombosis

2002
Novel biomedical risk markers for cardiovascular disease.
    Journal of cardiovascular risk, 2003, Volume: 10, Issue:1

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cell Adhesion Molecules; Fibrinogen; Homocysteine; Humans; Interleukin-6; Natriuretic Peptide, Brain; Risk Factors; von Willebrand Factor

2003
Pro-fibrogenic effects of magnesium deficiency in the cardiovascular system.
    Magnesium research, 2002, Volume: 15, Issue:3-4

    Topics: Cardiomyopathies; Cardiovascular Diseases; Cardiovascular System; Fibrinogen; Humans; Magnesium Deficiency

2002
Fibrin(ogen) in cardiovascular disease: an update.
    Thrombosis and haemostasis, 2003, Volume: 89, Issue:4

    Topics: Cardiovascular Diseases; Cell Division; Female; Fibrinogen; Genotype; Humans; Male; Models, Biological; Odds Ratio; Protein Binding; Risk Factors

2003
Inflammation, the metabolic syndrome and cardiovascular risk.
    International journal of clinical practice. Supplement, 2003, Issue:134

    Topics: Arteriosclerosis; Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Estrogens; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Metabolic Syndrome; Risk Factors

2003
[Recent progress in the "fibrinogen hypothesis"].
    Revue medicale de Bruxelles, 2003, Volume: 24, Issue:2

    Topics: Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Diabetes Complications; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Peripheral Vascular Diseases; Risk Factors

2003
Fibrinolytic function and atrial fibrillation.
    Thrombosis research, 2003, Mar-15, Volume: 109, Issue:5-6

    Topics: Atrial Fibrillation; Cardiovascular Diseases; Disease Susceptibility; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Insulin Resistance; Matrix Metalloproteinases; Plasminogen; Plasminogen Activator Inhibitor 1; Stroke; Thromboembolism; Tissue Plasminogen Activator

2003
Fibrinogen: biochemistry, epidemiology and determinants.
    QJM : monthly journal of the Association of Physicians, 2003, Volume: 96, Issue:10

    Topics: Adult; Aged; Alcohol Drinking; Cardiovascular Diseases; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Risk Factors; Sex Distribution; Smoking

2003
Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review.
    Annals of internal medicine, 2003, Oct-21, Volume: 139, Issue:8

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Fibrinogen; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Plasminogen Inactivators; Platelet Aggregation; Tissue Plasminogen Activator

2003
Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease.
    Chest, 2003, Volume: 124, Issue:5

    Topics: Blood Platelets; Cardiovascular Diseases; Continuous Positive Airway Pressure; Fibrinogen; Hemostasis; Humans; Risk Factors; Sleep Apnea, Obstructive; Thrombophilia

2003
[Inflammation markers in daily practice].
    Nephrologie, 2003, Volume: 24, Issue:7

    Topics: Biomarkers; Blood Sedimentation; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Cardiovascular Diseases; Decision Trees; Fibrinogen; Glycoproteins; Humans; Inflammation; Kidney Failure, Chronic; Protein Precursors; Renal Dialysis

2003
Is there a need for novel cardiovascular risk factors?
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:4

    Topics: Albuminuria; Apolipoproteins A; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Risk Assessment

2004
Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease.
    European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 2004, Volume: 11, Issue:1

    Topics: Biomarkers; Cardiovascular Diseases; Cooperative Behavior; Data Interpretation, Statistical; Fibrinogen; Humans; Meta-Analysis as Topic; Prospective Studies

2004
Pathophysiologic roles of the fibrinogen gamma chain.
    Current opinion in hematology, 2004, Volume: 11, Issue:3

    Topics: Animals; Blood Coagulation; Cardiovascular Diseases; Fibrin; Fibrinogen; Fibrinolysis; Fibroblast Growth Factor 2; Humans; Integrins; Protein Binding

2004
Obstructive sleep apnea and cardiovascular disease.
    Mayo Clinic proceedings, 2004, Volume: 79, Issue:8

    Topics: Arousal; Arrhythmias, Cardiac; Arteriosclerosis; C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; Fatigue; Fibrinogen; Heart Failure; Humans; Hypertension; Hypertension, Pulmonary; Interleukin-6; Ischemic Attack, Transient; Oxyhemoglobins; Plasminogen Inactivators; Platelet Aggregation; Polysomnography; Prevalence; Risk Factors; Severity of Illness Index; Sleep Apnea, Obstructive; Stroke

2004
Smokeless tobacco and cardiovascular risk.
    Archives of internal medicine, 2004, Sep-27, Volume: 164, Issue:17

    Topics: Blood Pressure; Cardiovascular Diseases; Fibrinogen; Humans; Lipoproteins; Male; Middle Aged; Platelet Activation; Risk Factors; Tobacco, Smokeless

2004
Heart and mind: (1) relationship between cardiovascular and psychiatric conditions.
    Postgraduate medical journal, 2004, Volume: 80, Issue:950

    Topics: Acute Disease; Anxiety; Arrhythmias, Cardiac; Blood Platelet Disorders; Cardiovascular Diseases; Chronic Disease; Fibrinogen; Humans; Mental Disorders; Neurosecretory Systems; Stress, Psychological

2004
Plasma fibrinogen.
    Annals of clinical biochemistry, 2004, Volume: 41, Issue:Pt 6

    Topics: Biomarkers; Blood Coagulation; Blood Coagulation Tests; Cardiovascular Diseases; Coronary Disease; Fibrinogen; Humans; Immunoassay

2004
[New cardiovascular risk factors and chronic kidney disease. Hypertrophy of the left ventricle. Atrial fibrillation. Smoking. Obesity. Emerging cardiovascular risk factors: homocysteine, Reactive C protein. Fibrinogen].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2004, Volume: 24 Suppl, Issue:6

    Topics: Atrial Fibrillation; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Obesity; Risk Factors; Smoking

2004
Novel serologic markers of cardiovascular risk.
    Current atherosclerosis reports, 2005, Volume: 7, Issue:2

    Topics: Antioxidants; Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; Cytokines; Drug Resistance; Fibrinogen; Homocysteine; Humans; Platelet Aggregation Inhibitors; Risk Factors; Survival Rate

2005
Effect of alpha linolenic acid on cardiovascular risk markers: a systematic review.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:2

    Topics: alpha-Linolenic Acid; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Cholesterol; Dietary Supplements; Fibrinogen; Humans; Risk Factors; Triglycerides

2006
The past decade: fibrinogen.
    Collegium antropologicum, 2005, Volume: 29, Issue:1

    Topics: Afibrinogenemia; Cardiovascular Diseases; Fibrinogen; Hemostasis; Humans; Platelet Aggregation; Wound Healing

2005
Boiled or filtered coffee? Effects of coffee and caffeine on cholesterol, fibrinogen and C-reactive protein.
    Toxicological reviews, 2006, Volume: 25, Issue:1

    Topics: Biomarkers; C-Reactive Protein; Caffeine; Cardiovascular Diseases; Cholesterol; Coffee; Fibrinogen; Humans; Risk

2006
Biochemistry of protein tyrosine nitration in cardiovascular pathology.
    Cardiovascular research, 2007, Jul-15, Volume: 75, Issue:2

    Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Fibrinogen; Humans; Nitric Oxide; Nitrosation; Signal Transduction; Superoxide Dismutase; Tyrosine

2007
Fibrinogen: a predictor of vascular disease.
    Current pharmaceutical design, 2007, Volume: 13, Issue:16

    Topics: Biomarkers; Blood Coagulation; Cardiovascular Agents; Cardiovascular Diseases; Fibrinogen; Humans; Risk Assessment; Risk Factors; Up-Regulation

2007
Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collab
    American journal of epidemiology, 2007, Oct-15, Volume: 166, Issue:8

    Topics: Adult; Age Factors; Biomarkers; Black or African American; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Humans; Linear Models; Male; Prospective Studies; Risk Factors; Sex Factors; Smoking; Social Class; United States

2007
Nutrition and hemostasis: a focus on urbanization in South Africa.
    Molecular nutrition & food research, 2008, Volume: 52, Issue:1

    Topics: Black People; Cardiovascular Diseases; Diet; Dietary Fats; Dietary Proteins; Fibrin; Fibrinogen; Hemostasis; Humans; Nutritional Physiological Phenomena; Plasminogen Activator Inhibitor 1; Rural Population; South Africa; Stroke; Urbanization

2008
Inflammatory biomarkers, race/ethnicity and cardiovascular disease.
    Nutrition reviews, 2007, Volume: 65, Issue:12 Pt 2

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Ethnicity; Fibrinogen; Homocysteine; Humans; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1

2007
The haemocoagulation system and macroangiopathy in insulin dependent (type I) diabetes.
    Annals of clinical research, 1984, Volume: 16, Issue:3

    Topics: Antithrombin III; Arachidonic Acids; beta-Thromboglobulin; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Platelet Adhesiveness; Platelet Aggregation

1984
[Nonenzymatic fibrinolysis].
    Vutreshni bolesti, 1981, Volume: 20, Issue:3

    Topics: Animals; Blood Coagulation; Blood Proteins; Cardiovascular Diseases; Factor XIII; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemostasis; Heparin; Humans; Hydrolysis; Plasminogen; Thrombosis

1981
[Use of radioisotopes for the diagnosis of thromboembolic disorders].
    Nederlands tijdschrift voor geneeskunde, 1980, Aug-23, Volume: 124, Issue:34

    Topics: Blood Platelets; Cardiovascular Diseases; Cell Survival; Fibrinogen; Humans; Iodine Radioisotopes; Pulmonary Embolism; Radionuclide Imaging; Technetium; Thromboembolism; Thrombophlebitis

1980
[Fibrinogen as a cardiovascular risk factor].
    Minerva cardioangiologica, 1995, Volume: 43, Issue:5

    Topics: Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Female; Fibrinogen; Humans; Hypercholesterolemia; Hypertension; Liver; Male; Middle Aged; Risk Factors

1995
New anticoagulant strategies. Current status and future potential.
    Drugs, 1994, Volume: 48, Issue:4

    Topics: Anticoagulants; Cardiovascular Diseases; Fibrinogen; Fibrinolytic Agents; Forecasting; Heparin, Low-Molecular-Weight; Humans; Thrombin

1994
Fibrinogen and cardiovascular risk.
    Journal of cardiovascular risk, 1995, Volume: 2, Issue:3

    Topics: Animals; Cardiovascular Diseases; Female; Fibrinogen; Humans; Incidence; Male; Risk Factors

1995
Fibrinogen and cardiovascular disorders.
    QJM : monthly journal of the Association of Physicians, 1995, Volume: 88, Issue:3

    Topics: Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Female; Fibrinogen; Gonadal Steroid Hormones; Heart Diseases; Humans; Hyperlipidemias; Hypertension; Male; Risk Factors; Smoking

1995
Genetic regulation of fibrinogen.
    European heart journal, 1995, Volume: 16 Suppl A

    Topics: Cardiovascular Diseases; Chromosome Aberrations; Chromosome Mapping; Fibrinogen; Gene Expression Regulation; Humans; Polymorphism, Genetic; Smoking

1995
Epidemiology of fibrinogen.
    European heart journal, 1995, Volume: 16 Suppl A

    Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Female; Fibrinogen; Humans; Life Style; Male; Middle Aged; Risk Factors; Sex Factors; Smoking

1995
Recent progress in the pathophysiology of fibrinogen.
    European heart journal, 1995, Volume: 16 Suppl A

    Topics: Arteriosclerosis; Cardiovascular Diseases; Cross-Cultural Comparison; Fibrinogen; Genetic Markers; Genotype; Humans; Life Style; Reference Values; Risk Factors; Smoking

1995
Therapeutic interventions to lower plasma fibrinogen concentration.
    European heart journal, 1995, Volume: 16 Suppl A

    Topics: Cardiovascular Diseases; Combined Modality Therapy; Fibrinogen; Humans; Risk Factors

1995
Recent progress in the clinical aspects of fibrinogen.
    European heart journal, 1995, Volume: 16 Suppl A

    Topics: Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Cerebral Infarction; Clinical Trials as Topic; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors

1995
Biochemistry and measurement of fibrinogen.
    European heart journal, 1995, Volume: 16 Suppl A

    Topics: Cardiovascular Diseases; Chemical Precipitation; Coronary Disease; Fibrinogen; Humans; Immunoassay; Molecular Weight; Reference Values; Whole Blood Coagulation Time

1995
Fibrinogen and cardiovascular disease in clinical practice.
    European heart journal, 1995, Volume: 16 Suppl A

    Topics: Arteriosclerosis; Cardiovascular Diseases; Coronary Disease; Fibrinogen; Humans; Lipoproteins; Myocardial Infarction; Prospective Studies; Reference Values; Risk Factors

1995
Haemostatic function, arterial disease and the prevention of arterial thrombosis.
    Bailliere's clinical haematology, 1994, Volume: 7, Issue:3

    Topics: Adult; Aged; Anticoagulants; Arteries; Aspirin; Blood Coagulation Factors; Cardiovascular Diseases; Case-Control Studies; Clinical Trials as Topic; Factor VII; Factor VIII; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemophilia A; Hemostasis; Humans; Male; Middle Aged; Models, Biological; Models, Cardiovascular; Prospective Studies; Regression Analysis; Risk Factors; Thrombosis

1994
A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease.
    Drug safety, 1994, Volume: 10, Issue:3

    Topics: Adrenergic beta-Antagonists; Carbohydrate Metabolism; Cardiovascular Diseases; Celiprolol; Drug Tolerance; Fibrinogen; Heart; Humans; Kidney; Respiratory System; Risk Factors

1994
Fibrinogen: a new major risk factor for cardiovascular disease. A review of the literature.
    The Journal of family practice, 1994, Volume: 39, Issue:5

    Topics: Adult; Aged; Cardiovascular Agents; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Europe; Female; Fibrinogen; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; United States

1994
Intraindividual variability of fibrinogen levels and cardiovascular risk profile.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1994, Volume: 14, Issue:12

    Topics: Adult; Blood Specimen Collection; Cardiovascular Diseases; Female; Fibrinogen; Humans; Logistic Models; Male; Middle Aged; Myocardial Ischemia; Reproducibility of Results; Risk Factors

1994
[Role of fibrinogen in cardiovascular diseases].
    Acta haematologica Polonica, 1994, Volume: 25, Issue:2 Suppl 2

    Topics: Cardiovascular Diseases; Fibrinogen; Humans; Myocardial Ischemia; Risk Factors

1994
Fibrinogen: its emerging role as a cardiovascular risk factor.
    Angiology, 1994, Volume: 45, Issue:2

    Topics: Adult; Aged; Arterial Occlusive Diseases; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Smoking

1994
Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation.
    European heart journal, 1993, Volume: 14 Suppl K

    Topics: Acute-Phase Reaction; Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Infections; Inflammation; Male; Middle Aged; Prospective Studies; Risk Factors

1993
Maternal nutrition and cardiovascular disease.
    Nutrition and health, 1993, Volume: 9, Issue:2

    Topics: Aged; Birth Weight; Blood Pressure; Body Mass Index; Body Weight; Cardiovascular Diseases; Embryonic and Fetal Development; England; Female; Fibrinogen; Follow-Up Studies; Glucose Tolerance Test; Growth; Humans; Infant, Newborn; Male; Middle Aged; Nutritional Physiological Phenomena; Organ Size; Placenta; Poverty; Pregnancy; Risk Factors; Wales

1993
Fibrinogen: an important risk factor for atherothrombotic diseases.
    Annals of medicine, 1994, Volume: 26, Issue:1

    Topics: Arteriosclerosis; Cardiovascular Diseases; Cross-Sectional Studies; Fibrinogen; Humans; Risk Factors

1994
The intrauterine origins of cardiovascular disease.
    Acta paediatrica (Oslo, Norway : 1992). Supplement, 1993, Volume: 82 Suppl 391

    Topics: Adult; Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fetal Growth Retardation; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Infant, Newborn; Insulin; Insulin Resistance; Lipids; Male; Maternal Welfare; Middle Aged; Nutritional Physiological Phenomena

1993
The role of fibrinogen as a cardiovascular risk factor.
    Atherosclerosis, 1993, Volume: 100, Issue:1

    Topics: Arteriosclerosis; Cardiovascular Diseases; Fibrinogen; Humans; Risk Factors; Thrombosis

1993
Fetal and infant origins of cardiovascular disease.
    Archives of disease in childhood, 1993, Volume: 68, Issue:6

    Topics: Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Female; Fetal Growth Retardation; Fibrinogen; Humans; Hypertension; Infant; Infant, Newborn; Infant, Small for Gestational Age; Male; Pregnancy; Risk Factors; Time Factors

1993
Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature.
    Annals of internal medicine, 1993, Jun-15, Volume: 118, Issue:12

    Topics: Cardiovascular Diseases; Causality; Fibrinogen; Humans; Prospective Studies; Risk Factors

1993
Hemostatic factors as triggers of cardiovascular events.
    Cardiology clinics, 1996, Volume: 14, Issue:2

    Topics: Blood Platelets; Cardiovascular Diseases; Circadian Rhythm; Coronary Disease; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Risk Factors

1996
Haemorheological consequences of chronic cigarette smoking.
    Journal of cardiovascular risk, 1995, Volume: 2, Issue:5

    Topics: Arteriosclerosis; Blood Viscosity; Cardiovascular Diseases; Erythrocyte Deformability; Fibrinogen; Hematocrit; Humans; Leukocyte Count; Rheology; Risk Factors; Smoking

1995
Haemostatic parameters and vascular risk.
    Atherosclerosis, 1996, Volume: 124 Suppl

    Topics: Alleles; Animals; Cardiovascular Diseases; Factor VII; Fibrinogen; Hemostasis; Humans; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Risk Factors

1996
Menopause and risk of cardiovascular disease.
    Thrombosis research, 1996, Oct-01, Volume: 84, Issue:1

    Topics: Adult; Aged; Animals; Antioxidants; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Cohort Studies; Coronary Artery Disease; Diet; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Follow-Up Studies; Glucose; Hemostasis; Homocysteine; Humans; Incidence; Lipid Metabolism; Menopause; Middle Aged; Ovary; Risk; Risk Factors; Vitamins

1996
[Role of fibrinogen in arterial vascular pathology].
    Sangre, 1997, Volume: 42, Issue:1

    Topics: Adult; Arteriosclerosis; Blood Viscosity; Cardiovascular Diseases; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Obesity; Platelet Aggregation; Prospective Studies; Risk Factors; Sex Factors; Smoking; Thrombosis

1997
Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease.
    The American journal of clinical nutrition, 1997, Volume: 65, Issue:5 Suppl

    Topics: Blood Coagulation; Cardiovascular Diseases; Factor VII; Factor VIII; Fibrinogen; Hemostasis; Humans; Incidence; Lipoprotein(a); Plasminogen; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Risk Factors; Thrombosis; Tissue Plasminogen Activator

1997
Dietary factors in thrombosis and hemostasis: summary and conclusions.
    The American journal of clinical nutrition, 1997, Volume: 65, Issue:5 Suppl

    Topics: Animals; Cardiovascular Diseases; Cholesterol; Diet; Dietary Fats; Disease Models, Animal; Fibrinogen; Hemostasis; Humans; Incidence; Lipids; Platelet Activation; Thrombosis

1997
Fibrinogen as a cardiovascular risk factor.
    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 1997, Volume: 16, Issue:3

    Topics: Cardiovascular Diseases; Fibrinogen; Humans; Risk Factors

1997
Fibrin(ogen) and diabetes mellitus: don't forget fibrinolysis.
    Diabetologia, 1997, Volume: 40, Issue:6

    Topics: Arteriosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; Fibrin; Fibrinogen; Fibrinolysis; Humans; Plasminogen Activator Inhibitor 1; Risk Factors

1997
Defibrinogenating enzymes.
    Drugs, 1997, Volume: 54 Suppl 3

    Topics: Ancrod; Animals; Batroxobin; Blood Coagulation; Cardiovascular Diseases; Cerebrovascular Disorders; Fibrinogen; Fibrinolytic Agents; Humans; Serine Endopeptidases; Snakes

1997
Influence of fibrinogen on cardiovascular disease.
    Drugs, 1997, Volume: 54 Suppl 3

    Topics: Cardiovascular Diseases; Female; Fibrinogen; Humans; Incidence; Male; Risk Factors

1997
Fibrinogen and cardiovascular risk.
    Vascular medicine (London, England), 1997, Volume: 2, Issue:2

    Topics: Arterial Occlusive Diseases; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Fibrinogen; Humans; Myocardial Ischemia; Peripheral Vascular Diseases; Reference Values; Risk Factors

1997
Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.
    JAMA, 1998, May-27, Volume: 279, Issue:20

    Topics: Animals; Antithrombins; Cardiovascular Diseases; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Endothelium, Vascular; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Inflammation; Lovastatin; Muscle, Smooth, Vascular; Platelet Aggregation; Pravastatin; Simvastatin; Thromboplastin; Thrombosis

1998
Homocysteine, lipoprotein(a) and fibrinogen: metabolic risk factors for cardiovascular complications of chronic renal disease.
    Current opinion in nephrology and hypertension, 1998, Volume: 7, Issue:3

    Topics: Arteriosclerosis; Cardiovascular Diseases; Chronic Disease; Fibrinogen; Folic Acid; Homocysteine; Humans; Kidney Diseases; Lipoprotein(a); Risk Factors

1998
[Molecular biology in the diagnosis of cardiovascular diseases].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1998, Jun-10, Volume: 118, Issue:15

    Topics: Biomarkers; Cardiovascular Diseases; DNA Mutational Analysis; Fibrinogen; Genetic Variation; Homocysteine; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Molecular Biology; Polymorphism, Genetic; Risk Factors

1998
Beyond coagulation: fibrinogen as a cause of cardiovascular surgical disease.
    Cardiovascular drugs and therapy, 1998, Volume: 12, Issue:3

    Topics: Blood Coagulation Disorders; Cardiovascular Diseases; Fibrinogen; Genotype; Humans; Risk Factors

1998
What are the benefits of moderate weight loss?
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1998, Volume: 106 Suppl 2

    Topics: Body Constitution; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet, Reducing; Female; Fibrinogen; Gastric Bypass; Humans; Hypertension; Insulin; Male; Morbidity; Obesity; Quality of Life; Risk Factors; Weight Loss

1998
[Hyperfibrinogenemia].
    Ryoikibetsu shokogun shirizu, 1998, Issue:22 Pt 3

    Topics: Acute-Phase Proteins; Arteriosclerosis; Cardiovascular Diseases; Cerebral Infarction; Fibrinogen; Humans; Polymorphism, Genetic; Promoter Regions, Genetic; Reference Values; Risk Factors

1998
Clinical benefit of fibrinogen evaluation.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1999, Volume: 10 Suppl 1

    Topics: Biomarkers; Cardiovascular Diseases; Fibrinogen; Humans; Risk Factors

1999
Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?
    Diabetes care, 1999, Volume: 22 Suppl 3

    Topics: Blood Coagulation Disorders; Cardiovascular Diseases; Fibrinogen; Fibrinolysis; Humans; Insulin Resistance; Risk Factors; von Willebrand Factor

1999
Gene-environment interactions: implications for cardiovascular disease.
    Cardiologia (Rome, Italy), 1999, Volume: 44, Issue:3

    Topics: Cardiovascular Diseases; Environment; Factor VII; Female; Fibrinogen; Genetic Variation; Genotype; Hemostasis; Humans; Male; Myocardial Infarction; Polymorphism, Genetic; Risk Factors

1999
A panorama of cardiac risk.
    CAP today, 1999, Volume: 13, Issue:2

    Topics: Adult; Aged; Amyloid; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Prospective Studies; Research; Retrospective Studies; Risk Factors; Time Factors; Triglycerides; Vitamin E

1999
[Psychogenic factors and psychosomatic role of hyperfibrinogenemia].
    Terapevticheskii arkhiv, 1999, Volume: 71, Issue:4

    Topics: Animals; Biomarkers; Blood Coagulation Disorders; Cardiovascular Diseases; Fibrinogen; Humans; Psychology; Risk Factors

1999
Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen.
    Annals of internal medicine, 1999, Sep-07, Volume: 131, Issue:5

    Topics: Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Hypertriglyceridemia; Hypertrophy, Left Ventricular; Lipoprotein(a); Oxidative Stress; Risk Factors; Triglycerides

1999
[Fibrinogen as a cardiovascular risk factor--marker or causal factor?].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1999, Aug-20, Volume: 119, Issue:19

    Topics: Adult; Arteriosclerosis; Biomarkers; Blood Viscosity; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors

1999
Fibrinogen and women's health.
    Thrombosis research, 1999, Aug-15, Volume: 95, Issue:4

    Topics: Cardiovascular Diseases; Contraceptives, Oral; Female; Fibrinogen; Hormone Replacement Therapy; Humans; Risk Factors; Sex Characteristics; Structure-Activity Relationship

1999
Epidemiological evidence for inflammation in cardiovascular disease.
    Thrombosis and haemostasis, 1999, Volume: 82, Issue:2

    Topics: C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Humans; Inflammation

1999
Interaction of physical activity and diet: implications for haemostatic factors.
    Public health nutrition, 1999, Volume: 2, Issue:3A

    Topics: Blood Platelets; Cardiovascular Diseases; Diet; Dietary Carbohydrates; Dietary Fats; Exercise; Fibrinogen; Hemostasis; Humans; Lipoproteins; Randomized Controlled Trials as Topic

1999
The effect of hormone replacement therapy and exercise on cardiovascular disease risk factors in postmenopausal women.
    Sports medicine (Auckland, N.Z.), 2000, Volume: 29, Issue:1

    Topics: Aged; Cardiovascular Diseases; Exercise; Female; Fibrinogen; Hormone Replacement Therapy; Humans; Lipids; Middle Aged; Postmenopause; Risk Factors

2000
Hyperlipidaemia and cardiovascular disease.
    Current opinion in lipidology, 2000, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Cardiovascular Diseases; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Obesity; Risk Factors

2000
Fibrinogen, stroke, and obstructive sleep apnea: an evolving paradigm of cardiovascular risk.
    American journal of respiratory and critical care medicine, 2000, Volume: 162, Issue:6

    Topics: Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Risk Factors; Sex Characteristics; Sleep Apnea, Obstructive; Stroke

2000
Genetic variation and the response to exercise.
    World review of nutrition and dietetics, 2001, Volume: 89

    Topics: Bone and Bones; Bone Density; Cardiovascular Diseases; Exercise; Fibrinogen; Genetic Variation; Heart Ventricles; Humans; Muscle, Skeletal; Phenotype; Physical Endurance; Physical Fitness

2001
Genes encoding fibrinogen and cardiovascular risk.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:5

    Topics: Cardiovascular Diseases; Environment; Fibrinogen; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic; Risk Factors

2001
Fibrinogen-fibrin system regulators from bloodsuckers.
    Biochemistry. Biokhimiia, 2002, Volume: 67, Issue:1

    Topics: Animals; Cardiovascular Diseases; Chiroptera; Factor XIIIa; Fibrin; Fibrinogen; Fibrinolysis; Humans; Leeches; Temperature; Thrombin; Time Factors

2002
Hormones, genetic factors, and gender differences in cardiovascular disease.
    Cardiovascular research, 2002, Feb-15, Volume: 53, Issue:3

    Topics: Age of Onset; Aged; Blood Coagulation Factors; Cardiovascular Diseases; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Polymorphism, Genetic; Risk Factors; Sex

2002
[Clinical implications of rheology in cardiovascular diseases].
    Recenti progressi in medicina, 2002, Volume: 93, Issue:3

    Topics: Adult; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cerebrovascular Disorders; Child; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Leukemia; Leukocytes; Malaria; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Thrombosis

2002
Interactions of intercellular adhesion molecule-1 with fibrinogen.
    Trends in cardiovascular medicine, 2002, Volume: 12, Issue:3

    Topics: Animals; Cardiovascular Diseases; Endothelium, Vascular; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Models, Molecular; Phosphorylation; Protein Binding; Signal Transduction

2002
The emergence of cardiovascular disease during urbanisation of Africans.
    Public health nutrition, 2002, Volume: 5, Issue:1A

    Topics: Black or African American; Black People; Cardiovascular Diseases; Cholesterol; Diet; Female; Fibrinogen; Health Transition; Humans; Hypertension; Male; Myocardial Ischemia; Risk Factors; Rural Population; Sex Factors; Smoking; South Africa; Stroke; Urban Population; Urbanization

2002
Hypercoagulability and reduced fibrinolysis in hyperlipidemia: relationship to the metabolic cardiovascular syndrome.
    Journal of cardiovascular pharmacology, 1992, Volume: 20 Suppl 8

    Topics: Blood Coagulation; Cardiovascular Diseases; Cholesterol; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Lipoproteins, LDL; Metabolic Diseases; Plasminogen Inactivators; Syndrome

1992
[Fibrinogen as an independent risk factor of cardiovascular disease].
    Lakartidningen, 1992, Aug-19, Volume: 89, Issue:34

    Topics: Cardiovascular Diseases; Fibrinogen; Humans; Risk Factors

1992
The effect of nutrition of the fetus and neonate on cardiovascular disease in adult life.
    The Proceedings of the Nutrition Society, 1992, Volume: 51, Issue:2

    Topics: Aged; Animals; Birth Weight; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Female; Fetus; Fibrinogen; Glucose; Humans; Infant; Infant Nutritional Physiological Phenomena; Male; Middle Aged; Mortality; Placenta

1992
Thrombosis and cardiovascular risk in the elderly.
    Archives of pathology & laboratory medicine, 1992, Volume: 116, Issue:12

    Topics: Age Factors; Aged; Aging; Cardiovascular Diseases; Factor VII; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Risk Factors; Thrombosis

1992
Hemostasis and cardiovascular risk. The British and European experience.
    Archives of pathology & laboratory medicine, 1992, Volume: 116, Issue:12

    Topics: Cardiovascular Diseases; Europe; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Male; Risk Factors; United Kingdom

1992
Hemostatic factors and risk of cardiovascular disease in women. An overview.
    Archives of pathology & laboratory medicine, 1992, Volume: 116, Issue:12

    Topics: Cardiovascular Diseases; Female; Fibrinogen; Gonadal Steroid Hormones; Hemostasis; Humans; Male; Risk Factors; Sex Factors

1992
Oral contraceptives, fibrinogen and cardiovascular risk.
    Atherosclerosis, 1992, Volume: 93, Issue:1-2

    Topics: Cardiovascular Diseases; Contraceptives, Oral; Female; Fibrinogen; Humans; Risk Factors

1992
[Fibrinogen: a "new" cardiovascular risk factor].
    Wiener medizinische Wochenschrift (1946), 1991, Volume: 141, Issue:17

    Topics: Austria; Cardiovascular Diseases; Fibrinogen; Humans; Prospective Studies; Risk Factors

1991
[Fibrinogen and factor VII levels in patients under estrogen-progestin therapy].
    Minerva ginecologica, 1991, Volume: 43, Issue:11

    Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Cardiovascular Diseases; Estrogens; Factor VII; Female; Fibrinogen; Humans; Progestins

1991
[Plasma fibrinogen and cardiovascular disease].
    Ugeskrift for laeger, 1991, Aug-19, Volume: 153, Issue:34

    Topics: Cardiovascular Diseases; Fibrinogen; Humans; Risk Factors

1991
Fibrinogen and factor VII as risk factors in vascular disease.
    Progress in hemostasis and thrombosis, 1991, Volume: 10

    Topics: Adult; Aged; Animals; Cardiovascular Diseases; Cerebrovascular Disorders; Cohort Studies; Cross-Sectional Studies; Epidemiologic Methods; Europe; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Thromboplastin; Triglycerides; United States

1991
Adhesive interactions of platelets and their blockade.
    Annals of the New York Academy of Sciences, 1991, Volume: 614

    Topics: Amino Acid Sequence; Blood Platelets; Cardiovascular Diseases; Fibrinogen; Humans; Models, Biological; Molecular Sequence Data; Platelet Adhesiveness; Platelet Membrane Glycoproteins; Thrombosis

1991
Lp(a): an interloper into the fibrinolytic system?
    Thrombosis and haemostasis, 1990, Jun-28, Volume: 63, Issue:3

    Topics: Amino Acid Sequence; Apolipoproteins A; Base Sequence; Binding, Competitive; Blood Proteins; Cardiovascular Diseases; Fibrin; Fibrinogen; Humans; Lectins, C-Type; Lipoprotein(a); Lipoproteins; Lysine; Molecular Sequence Data; Molecular Structure; Plasminogen; Plasminogen Activators; Protein Binding; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator

1990
Plasma fibrinogen--an independent cardiovascular risk factor.
    Journal of internal medicine, 1990, Volume: 227, Issue:6

    Topics: Animals; Blood Viscosity; Cardiovascular Diseases; Fibrinogen; Humans; Risk Factors

1990
Fibrinogen as a major risk factor in cardiovascular disease.
    Trends in pharmacological sciences, 1990, Volume: 11, Issue:11

    Topics: Animals; Cardiovascular Diseases; Fibrinogen; Humans; Platelet Membrane Glycoproteins; Risk Factors

1990
Risks and mechanisms of cardiovascular events in users of oral contraceptives.
    American journal of obstetrics and gynecology, 1988, Volume: 158, Issue:6 Pt 2

    Topics: Antigens; Cardiovascular Diseases; Contraceptives, Oral, Hormonal; Coronary Disease; Dose-Response Relationship, Drug; Estrogens; Factor VII; Female; Fibrinogen; Humans; Male; Progestins; Risk Factors; Thromboembolism

1988
[Blood rheology as a risk indicator in cardiovascular diseases?].
    Deutsche medizinische Wochenschrift (1946), 1985, Jun-14, Volume: 110, Issue:24

    Topics: Blood Sedimentation; Cardiovascular Diseases; Fibrinogen; Hematocrit; Hemoglobins; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Retrospective Studies; Rheology; Risk

1985
The relation of thromboembolic disease to cardiovascular disease.
    The Milbank Memorial Fund quarterly, 1972, Volume: 50, Issue:1

    Topics: Autopsy; Blood Group Antigens; Cardiovascular Diseases; Environment; Fibrinogen; Humans; Iodine Radioisotopes; Myocardial Infarction; Obesity; Posture; Pulmonary Embolism; Stress, Physiological; Thromboembolism; Thrombophlebitis

1972
Circulatory effects of estrogen.
    The Ohio State medical journal, 1970, Volume: 66, Issue:10

    Topics: Adult; Animals; Blood Coagulation Disorders; Blood Platelets; Cardiovascular Diseases; Cardiovascular System; Contraceptives, Oral; Coronary Disease; Dogs; Estrogens; Factor IX; Factor VII; Factor VIII; Factor X; Female; Fibrinogen; Humans; Pregnancy; Rats; Sheep; Thromboembolism; Thrombophlebitis; Veins

1970

Trials

85 trial(s) available for fibrinogen and Cardiovascular Diseases

ArticleYear
Effects of Olive Oil Consumption on Cardiovascular Risk Factors in Patients with Fibromyalgia.
    Nutrients, 2020, Mar-27, Volume: 12, Issue:4

    Topics: Blood Sedimentation; Cardiovascular Diseases; Cytokines; Double-Blind Method; Female; Fibrinogen; Fibromyalgia; Heart Disease Risk Factors; Humans; Hydrocortisone; Lipids; Middle Aged; Olive Oil

2020
The Type and Amount of Dietary Fat Affect Plasma Factor VIIc, Fibrinogen, and PAI-1 in Healthy Individuals and Individuals at High Cardiovascular Disease Risk: 2 Randomized Controlled Trials.
    The Journal of nutrition, 2020, 08-01, Volume: 150, Issue:8

    Topics: Adult; Aged; Cardiovascular Diseases; Diet; Dietary Fats; Factor VII; Female; Fibrinogen; Gene Expression Regulation; Hemostasis; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Young Adult

2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Different Effects of Atorvastatin on Cardiometabolic Risk Factors in Young Women With and Without Hyperprolactinemia.
    Journal of clinical pharmacology, 2019, Volume: 59, Issue:1

    Topics: Adult; Atorvastatin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperprolactinemia; Lipids; Metabolic Diseases; Middle Aged; Prolactin; Risk Factors

2019
Obesity-related increased γ' fibrinogen concentration in children and its reduction by a physical activity-based lifestyle intervention: a randomized controlled study.
    The Journal of pediatrics, 2013, Volume: 163, Issue:2

    Topics: Adiposity; Adolescent; Cardiovascular Diseases; Exercise; Female; Fibrinogen; Humans; Insulin Resistance; Life Style; Male; Motor Activity; Obesity; Risk Factors

2013
Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study.
    Annals of the rheumatic diseases, 2015, Volume: 74, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Aryldialkylphosphatase; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Dyslipidemias; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Group II Phospholipases A2; Humans; Lipoprotein(a); Male; Middle Aged; Pulse Wave Analysis; Receptors, Interleukin-6; Serum Amyloid A Protein; Triglycerides; Ultrasonography

2015
Hydroxychloroquine's Efficacy as an Antiplatelet Agent Study in Healthy Volunteers: A Proof of Concept Study.
    Journal of cardiovascular pharmacology and therapeutics, 2015, Volume: 20, Issue:2

    Topics: Aspirin; Cardiovascular Diseases; Fibrinogen; Healthy Volunteers; Humans; Hydroxychloroquine; Platelet Aggregation; Platelet Aggregation Inhibitors

2015
Improved sleep quality in older adults with insomnia reduces biomarkers of disease risk: pilot results from a randomized controlled comparative efficacy trial.
    Psychoneuroendocrinology, 2015, Volume: 55

    Topics: Aged; Allostasis; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cognitive Behavioral Therapy; Diabetes Mellitus; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Patient Education as Topic; Pilot Projects; Sleep Initiation and Maintenance Disorders; Tai Ji; Treatment Outcome; Triglycerides

2015
Effects of long-term risedronate treatment on serum ferritin levels in postmenopausal women with osteoporosis: the impact of cardiovascular risk factor load.
    Menopause (New York, N.Y.), 2016, Volume: 23, Issue:1

    Topics: Aged; Bone Density Conservation Agents; C-Reactive Protein; Cardiovascular Diseases; Female; Ferritins; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Linear Models; Lipids; Lipoproteins, HDL; Middle Aged; Osteoporosis, Postmenopausal; Osteoprotegerin; Postmenopause; Prospective Studies; Pulse Wave Analysis; Research Design; Risedronic Acid; Risk Factors; Time Factors

2016
Aerobic exercise reduces biomarkers related to cardiovascular risk among cleaners: effects of a worksite intervention RCT.
    International archives of occupational and environmental health, 2016, Volume: 89, Issue:2

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Exercise; Female; Fibrinogen; Health Education; Health Promotion; Household Work; Humans; Male; Middle Aged; Occupational Health; Risk Factors; Triglycerides; Workplace

2016
The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.
    Cardiovascular therapeutics, 2015, Volume: 33, Issue:5

    Topics: Adult; Atorvastatin; Bromocriptine; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet; Dopamine Agonists; Exercise; Female; Fibrinogen; Homocysteine; Humans; Hypercholesterolemia; Hyperprolactinemia; Hypoglycemic Agents; Hypolipidemic Agents; Metformin; Middle Aged; Premenopause; Risk Factors; Uric Acid

2015
Baseline Platelet Activation and Reactivity in Patients with Critical Limb Ischemia.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Case-Control Studies; Collagen; Female; Fibrinogen; Humans; Ischemia; Male; Middle Aged; Peripheral Arterial Disease; Platelet Activation; Risk Factors; Thrombin

2015
The effect of moderate alcohol consumption on biomarkers of inflammation and hemostatic factors in postmenopausal women.
    European journal of clinical nutrition, 2016, Volume: 70, Issue:4

    Topics: Aged; Alcohol Drinking; Antigens; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cross-Over Studies; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Hemostatics; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause

2016
The effects of alcohol on ambulatory blood pressure and other cardiovascular risk factors in type 2 diabetes: a randomized intervention.
    Journal of hypertension, 2016, Volume: 34, Issue:3

    Topics: Aged; Alcohol Drinking; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Heart Rate; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Wine

2016
Bromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial.
    Chinese journal of integrative medicine, 2016, Volume: 22, Issue:10

    Topics: Blood Glucose; Bromelains; C-Reactive Protein; Cardiovascular Diseases; Demography; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Placebos; Risk Factors; Treatment Outcome

2016
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT study.
    Atherosclerosis, 2009, Volume: 204, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Artery Disease; Coronary Thrombosis; Double-Blind Method; Europe; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Inflammation Mediators; Kaplan-Meier Estimate; Perindopril; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha

2009
Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
    European journal of obstetrics, gynecology, and reproductive biology, 2009, Volume: 142, Issue:2

    Topics: Adult; alpha-2-Antiplasmin; Antigens; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Drug Combinations; Dydrogesterone; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Fibrinolysin; Homocysteine; Humans; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Risk Factors; Time Factors; Tissue Plasminogen Activator

2009
Pleiotropic action of short-term metformin and fenofibrate treatment, combined with lifestyle intervention, in type 2 diabetic patients with mixed dyslipidemia.
    Diabetes care, 2009, Volume: 32, Issue:8

    Topics: Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Combined Modality Therapy; Cytokines; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Fenofibrate; Fibrinogen; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Life Style; Metformin; Placebos; Plasminogen Activator Inhibitor 1; Risk Factors

2009
Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen
    Clinics (Sao Paulo, Brazil), 2009, Volume: 64, Issue:5

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Humans; Hypoglycemic Agents; Male; Metabolic Syndrome; Metformin; Middle Aged; Pedigree; Risk Factors; Statistics, Nonparametric

2009
Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
    Archives of gynecology and obstetrics, 2010, Volume: 281, Issue:5

    Topics: Biomarkers; Blood Glucose; C-Reactive Protein; Carbohydrate Metabolism; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Lipid Metabolism; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors

2010
The effect of initial treatment of periodontitis on systemic markers of inflammation and cardiovascular risk: a randomized controlled trial.
    European journal of oral sciences, 2010, Volume: 118, Issue:4

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Chronic Periodontitis; Female; Fibrinogen; Follow-Up Studies; Gingival Hemorrhage; Gingival Recession; Hematocrit; Hemoglobins; Humans; Inflammation Mediators; Lymphocyte Count; Male; Middle Aged; Periodontal Attachment Loss; Periodontal Pocket; Plasminogen Activator Inhibitor 1; Prospective Studies; Risk Factors; Tissue Plasminogen Activator; Treatment Outcome; von Willebrand Factor

2010
Association between γ' fibrinogen levels and inflammation.
    Thrombosis and haemostasis, 2011, Volume: 105, Issue:4

    Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Periodontitis; Risk

2011
Randomised clinical trial of an intensive intervention in the primary care setting of patients with high plasma fibrinogen in the primary prevention of cardiovascular disease.
    BMC research notes, 2012, Mar-01, Volume: 5

    Topics: Adult; Aged; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Diet; Exercise; Female; Fibrinogen; Humans; Hypertension; Life Style; Male; Middle Aged; Obesity; Primary Health Care; Primary Prevention; Risk Factors; Smoking; Smoking Cessation

2012
Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 2013, Volume: 68, Issue:2

    Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Estradiol; Estrone; Fibrinogen; Humans; Interleukin-6; Male; Mobility Limitation; Natriuretic Peptide, Brain; Plasminogen Activator Inhibitor 1; Risk Factors; Testosterone

2013
Impact of exercise training on inflammation and platelet activation in patients with intermittent claudication.
    Swiss medical weekly, 2012, Volume: 142

    Topics: Aged; Aged, 80 and over; Biomarkers; Blood Platelets; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cell Aggregation; Cholesterol, LDL; Exercise Therapy; Female; Fibrinogen; Glycated Hemoglobin; Humans; Inflammation; Interleukin-1; Intermittent Claudication; Male; Middle Aged; Monocytes; P-Selectin; Peptide Fragments; Peripheral Arterial Disease; Prothrombin; Risk Factors; Statistics, Nonparametric; Walking

2012
Effects of 5 % weight loss through diet or diet plus exercise on cardiovascular parameters of obese: a randomized clinical trial.
    European journal of nutrition, 2013, Volume: 52, Issue:5

    Topics: Adult; Body Height; Body Weight; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diet, Reducing; Endothelium; Exercise; Female; Fibrinogen; Humans; Inflammation; Male; Obesity; Risk Factors; Triglycerides; Vasodilation; Weight Loss; Young Adult

2013
A high intake of dietary fiber influences C-reactive protein and fibrinogen, but not glucose and lipid metabolism, in mildly hypercholesterolemic subjects.
    European journal of nutrition, 2014, Volume: 53, Issue:1

    Topics: Adult; Aged; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Dietary Fiber; Female; Fibrinogen; Healthy Volunteers; Humans; Hypercholesterolemia; Lipid Metabolism; Male; Middle Aged; Single-Blind Method

2014
Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology.
    Journal of internal medicine, 2002, Volume: 252, Issue:2

    Topics: Adult; Blood Cell Count; Blood Flow Velocity; Blood Viscosity; Capillaries; Carbon Monoxide; Cardiovascular Diseases; Erythrocyte Deformability; Fibrinogen; Hemorheology; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Oxygen; Risk Factors; Smoking

2002
Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study.
    European journal of clinical nutrition, 2002, Volume: 56, Issue:11

    Topics: Alcohol Drinking; Beer; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cross-Over Studies; Diet; Female; Fibrinogen; Humans; Liver; Male; Middle Aged; Postmenopause; Triglycerides

2002
Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers.
    The American journal of clinical nutrition, 2002, Volume: 76, Issue:6

    Topics: Adult; Cardiovascular Diseases; Cell Adhesion; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Endothelium, Vascular; F2-Isoprostanes; Feces; Female; Fibrinogen; Flow Cytometry; Food Microbiology; Humans; Interleukin-6; Lactobacillus; Lipids; Male; Middle Aged; Monocytes; Placebos; Probiotics; Reactive Oxygen Species; Risk Factors; Smoking

2002
[Effect of molsidomine on rheological parameters and the incidence of cardiovascular events].
    Deutsche medizinische Wochenschrift (1946), 2003, Jun-13, Volume: 128, Issue:24

    Topics: Blood Viscosity; Cardiovascular Diseases; Delayed-Action Preparations; Double-Blind Method; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Humans; Incidence; Leukocytes; Logistic Models; Male; Middle Aged; Molsidomine; Rheology; Survival Analysis; Vasodilator Agents

2003
Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin.
    The Netherlands journal of medicine, 2003, Volume: 61, Issue:4

    Topics: Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Proinsulin; Risk Factors; Time Factors; Triglycerides; von Willebrand Factor

2003
Decrease of hemostatic cardiovascular risk factors by aggressive vs. conventional atorvastatin treatment in patients with Type 2 diabetes mellitus.
    Journal of thrombosis and haemostasis : JTH, 2003, Volume: 1, Issue:8

    Topics: Aged; Atorvastatin; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Factor VIIIa; Female; Fibrinogen; Hemostatics; Heptanoic Acids; Humans; Hyperlipidemias; Male; Middle Aged; Placebos; Pyrroles; Risk Factors; Time Factors; Tissue Plasminogen Activator; von Willebrand Factor

2003
Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
    Contraception, 2003, Volume: 68, Issue:3

    Topics: Adolescent; Adult; Antithrombins; Blood Coagulation; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Factor VII; Factor X; Female; Fibrinogen; Fibrinolysis; Hemoglobins; Humans; Injections; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Partial Thromboplastin Time; Plasminogen; Plasminogen Inactivators; Platelet Count; Protein C; Prothrombin

2003
Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients.
    Transplantation, 2004, Apr-27, Volume: 77, Issue:8

    Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Cyclosporine; Female; Fibrinogen; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Risk Factors; Tacrolimus

2004
Effects of a 12-month physical activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes.
    Diabetologia, 2004, Volume: 47, Issue:5

    Topics: Blood Pressure; Cardiovascular Diseases; Counseling; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Exercise; Fibrinogen; Follow-Up Studies; Humans; Oxygen Consumption; Risk Factors; Time Factors

2004
Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
    Clinical endocrinology, 2004, Volume: 61, Issue:6

    Topics: Aryldialkylphosphatase; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Desogestrel; Drug Administration Schedule; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Insulin; Lipoproteins; Medroxyprogesterone; Middle Aged; Norethindrone; Postmenopause; Progestins; Risk Factors; Statistics, Nonparametric; Triglycerides

2004
Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease.
    European journal of clinical nutrition, 2005, Volume: 59, Issue:3

    Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Ethanol; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Risk Factors; Weight Gain; Wine

2005
Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents.
    The Journal of pediatrics, 2005, Volume: 146, Issue:3

    Topics: Adolescent; Analysis of Variance; Body Mass Index; Body Weight; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diet, Fat-Restricted; Discriminant Analysis; Exercise; Female; Fibrinogen; Humans; Inflammation; Insulin Resistance; Interleukin-6; Life Style; Male; Obesity; Risk Factors; Time Factors

2005
Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women.
    Menopause (New York, N.Y.), 2005, Volume: 12, Issue:2

    Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Double-Blind Method; Estrogen Replacement Therapy; Female; Fibrinogen; Genistein; Glycoproteins; Humans; Insulin; Middle Aged; Osteoprotegerin; Phytoestrogens; Phytotherapy; Postmenopause; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Sex Hormone-Binding Globulin; Treatment Outcome

2005
[Randomised clinical trial of an intensive intervention into life-styles of patients with hyperfibrinogenaemia in primary prevention of cardiovascular pathology in primary health care].
    Atencion primaria, 2005, Mar-31, Volume: 35, Issue:5

    Topics: Adult; Aged; Cardiovascular Diseases; Coagulation Protein Disorders; Female; Fibrinogen; Humans; Life Style; Male; Middle Aged; Primary Health Care; Risk Factors

2005
Inflammatory markers and the metabolic syndrome.
    Atherosclerosis, 2005, Volume: 183, Issue:1

    Topics: Antihypertensive Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Fenofibrate; Fibrinogen; Heptanoic Acids; Humans; Hypolipidemic Agents; Inflammation; Lactones; Leukocyte Count; Metabolic Syndrome; Metformin; Orlistat; Prospective Studies; Pyrroles; Treatment Outcome

2005
Effects of exercise training on 5 inflammatory markers associated with cardiovascular risk.
    American heart journal, 2006, Volume: 151, Issue:2

    Topics: Adult; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; CD40 Ligand; Exercise; Female; Fibrinogen; Health Education; Health Status; Humans; Inflammation; Intercellular Adhesion Molecule-1; Leukocyte Count; Physical Fitness; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Statistics, Nonparametric; Time Factors

2006
Vascular risk factors in sudden hearing loss.
    Thrombosis and haemostasis, 2006, Volume: 95, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Fibrinogen; Hearing Loss, Sudden; Humans; Incidence; Integrin alpha2; Male; Middle Aged; Multivariate Analysis; Polymorphism, Genetic; Risk Factors; Smoking

2006
Ratio of oleic to palmitic acid is a dietary determinant of thrombogenic and fibrinolytic factors during the postprandial state in men.
    The American journal of clinical nutrition, 2006, Volume: 84, Issue:2

    Topics: Adult; Area Under Curve; Cardiovascular Diseases; Cross-Over Studies; Dietary Fats; Dietary Fats, Unsaturated; Enzyme Inhibitors; Fibrinogen; Humans; Male; Oleic Acid; Palmitic Acid; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Postprandial Period; Risk Factors; Thromboplastin; Thrombosis; Triglycerides

2006
Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.
    Drugs & aging, 2006, Volume: 23, Issue:7

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Viscosity; Cardiovascular Diseases; Cell Aggregation; Drug Antagonism; Drug Resistance; Drug Therapy, Combination; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors

2006
Alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects.
    Journal of the American College of Nutrition, 2006, Volume: 25, Issue:5

    Topics: Acute-Phase Reaction; alpha-Tocopherol; Antioxidants; C-Reactive Protein; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Dietary Supplements; Dose-Response Relationship, Drug; Female; Fibrinogen; Humans; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Oxidation-Reduction; Stereoisomerism

2006
Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
    Journal of the American Society of Nephrology : JASN, 2006, Volume: 17, Issue:12 Suppl 3

    Topics: Aged; Aged, 80 and over; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Dose-Response Relationship, Drug; Dyslipidemias; Female; Fibrinogen; Fibrinolysis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-6; Kidney Diseases; Lipid Metabolism; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Pyrroles; Tissue Plasminogen Activator

2006
Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    Thrombosis and haemostasis, 2007, Volume: 97, Issue:2

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Denmark; Estrogen Receptor alpha; Estrogen Replacement Therapy; Female; Fibrinogen; Follow-Up Studies; Genetic Variation; Genotype; Humans; Hysterectomy; Inflammation; Middle Aged; Polymorphism, Genetic; Postmenopause; Predictive Value of Tests; Prospective Studies; Reference Values; Risk Factors; Smoking; Time Factors; Treatment Outcome

2007
Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?
    Thrombosis and haemostasis, 2007, Volume: 97, Issue:4

    Topics: Administration, Cutaneous; Administration, Oral; Aged; alpha-2-Antiplasmin; Antigens; Antithrombins; Blood Coagulation; Cardiovascular Diseases; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Ireland; Middle Aged; Norethindrone; Norethindrone Acetate; Peptide Fragments; Postmenopause; Prothrombin; Risk Factors; Time Factors; Tissue Plasminogen Activator; Treatment Outcome

2007
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:8

    Topics: Aged; Biomarkers; Blood Glucose; Bone Density; Bone Diseases, Metabolic; Cardiovascular Diseases; Diet; Double-Blind Method; Female; Fibrinogen; Genistein; Humans; Insulin; Intercellular Adhesion Molecule-1; Isoprostanes; Lipids; Middle Aged; Osteoprotegerin; Postmenopause; Risk Factors; Treatment Outcome; Ultrasonography; Uterus; Vascular Cell Adhesion Molecule-1

2007
[Influence of birthweight and current body mass on cardiovascular risk factors in young adults].
    Polskie Archiwum Medycyny Wewnetrznej, 2007, Volume: 117, Issue:3

    Topics: Adult; Birth Weight; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Cardiovascular Diseases; Cholesterol; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Male; Prevalence; Risk Factors; Triglycerides

2007
Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial.
    Nutrition (Burbank, Los Angeles County, Calif.), 2008, Volume: 24, Issue:1

    Topics: Aged; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Female; Fibrinogen; Flax; Humans; Insulin; Lipoproteins, LDL; Menopause; Middle Aged; Particle Size; Placebos; Quebec; Triticum

2008
Hypertriglyceridaemia and hypercoagulability.
    Lancet (London, England), 1983, Apr-09, Volume: 1, Issue:8328

    Topics: Adult; Antigens; Blood Coagulation; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Factor VII; Factor VIII; Factor X; Fibrinogen; Fibrinolysis; Humans; Hyperlipoproteinemias; Male; Middle Aged; Risk; Triglycerides

1983
Effects of the nonsteroidal antiandrogen Casodex on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia.
    European urology, 1995, Volume: 27, Issue:4

    Topics: Aged; Androgen Antagonists; Anilides; Apolipoprotein A-I; Apolipoproteins B; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Estradiol; Fibrinogen; Humans; Lipoproteins; Luteinizing Hormone; Male; Middle Aged; Nitriles; Plasminogen Activator Inhibitor 1; Prostatic Hyperplasia; Risk Factors; Testosterone; Tosyl Compounds; Triglycerides

1995
Effect of immunosuppressive drug regime on cardiovascular risk profile following kidney transplantation.
    Atherosclerosis, 1995, Volume: 116, Issue:2

    Topics: Apolipoproteins A; Cardiovascular Diseases; Female; Fibrinogen; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Risk Factors

1995
Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol.
    Fertility and sterility, 1995, Volume: 64, Issue:5

    Topics: Apoproteins; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cholesterol; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Follicle Stimulating Hormone; Humans; Lipoproteins; Megestrol; Middle Aged; Norpregnadienes; Plasminogen; Progesterone Congeners; Prospective Studies; Renin; Risk Factors; Triglycerides

1995
The effect of the anti-estrogen tamoxifen on cardiovascular risk factors in normal postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:11

    Topics: Adipose Tissue; Body Composition; Body Mass Index; Cardiovascular Diseases; Estrogen Antagonists; Female; Fibrinogen; Humans; Lipids; Middle Aged; Postmenopause; Reference Values; Risk Factors; Tamoxifen

1995
No influence of beta-carotene on haemostatic balance in healthy male smokers.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1995, Volume: 6, Issue:1

    Topics: Adult; Antioxidants; beta Carotene; Cardiovascular Diseases; Carotenoids; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Smoking; Tissue Plasminogen Activator; Vitamins

1995
Both fish oil and olive oil lowered plasma fibrinogen in women with high baseline fibrinogen levels.
    Thrombosis and haemostasis, 1994, Volume: 72, Issue:4

    Topics: Administration, Oral; Adult; Blood Coagulation Factors; Body Mass Index; Capsules; Cardiovascular Diseases; Cross-Over Studies; Double-Blind Method; Fatty Acids; Female; Fibrinogen; Fish Oils; Humans; Life Style; Male; Olive Oil; Plant Oils; Risk Factors; Sex Factors; Triglycerides; Vitamins

1994
Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment.
    Journal of the National Cancer Institute, 1994, Oct-19, Volume: 86, Issue:20

    Topics: Blood Glucose; Blood Platelets; Cardiovascular Diseases; Female; Fibrinogen; Humans; Lipids; Postmenopause; Risk Factors; Tamoxifen; Time Factors; Treatment Outcome

1994
Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors.
    Thrombosis and haemostasis, 1994, Volume: 71, Issue:5

    Topics: Adult; Antifibrinolytic Agents; Antithrombin III; Biomarkers; Cardiovascular Diseases; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Linear Models; Male; Middle Aged; Peptide Hydrolases; Prevalence; Reference Values; Risk Factors; Smoking

1994
Leisure, home, and occupational physical activity and cardiovascular risk factors in postmenopausal women. The Postmenopausal Estrogens/Progestins Intervention (PEPI) Study.
    Archives of internal medicine, 1996, Feb-26, Volume: 156, Issue:4

    Topics: Cardiovascular Diseases; Cholesterol, HDL; Cross-Sectional Studies; Ethnicity; Female; Fibrinogen; Humans; Insulin; Life Style; Middle Aged; Multivariate Analysis; Occupations; Physical Exertion; Postmenopause; Risk Factors; Surveys and Questionnaires

1996
Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study.
    Atherosclerosis, 1996, Volume: 120, Issue:1-2

    Topics: Adult; Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Comorbidity; Diabetes Mellitus; Disease Susceptibility; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Incidence; Italy; Leukocyte Count; Logistic Models; Male; Middle Aged; Odds Ratio; Peripheral Vascular Diseases; Phthalic Acids; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Thromboxane; Risk Factors; Smoking; Vascular Surgical Procedures

1996
[Lactovegetarian diet: effect on changes in body weight, lipid status, fibrinogen and lipoprotein (a) in cardiovascular patients during inpatient rehabilitation treatment].
    Zeitschrift fur Kardiologie, 1996, Volume: 85, Issue:6

    Topics: Adult; Aged; Body Weight; Cardiac Rehabilitation; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Coronary Disease; Diet, Fat-Restricted; Diet, Reducing; Diet, Vegetarian; Female; Fibrinogen; Humans; Lipids; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Patient Admission; Rehabilitation Centers; Treatment Outcome; Uric Acid

1996
Effects of smoking cessation on insulin and cardiovascular risk factors--a controlled study of 4 months' duration.
    Journal of internal medicine, 1996, Volume: 240, Issue:4

    Topics: Adult; Blood Glucose; C-Peptide; Cardiovascular Diseases; Feasibility Studies; Female; Fibrinogen; Humans; Insulin; Lipids; Male; Middle Aged; Psychotherapy, Group; Risk Factors; Smoking; Smoking Cessation; Weight Gain

1996
No effect of unfractioned or low molecular weight heparin treatment on markers of vascular wall and hemostatic function in incipient diabetic nephropathy.
    Diabetes care, 1997, Volume: 20, Issue:10

    Topics: Adult; Albuminuria; Antithrombin III; Capillaries; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Female; Fibrinogen; Hemostasis; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Peptide Fragments; Peptide Hydrolases; Placebos; Plasminogen Activator Inhibitor 1; Protein Precursors; Prothrombin; Tissue Plasminogen Activator; Triglycerides; von Willebrand Factor

1997
Hormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women.
    Arteriosclerosis, thrombosis, and vascular biology, 1998, Volume: 18, Issue:12

    Topics: Aged; Blood Viscosity; Cardiovascular Diseases; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Medroxyprogesterone; Middle Aged; Postmenopause; Triglycerides

1998
Effects of hormone replacement therapy on hemostatic cardiovascular risk factors.
    American journal of obstetrics and gynecology, 1999, Volume: 180, Issue:2 Pt 1

    Topics: Cardiovascular Diseases; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Lipoprotein(a); Middle Aged; Placebos; Plasminogen Activator Inhibitor 1; Postmenopause; Risk Factors; Tissue Plasminogen Activator

1999
Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation.
    Journal of internal medicine, 1999, Volume: 246, Issue:1

    Topics: Administration, Inhalation; Administration, Intranasal; Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Cholesterol; Double-Blind Method; Erythrocyte Indices; Female; Fibrinogen; Hematocrit; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Nicotine; Nicotinic Agonists; Platelet Count; Prospective Studies; Risk Factors; Smoking Cessation; Thrombosis

1999
Fenofibrate decreases plasma fibrinogen, improves lipid profile, and reduces uricemia.
    Clinical pharmacology and therapeutics, 1999, Volume: 66, Issue:2

    Topics: Aged; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Fenofibrate; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Treatment Outcome; Triglycerides; Uric Acid

1999
Serum lipids and lipoproteins and carotid artery wall intima-media thickness in a population of menopausal women.
    Menopause (New York, N.Y.), 1999,Fall, Volume: 6, Issue:3

    Topics: Adult; Age Distribution; Aged; Cardiovascular Diseases; Carotid Arteries; Cholesterol; Evaluation Studies as Topic; Female; Fibrinogen; Hormone Replacement Therapy; Humans; Hypertension; Lipoproteins, LDL; Menopause; Middle Aged; Risk Assessment; Triglycerides; Tunica Intima; Ultrasonography

1999
Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1.
    European journal of clinical pharmacology, 1999, Volume: 55, Issue:7

    Topics: Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fasting; Female; Fibrinogen; Glycated Hemoglobin; Humans; Iloprost; Insulin; Male; Middle Aged; Peripheral Vascular Diseases; Pilot Projects; Plasminogen; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Risk Factors; Time Factors; Treatment Outcome; Walking

1999
Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm.
    Atherosclerosis, 2000, Volume: 148, Issue:1

    Topics: Adrenergic beta-Agonists; Aged; Angina Pectoris; beta-Thromboglobulin; Calcium Channel Blockers; Cardiovascular Diseases; Double-Blind Method; Female; Fibrinogen; Hemostasis; Humans; Inflammation; Leukocyte Count; Male; Metoprolol; Middle Aged; Multivariate Analysis; Orosomucoid; Prognosis; Verapamil

2000
Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases.
    European journal of clinical nutrition, 2000, Volume: 54, Issue:4

    Topics: Adult; Analysis of Variance; Blood Pressure; Body Weight; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Female; Fibrinogen; Humans; Intestinal Absorption; Lactobacillus acidophilus; Male; Middle Aged; Obesity; Patient Compliance; Probiotics; Risk Factors; Yogurt

2000
Consumption of black and green tea had no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals.
    European journal of clinical nutrition, 2000, Volume: 54, Issue:10

    Topics: Acute-Phase Reaction; Adult; Antioxidants; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Endothelium, Vascular; Female; Fibrinogen; Flavonoids; Hemostasis; Humans; Inflammation; Male; Middle Aged; Netherlands; Phenols; Polymers; Polyphenols; Risk Factors; Smoking; Tea

2000
The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
    Family practice, 2000, Volume: 17, Issue:6

    Topics: Cardiovascular Diseases; Coronary Disease; Estrogen Replacement Therapy; Estrogens; Factor VII; Female; Fibrinogen; Humans; Lipoproteins; Middle Aged; Progestins; Risk Factors

2000
Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:2

    Topics: Administration, Oral; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Blood Coagulation; Breast Neoplasms; C-Reactive Protein; Cardiovascular Diseases; Cardiovascular System; Cholesterol; Double-Blind Method; Female; Fibrinogen; Humans; Placebos; Postmenopause; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen

2001
Aged garlic extract, a modulator of cardiovascular risk factors: a dose-finding study on the effects of AGE on platelet functions.
    The Journal of nutrition, 2001, Volume: 131, Issue:3s

    Topics: Cardiovascular Diseases; Collagen; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Female; Fibrinogen; Garlic; Humans; Male; Perfusion; Phytotherapy; Plant Extracts; Plants, Medicinal; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors; von Willebrand Factor

2001
Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors.
    European journal of clinical nutrition, 2001, Volume: 55, Issue:6

    Topics: Adult; Cardiovascular Diseases; Diet; Dietary Fats; Fibrinogen; Hemostasis; Humans; Male; Prospective Studies; Risk Factors; Wine

2001
Fruit and vegetables and cardiovascular risk profile: a diet controlled intervention study.
    European journal of clinical nutrition, 2001, Volume: 55, Issue:8

    Topics: Adult; Blood Pressure; Cardiovascular Diseases; Cholesterol; Diet; Fibrinogen; Fruit; Humans; Lipids; Middle Aged; Risk Factors; Vegetables

2001
Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:9

    Topics: Adult; Blood Pressure; Body Weight; Cardiovascular Diseases; Chromosomes; Diabetes Mellitus; Female; Fibrinogen; Gonadal Steroid Hormones; Heart Defects, Congenital; Humans; Hypertension; Karyotyping; Life Style; Lipids; Male; Middle Aged; Risk Factors; Turner Syndrome

2001
Effect of cocaine usage on C-reactive protein, von Willebrand factor, and fibrinogen.
    The American journal of cardiology, 2002, May-01, Volume: 89, Issue:9

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cocaine-Related Disorders; Fibrinogen; Humans; Reference Values; Risk; von Willebrand Factor

2002
Fish and fish oil intake: effect on haematological variables related to cardiovascular disease.
    Thrombosis research, 1991, Oct-15, Volume: 64, Issue:2

    Topics: Animals; Blood Coagulation Tests; Blood Platelets; Cardiovascular Diseases; Cell Membrane; Diet; Eicosanoids; Factor VII; Fatty Acids; Fibrinogen; Fibrinolysis; Fish Oils; Fishes; Hematologic Tests; Humans; Leukocyte Count; Male; Platelet Count

1991
Fish-oil concentrate: effects on variables related to cardiovascular disease.
    The American journal of clinical nutrition, 1990, Volume: 52, Issue:2

    Topics: Adult; Blood Pressure; Cardiovascular Diseases; Double-Blind Method; Eating; Erythrocytes; Fatty Acids; Fibrinogen; Fish Oils; Humans; Male; Phospholipids; Random Allocation; Receptors, LDL; Regression Analysis; Risk Factors; Triglycerides

1990

Other Studies

591 other study(ies) available for fibrinogen and Cardiovascular Diseases

ArticleYear
Obesity as a Thrombogenic and Cardiovascular Risk Factor in Children.
    Hormone research in paediatrics, 2021, Volume: 94, Issue:11-12

    Topics: Adult; Body Mass Index; Cardiovascular Diseases; Child; Fibrinogen; Heart Disease Risk Factors; Humans; Pediatric Obesity; Risk Factors

2021
Pro-inflammatory profiles in cardiovascular disease patients with peri-implantitis.
    Journal of periodontology, 2022, Volume: 93, Issue:6

    Topics: Cardiovascular Diseases; Dental Implants; Fibrinogen; Gingival Crevicular Fluid; Humans; Interleukin-8; Matrix Metalloproteinase 8; Peri-Implantitis; Periodontitis; Tissue Inhibitor of Metalloproteinase-2; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2022
Risks of Cardiovascular Events in Patients With Inflammatory Bowel Disease in China: A Retrospective Multicenter Cohort Study.
    Inflammatory bowel diseases, 2022, 06-02, Volume: 28, Issue:Supple 2

    Topics: Adolescent; Adult; Cardiovascular Diseases; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Female; Fibrinogen; Humans; Inflammatory Bowel Diseases; Male; Retrospective Studies; Young Adult

2022
Cardiometabolic profile of young women with hypoprolactinemia.
    Endocrine, 2022, Volume: 78, Issue:1

    Topics: C-Reactive Protein; Cabergoline; Cardiovascular Diseases; Carotid Intima-Media Thickness; Female; Fibrinogen; Genetic Diseases, Inborn; Glucose; Humans; Lactation Disorders; Prolactin; Risk Factors; Uric Acid

2022
Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study.
    Cardiology, 2022, Volume: 147, Issue:5-6

    Topics: Androgens; Atorvastatin; C-Reactive Protein; Cabergoline; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Insulin Resistance; Pilot Projects; Prolactin; Risk Factors; Uric Acid

2022
Impaired Cardiometabolic Effects of Bromocriptine in Men With Early-Onset Androgenic Alopecia.
    Journal of clinical pharmacology, 2023, Volume: 63, Issue:3

    Topics: Alopecia; Bromocriptine; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Fibrinogen; Humans; Insulin Resistance; Male; Prolactin; Risk Factors; Testosterone; Triglycerides; Uric Acid

2023
The Association of Inflammatory Factors With Peripheral Neuropathy: The Study of Women's Health Across the Nation.
    The Journal of clinical endocrinology and metabolism, 2023, 03-10, Volume: 108, Issue:4

    Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Female; Fibrinogen; Humans; Inflammation; Metabolic Syndrome; Middle Aged; Obesity; Peripheral Nervous System Diseases; Risk Factors; Women's Health

2023
Consumption of Plant Foods and Its Association with Cardiovascular Disease Risk Profile in South Africans at High-Risk of Type 2 Diabetes Mellitus.
    International journal of environmental research and public health, 2022, 10-14, Volume: 19, Issue:20

    Topics: Cardiovascular Diseases; Cholesterol, LDL; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Insulins; Male; Middle Aged; Obesity; Risk Factors; South Africa; Triglycerides; Vitamin A

2022
Exercise modulation in inflammation and metabolic hormonal disorders of COVID-19 to decrease risk factors in coronary heart disease.
    Hormone molecular biology and clinical investigation, 2023, Jun-01, Volume: 44, Issue:2

    Topics: C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; COVID-19; Exercise; Fibrinogen; Galectin 3; Humans; Inflammation; Insulin; Insulin Resistance; Leptin; Pandemics; Risk Factors

2023
Cardiometabolic Risk Factors in Atorvastatin-Treated Women with Euthyroid Autoimmune Thyroiditis.
    Pharmacology, 2023, Volume: 108, Issue:3

    Topics: Atorvastatin; C-Reactive Protein; Cardiometabolic Risk Factors; Cardiovascular Diseases; Cholesterol; Female; Fibrinogen; Hashimoto Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Risk Factors; Thyroiditis, Autoimmune; Uric Acid

2023
Autoimmune Thyroiditis Attenuates Cardiometabolic Effects of Cabergoline in Young Women With Hyperprolactinemia.
    Journal of clinical pharmacology, 2023, Volume: 63, Issue:8

    Topics: C-Reactive Protein; Cabergoline; Cardiovascular Diseases; Cholesterol; Creatinine; Female; Fibrinogen; Glycated Hemoglobin; Hashimoto Disease; Humans; Hyperprolactinemia; Insulin Resistance; Lipoproteins, HDL; Prolactin; Risk Factors; Thyroiditis, Autoimmune; Uric Acid

2023
Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome.
    Journal of clinical pharmacology, 2023, Volume: 63, Issue:9

    Topics: Androgens; Body Mass Index; C-Reactive Protein; Cardiometabolic Risk Factors; Cardiovascular Diseases; Female; Fibrinogen; Humans; Insulin; Insulin Resistance; Lisinopril; Polycystic Ovary Syndrome; Risk Factors; Siblings; Testosterone; Uric Acid

2023
Vitamin D Status Determines Cardiometabolic Effects of Cabergoline in Women with Elevated Prolactin Levels: A Pilot Study.
    Nutrients, 2023, May-14, Volume: 15, Issue:10

    Topics: C-Reactive Protein; Cabergoline; Cardiovascular Diseases; Female; Fibrinogen; Glucose; Humans; Hyperprolactinemia; Pilot Projects; Prolactin; Risk Factors; Triglycerides; Uric Acid; Vitamin D; Vitamin D Deficiency; Vitamins

2023
The Impact of Atorvastatin on Cardiometabolic Risk Factors in Sisters of Women with Polycystic Ovary Syndrome.
    Pharmacology, 2023, Volume: 108, Issue:5

    Topics: Androgens; Atorvastatin; C-Reactive Protein; Cardiometabolic Risk Factors; Cardiovascular Diseases; Female; Fibrinogen; Humans; Insulin Resistance; Polycystic Ovary Syndrome; Risk Factors; Siblings; Testosterone; Uric Acid

2023
Night shift work and cardiovascular disease biomarkers in female nurses.
    American journal of industrial medicine, 2020, Volume: 63, Issue:3

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chronobiology Disorders; Female; Fibrinogen; Heart Disease Risk Factors; Humans; Middle Aged; Nurses; Occupational Diseases; Shift Work Schedule; Surveys and Questionnaires; Triglycerides; Work Schedule Tolerance

2020
Associations of C-reactive protein and fibrinogen with mortality from all-causes, cardiovascular disease and cancer among U.S. adults.
    Preventive medicine, 2020, Volume: 139

    Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Neoplasms; Nutrition Surveys; Proportional Hazards Models; Risk Factors

2020
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.
    Journal of medical virology, 2020, Volume: 92, Issue:7

    Topics: Adult; Aged; Area Under Curve; Betacoronavirus; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Diabetes Complications; Diabetes Mellitus; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; SARS-CoV-2; Sensitivity and Specificity; Severity of Illness Index; Thrombin Time

2020
Prothrombotic fibrin network characteristics in patients with acromegaly: a novel mechanism for vascular complications.
    European journal of endocrinology, 2020, Volume: 182, Issue:5

    Topics: Acromegaly; Adult; Aged; Blood Coagulation Tests; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrin; Fibrinogen; Humans; Male; Middle Aged; Pilot Projects; Thrombosis

2020
Prognosis of COVID-19: Changes in laboratory parameters.
    Le infezioni in medicina, 2020, Jun-01, Volume: 28, Issue:suppl 1

    Topics: Adult; Aged; beta-Thalassemia; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Coronavirus Infections; COVID-19; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Greece; Humans; L-Lactate Dehydrogenase; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Prognosis; Retrospective Studies; Risk Factors

2020
GlycA, a novel marker for low grade inflammation, reflects gut microbiome diversity and is more accurate than high sensitive CRP in reflecting metabolomic profile.
    Metabolomics : Official journal of the Metabolomic Society, 2020, 06-20, Volume: 16, Issue:7

    Topics: Acetylglucosamine; Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Feces; Female; Fibrinogen; Gastrointestinal Microbiome; Glycoproteins; Haptoglobins; Humans; Inflammation; Metabolomics; Obesity; Pregnancy; Serum Amyloid A Protein

2020
Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering From Coronavirus Disease in Wuhan, China.
    Journal of the American Heart Association, 2020, 10-20, Volume: 9, Issue:19

    Topics: Adult; Aged; Aged, 80 and over; Betacoronavirus; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; China; Comorbidity; Coronavirus Infections; COVID-19; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Procalcitonin; Prognosis; Retrospective Studies; SARS-CoV-2; Survival Rate; Tomography, X-Ray Computed

2020
Plasma fibrinogen and mortality in patients undergoing peritoneal dialysis: a prospective cohort study.
    BMC nephrology, 2020, 08-17, Volume: 21, Issue:1

    Topics: Adult; Aged; Cardiovascular Diseases; Cause of Death; China; Cohort Studies; Female; Fibrinogen; Humans; Kidney Failure, Chronic; Linear Models; Male; Middle Aged; Mortality; Peritoneal Dialysis; Prospective Studies

2020
Relation of Fibrinogen-to-Albumin Ratio to Severity of Coronary Artery Disease and Long-Term Prognosis in Patients with Non-ST Elevation Acute Coronary Syndrome.
    BioMed research international, 2020, Volume: 2020

    Topics: Acute Coronary Syndrome; Aged; Cardiovascular Diseases; Coronary Artery Disease; Creatine Kinase, MB Form; Drug-Eluting Stents; Electrocardiography; Female; Fibrinogen; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Prospective Studies; Risk Factors; Serum Albumin; Troponin I

2020
Biomarker association with cardiovascular disease and mortality - The role of fibrinogen. A report from the NHANES study.
    Thrombosis research, 2021, Volume: 198

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Humans; Nutrition Surveys; Risk Factors

2021
Circulating neurotrophins and hemostatic risk factors of atherothrombotic cardiovascular disease at baseline and during sympathetic challenge: the SABPA study.
    Scientific reports, 2021, 01-27, Volume: 11, Issue:1

    Topics: Adult; Black People; Cardiovascular Diseases; Female; Fibrinogen; Glial Cell Line-Derived Neurotrophic Factor; Humans; Male; Middle Aged; Nerve Growth Factors; Risk Factors; von Willebrand Factor

2021
Fibrinogen and hemoglobin predict near future cardiovascular events in asymptomatic individuals.
    Scientific reports, 2021, 02-25, Volume: 11, Issue:1

    Topics: Aged; Cardiovascular Diseases; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Heart Disease Risk Factors; Hemoglobins; Humans; Male; Mass Spectrometry; Predictive Value of Tests; Proportional Hazards Models

2021
Soluble thrombomodulin and cardiovascular disease risk factors in Japanese children.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2021, Jun-01, Volume: 32, Issue:4

    Topics: Cardiovascular Diseases; Child; Cholesterol, HDL; Female; Fibrinogen; Heart Disease Risk Factors; Humans; Japan; Leptin; Male; Obesity; Thrombomodulin; Waist Circumference

2021
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2021, Dec-01, Volume: 32, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Black or African American; Cardiovascular Diseases; Comorbidity; COVID-19; COVID-19 Testing; Diabetes Mellitus; Early Diagnosis; Female; Fibrin; Fibrin Clot Lysis Time; Fibrinogen; Hospitalization; Humans; Hyperlipidemias; L-Lactate Dehydrogenase; Male; Middle Aged; Obesity; Organ Dysfunction Scores; Prognosis; Prospective Studies; SARS-CoV-2; Thrombelastography; Thrombophilia; Treatment Outcome; White People

2021
Television viewing and risk of mortality: Exploring the biological plausibility.
    Atherosclerosis, 2017, Volume: 263

    Topics: Age Factors; Aged; Aging; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; England; Female; Fibrinogen; Humans; Inflammation Mediators; Leisure Activities; Longitudinal Studies; Male; Middle Aged; Proportional Hazards Models; Risk Assessment; Risk Factors; Sedentary Behavior; Television; Time Factors

2017
Relation between Arterial Stiffness and Markers of Inflammation and Hemostasis - Data from the Population-based Gutenberg Health Study.
    Scientific reports, 2017, 07-24, Volume: 7, Issue:1

    Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Hemostasis; Humans; Inflammation Mediators; Interleukin 1 Receptor Antagonist Protein; Interleukin-18; Leukocyte Count; Male; Middle Aged; Neopterin; Prognosis; Prospective Studies; Risk Factors; Survival Analysis; Vascular Stiffness

2017
Quantile causal mediation analysis allowing longitudinal data.
    Statistics in medicine, 2017, Nov-20, Volume: 36, Issue:26

    Topics: Air Pollutants; Air Pollution; Boston; Cardiovascular Diseases; Causality; Computer Simulation; Confounding Factors, Epidemiologic; Data Interpretation, Statistical; Fibrinogen; Humans; Longitudinal Studies; Particulate Matter; Regression Analysis

2017
Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples.
    BMJ (Clinical research ed.), 2017, 09-13, Volume: 358

    Topics: Antineoplastic Agents, Hormonal; Cardiovascular Diseases; Clinical Trials as Topic; Endometrial Neoplasms; Female; Fibrinogen; Humans; Multivariate Analysis; Myocardial Infarction; Network Meta-Analysis; Progesterone; Thrombolytic Therapy; Treatment Outcome

2017
Essential arterial hypertension patients present higher cell adhesion forces, contributing to fibrinogen-dependent cardiovascular risk.
    Nanoscale, 2017, Oct-12, Volume: 9, Issue:39

    Topics: Cardiovascular Diseases; Cell Adhesion; Erythrocyte Aggregation; Erythrocytes; Essential Hypertension; Fibrinogen; Humans; Microscopy, Atomic Force; Risk Factors; Single-Cell Analysis

2017
Ability of Nontraditional Risk Factors and Inflammatory Biomarkers for Cardiovascular Disease to Identify High Cardiometabolic Risk in Adolescents: Results From the LabMed Physical Activity Study.
    The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2018, Volume: 62, Issue:3

    Topics: Adolescent; Biomarkers; C-Reactive Protein; Cardiorespiratory Fitness; Cardiovascular Diseases; Cross-Sectional Studies; Exercise; Female; Fibrinogen; Humans; Inflammation; Leptin; Male; Portugal; Risk Factors

2018
Associations between metabolic syndrome components and markers of inflammation in Welsh school children.
    European journal of pediatrics, 2018, Volume: 177, Issue:3

    Topics: Adolescent; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Child; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Male; Metabolic Syndrome; Multivariate Analysis; Risk Assessment; Risk Factors; Waist Circumference; Wales

2018
Coagulation and inflammation in long-term cancer survivors: results from the adult population.
    Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:4

    Topics: Adult; Aged; Biomarkers; Blood Coagulation; Cancer Survivors; Cardiovascular Diseases; Female; Fibrinogen; Germany; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Time Factors; von Willebrand Factor

2018
A multi-cellular 3D bioprinting approach for vascularized heart tissue engineering based on HUVECs and iPSC-derived cardiomyocytes.
    Scientific reports, 2018, 09-10, Volume: 8, Issue:1

    Topics: Alginates; Animals; Bioprinting; Bioprosthesis; Cardiac Surgical Procedures; Cardiovascular Diseases; Cell Culture Techniques; Cell Differentiation; Coronary Vessels; Fibrinogen; Fibroblasts; Human Umbilical Vein Endothelial Cells; Humans; Hydrogels; Induced Pluripotent Stem Cells; Mice; Mice, Inbred C57BL; Microfluidics; Models, Animal; Myocardium; Myocytes, Cardiac; Primary Cell Culture; Printing, Three-Dimensional; Prosthesis Implantation; Skin; Tissue Engineering; Tissue Scaffolds

2018
An integrated microfluidic platform to perform uninterrupted SELEX cycles to screen affinity reagents specific to cardiovascular biomarkers.
    Biosensors & bioelectronics, 2018, Dec-30, Volume: 122

    Topics: Aptamers, Nucleotide; Biomarkers; Biosensing Techniques; Cardiovascular Diseases; Equipment Design; Fibrinogen; Humans; Lab-On-A-Chip Devices; Natriuretic Peptide, Brain; Peptide Fragments; SELEX Aptamer Technique; Troponin I

2018
Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population-Based Gutenberg Health Study.
    Journal of the American Heart Association, 2018, 09-04, Volume: 7, Issue:17

    Topics: Adrenomedullin; Adult; Aged; Ankle Brachial Index; Anticoagulants; Asymptomatic Diseases; Atrial Fibrillation; Atrial Natriuretic Factor; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Female; Fibrinogen; Germany; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Phenprocoumon; Protein Precursors; Pulmonary Embolism; Risk Factors; Stroke; Stroke Volume; Vascular Stiffness; Venous Thrombosis; Warfarin

2018
Inverse association between serum antioxidant levels and inflammatory markers is moderated by adiposity: a report based on a large representative population sample of American adults.
    The British journal of nutrition, 2018, Volume: 120, Issue:11

    Topics: Adiposity; Adult; Antioxidants; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Data Collection; Female; Fibrinogen; Humans; Inflammation; Linear Models; Male; Middle Aged; Nutrition Surveys; United States

2018
Associations between dietary insulin load with cardiovascular risk factors and inflammatory parameters in elderly men: a cross-sectional study.
    The British journal of nutrition, 2019, Volume: 121, Issue:7

    Topics: Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cross-Sectional Studies; Diet; Fibrinogen; Humans; Inflammation; Insulin; Insulin Resistance; Iran; Male; Middle Aged; Risk Factors; Triglycerides

2019
An integrated microfluidic system with field-effect-transistor sensor arrays for detecting multiple cardiovascular biomarkers from clinical samples.
    Biosensors & bioelectronics, 2019, Mar-15, Volume: 129

    Topics: Aptamers, Nucleotide; Biomarkers; Biosensing Techniques; C-Reactive Protein; Cardiovascular Diseases; Equipment Design; Fibrinogen; Humans; Lab-On-A-Chip Devices; Limit of Detection; Natriuretic Peptide, Brain; Peptide Fragments; Point-of-Care Systems; Transistors, Electronic; Troponin I

2019
Cardiometabolic risk factors in young women with macroprolactinaemia.
    Endokrynologia Polska, 2019, Volume: 70, Issue:4

    Topics: Adult; Cardiovascular Diseases; Cholesterol, LDL; Female; Fibrinogen; Humans; Insulin Resistance; Middle Aged; Prolactin; Risk Factors; Triglycerides; Uric Acid; Young Adult

2019
Thyroid Function and Cardiovascular Disease: The Mediating Role of Coagulation Factors.
    The Journal of clinical endocrinology and metabolism, 2019, 08-01, Volume: 104, Issue:8

    Topics: ADAMTS13 Protein; Aged; Aged, 80 and over; Blood Coagulation; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Thyroid Gland; Thyroxine; von Willebrand Factor

2019
Does weight loss affect the parameters that are metabolically related to cardiovascular diseases?
    Saudi medical journal, 2019, Volume: 40, Issue:4

    Topics: Adult; Aged; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diet, Reducing; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Insulin; Leptin; Male; Middle Aged; Obesity; Triglycerides; Uric Acid; Weight Loss

2019
The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study.
    Pharmacological reports : PR, 2019, Volume: 71, Issue:3

    Topics: Adrenal Hyperplasia, Congenital; Adult; Androgens; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Dehydroepiandrosterone Sulfate; Female; Fibrinogen; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Pilot Projects; Risk Factors; Testosterone; Uric Acid; Vitamin D

2019
Evidence that fibrinogen γ' regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans.
    Blood, 2013, Apr-18, Volume: 121, Issue:16

    Topics: Adult; Aged; Black People; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Female; Fibrin; Fibrin Clot Lysis Time; Fibrinogen; Fibrinogens, Abnormal; Fibrinolysis; Humans; Male; Middle Aged; Regression Analysis; Risk Factors; South Africa

2013
Role of relationship between HbA1c, fibrinogen and HDL-cholesterol on cardiovascular disease in patients with type 2 diabetes mellitus.
    Atherosclerosis, 2013, Volume: 228, Issue:1

    Topics: Aged; Atherosclerosis; Cardiovascular Diseases; Cholesterol, HDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Risk Factors

2013
Aldosterone levels and inflammatory stimulation in essential hypertensive patients.
    Journal of human hypertension, 2013, Volume: 27, Issue:9

    Topics: Adult; Aged; Aldosterone; Biomarkers; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Essential Hypertension; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Inflammation; Leukocyte Count; Male; Middle Aged; Renin; Risk Factors

2013
Effects of caffeine and stress on biomarkers of cardiovascular disease in healthy men and women with a family history of hypertension.
    Stress and health : journal of the International Society for the Investigation of Stress, 2013, Volume: 29, Issue:5

    Topics: Adolescent; Adult; Blood Pressure; C-Reactive Protein; Caffeine; Cardiovascular Diseases; Female; Fibrinogen; Heart Rate; Humans; Hydrocortisone; Hypertension; Male; Stress, Psychological; Young Adult

2013
Socioeconomic status gradients in inflammation in adolescence.
    Psychosomatic medicine, 2013, Volume: 75, Issue:5

    Topics: Adiposity; Adolescent; Biomarkers; Black or African American; Body Mass Index; Cardiovascular Diseases; Child; Cohort Studies; Cross-Sectional Studies; Educational Status; Female; Fibrinogen; Health Status Disparities; Humans; Inflammation; Interleukin-6; Linear Models; Male; Obesity; Ohio; Parents; Receptors, Tumor Necrosis Factor, Type II; Risk Factors; Social Class; White People

2013
The relationship between five different measures of structural social capital, medical examination outcomes, and mortality.
    Social science & medicine (1982), 2013, Volume: 85

    Topics: Adult; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; Cholesterol; Cross-Sectional Studies; Female; Fibrinogen; Follow-Up Studies; Health Status Disparities; Humans; Male; Mortality; Nutrition Surveys; Risk Factors; Social Support; Socioeconomic Factors; United States

2013
Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature.
    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2013, Volume: 20, Issue:2

    Topics: Aged; Amyloid; Amyloidosis, Familial; Cardiovascular Diseases; Female; Fibrinogen; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Mutation; Pedigree; Prognosis; Proteinuria; Review Literature as Topic; Spain

2013
Relationship between inflammatory markers of cardiovascular disease and VO2peak in asymptomatic females.
    The Journal of sports medicine and physical fitness, 2013, Volume: 53, Issue:2

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Leukocyte Count; Lipids; Middle Aged; Oxygen Consumption; Premenopause

2013
Non-surgical periodontal treatment reduces cardiovascular risk in refractory hypertensive patients: a pilot study.
    Journal of clinical periodontology, 2013, Volume: 40, Issue:7

    Topics: Arteries; Blood Flow Velocity; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Chronic Periodontitis; Cohort Studies; Dental Plaque Index; Dental Scaling; Fibrinogen; Follow-Up Studies; Gingival Hemorrhage; Humans; Hypertension; Interleukin-6; Middle Aged; Oral Hygiene; Periodontal Attachment Loss; Periodontal Debridement; Periodontal Index; Periodontal Pocket; Pilot Projects; Prospective Studies; Risk Factors; Ventricular Function, Left

2013
Rheological blood behavior is not only influenced by cardiovascular risk factors but also by aging itself. Research into 927 healthy Spanish Mediterranean subjects.
    Clinical hemorheology and microcirculation, 2013, Jan-01, Volume: 54, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Blood Glucose; Cardiovascular Diseases; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Lipids; Male; Middle Aged; Risk Factors; Spain; Young Adult

2013
Direct comparisons of three alternative plasma fibrinogen assays with the von Clauss assay in prediction of cardiovascular disease and all-causes mortality: the Scottish Heart Health Extended Cohort.
    British journal of haematology, 2013, Volume: 162, Issue:3

    Topics: Adult; Biomarkers; Blood Coagulation Tests; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Middle Aged; Mortality; Nephelometry and Turbidimetry; Predictive Value of Tests; Prospective Studies; Prothrombin Time; Reproducibility of Results; Risk Assessment; Scotland

2013
Relationship between inflammatory markers and new cardiovascular events in patients with acute myocardial infarction who underwent primary angioplasty.
    Global journal of health science, 2013, Mar-20, Volume: 5, Issue:4

    Topics: Acute Disease; Age Factors; Angioplasty; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cardiovascular Agents; Cardiovascular Diseases; Electrocardiography; Fibrinogen; Humans; Inflammation Mediators; Myocardial Infarction; Socioeconomic Factors

2013
Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study.
    European journal of epidemiology, 2013, Volume: 28, Issue:7

    Topics: Adult; Aged; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; Cholesterol; England; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Mortality; Prospective Studies; Risk Factors; Surveys and Questionnaires; Time Factors

2013
Total bilirubin in young men and women: association with risk markers for cardiovascular diseases.
    Clinical biochemistry, 2013, Volume: 46, Issue:15

    Topics: Bilirubin; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Fasting; Female; Fibrinogen; Humans; Lipoproteins, LDL; Male; Oxidative Stress; Physical Examination; Risk Factors; Serum Albumin; Sex Factors; Thiobarbituric Acid Reactive Substances; Uric Acid; Young Adult

2013
Are current UK National Institute for Health and Clinical Excellence (NICE) obesity risk guidelines useful? Cross-sectional associations with cardiovascular disease risk factors in a large, representative English population.
    PloS one, 2013, Volume: 8, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cross-Sectional Studies; England; Female; Fibrinogen; Glycated Hemoglobin; Health Surveys; Humans; Male; Middle Aged; Obesity; Odds Ratio; Practice Guidelines as Topic; Risk Factors; Waist Circumference

2013
Relationships and cardiovascular risk: perceived spousal ambivalence in specific relationship contexts and its links to inflammation.
    Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 2013, Volume: 32, Issue:10

    Topics: Adult; Affect; Aged; C-Reactive Protein; Cardiovascular Diseases; Cardiovascular System; Female; Fibrinogen; Humans; Inflammation; Interpersonal Relations; Male; Marriage; Middle Aged; Perception; Psychiatric Status Rating Scales; Risk Factors; Social Support; Spouses; Stress, Psychological

2013
Fibrinogen: a circulating factor in search of its genetic architecture.
    Circulation, 2013, Sep-17, Volume: 128, Issue:12

    Topics: Cardiovascular Diseases; Female; Fibrinogen; Genetic Loci; Genome-Wide Association Study; Humans; Male

2013
Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.
    American journal of respiratory and critical care medicine, 2013, Nov-01, Volume: 188, Issue:9

    Topics: Aged; Aged, 80 and over; Aorta; Blood Pressure; C-Reactive Protein; Cardiomyopathies; Cardiovascular Diseases; Cohort Studies; Disease Progression; Female; Fibrinogen; Heart Rate; Humans; Interleukin-6; Interleukin-8; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulse Wave Analysis; Risk Factors; Spirometry; Sputum; Troponin T; Vascular Stiffness

2013
Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study.
    Journal of hypertension, 2013, Volume: 31, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; Cardiovascular Diseases; Cross-Sectional Studies; Diastole; Echocardiography, Doppler; Essential Hypertension; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Hemostasis; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Myocardium; Plasminogen Activator Inhibitor 1; Prothrombin; Risk Factors; Thrombosis; Tissue Plasminogen Activator; Young Adult

2013
Fruits and vegetables diet improves some selected haemorheological parameters predisposing to cardiovascular disease in non insulin dependent diabetes mellitus NIDDM subjects.
    Pakistan journal of biological sciences : PJBS, 2012, Jul-15, Volume: 15, Issue:14

    Topics: Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 2; Diet; Fibrinogen; Fruit; Hematocrit; Hemorheology; Humans; Nigeria; Risk Factors; Vegetables

2012
Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study.
    Diabetes, 2014, Volume: 63, Issue:3

    Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Risk Factors

2014
Homocysteine and other cardiovascular risk factors in patients with lichen planus.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2014, Volume: 28, Issue:11

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Dyslipidemias; Female; Fibrinogen; Homocysteine; Humans; Lichen Planus; Male; Metabolic Syndrome; Middle Aged; Risk Factors

2014
C-reactive protein and fibrinogen levels as determinants of recurrent preeclampsia: a prospective cohort study.
    Journal of hypertension, 2014, Volume: 32, Issue:2

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Gestational Age; Humans; Infant, Newborn; Inflammation Mediators; Labor, Induced; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Third; Prospective Studies; Recurrence; Risk Factors

2014
Cluster of cardiometabolic risk factors in children with GH deficiency: a prospective, case-control study.
    Clinical endocrinology, 2014, Volume: 80, Issue:6

    Topics: Adipokines; Adiponectin; Biomarkers; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Child; Cholesterol; Female; Fibrinogen; Homocysteine; Human Growth Hormone; Humans; Inflammation; Leptin; Male; Prospective Studies; Risk Factors; Treatment Outcome

2014
The additive impact of periodic limb movements during sleep on inflammation in patients with obstructive sleep apnea.
    Annals of the American Thoracic Society, 2014, Volume: 11, Issue:3

    Topics: Adult; Aged; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Nocturnal Myoclonus Syndrome; Polysomnography; Risk Factors; Sleep Apnea, Obstructive

2014
Analysis of a sample of type 2 diabetic patients with obesity or overweight and at cardiovascular risk: a cross sectional study in Spain.
    BMC research notes, 2014, Jan-21, Volume: 7

    Topics: Age of Onset; Anthropometry; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diet; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypertension; Insulin; Life Style; Lipids; Male; Middle Aged; Motor Activity; Obesity; Overweight; Risk Factors; Spain

2014
Clinical and laboratory parameters associated with metabolic syndrome in Turkish patients with psoriasis.
    The Journal of international medical research, 2014, Volume: 42, Issue:2

    Topics: Adiponectin; Adult; Body Mass Index; Cardiovascular Diseases; Female; Fibrinogen; Humans; Hyperglycemia; Hypertriglyceridemia; Lipoproteins, HDL; Male; Metabolic Syndrome; Obesity; Psoriasis; Triglycerides; Turkey

2014
Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients.
    Sleep & breathing = Schlaf & Atmung, 2014, Volume: 18, Issue:4

    Topics: Adult; Aged; Cardiovascular Diseases; Fibrinogen; Humans; Male; Middle Aged; Polysomnography; Prospective Studies; Reference Values; Risk Factors; Sleep Apnea, Obstructive

2014
Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile.
    Acta diabetologica, 2014, Volume: 51, Issue:6

    Topics: Adult; Aged; Asymptomatic Diseases; Blood Glucose; Blood Sedimentation; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Complement C3; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Tolerance Test; Humans; Inflammation; Male; Metabolome; Middle Aged; Prediabetic State; Risk Factors; Time Factors

2014
Plasma fibrinogen associates independently with total and cardiovascular mortality among subjects with normal and reduced kidney function in the general population.
    QJM : monthly journal of the Association of Physicians, 2014, Volume: 107, Issue:9

    Topics: Cardiovascular Diseases; Cause of Death; Confidence Intervals; Female; Fibrinogen; Humans; Ireland; Kidney Function Tests; Male; Middle Aged; Mortality; Nutrition Surveys; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Factors; Severity of Illness Index

2014
Heterogeneity of cardiovascular risk factors profile in non-diabetic women 2-24 months post gestational diabetes mellitus.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:5

    Topics: Adult; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Diabetes, Gestational; E-Selectin; Female; Fibrinogen; Humans; Insulin; Postpartum Period; Pregnancy; Statistics, Nonparametric; Triglycerides; Waist Circumference; Young Adult

2014
Proinflammatory and prothrombotic state in subjects with different glucose tolerance status before cardiovascular disease.
    Journal of diabetes research, 2014, Volume: 2014

    Topics: Adult; Aged; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Early Diagnosis; Female; Fibrinogen; Glucose Intolerance; Glycated Hemoglobin; Humans; Male; Mexico; Middle Aged; Overweight; Prediabetic State; Risk Factors; Thrombosis; Vasculitis

2014
Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: associations with inflammatory and cardiometabolic markers in 4391 subjects.
    Diabetes & metabolism, 2014, Volume: 40, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Inflammation; Insulin Resistance; Iran; Lipids; Liver; Male; Metabolic Syndrome; Middle Aged; Obesity; Vitamin D; Waist Circumference

2014
Relationship of coagulation and fibrinolytic variables with arterial structure and function in Africans.
    Thrombosis research, 2014, Volume: 134, Issue:1

    Topics: Africa; Black People; Blood Coagulation; Cardiovascular Diseases; Cohort Studies; Disease Progression; Female; Fibrin Clot Lysis Time; Fibrinogen; Fibrinolysis; Humans; Male; Prospective Studies; Risk Factors

2014
Evaluating the role of inflammation in chronic airways disease: the ERICA study.
    COPD, 2014, Volume: 11, Issue:5

    Topics: Adult; Aged; Cardiovascular Diseases; Carotid Intima-Media Thickness; Exercise Test; Female; Fibrinogen; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Muscle Strength; Muscular Diseases; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulse Wave Analysis; Quadriceps Muscle; Respiratory Muscles; Smoking

2014
A genetic association study of D-dimer levels with 50K SNPs from a candidate gene chip in four ethnic groups.
    Thrombosis research, 2014, Volume: 134, Issue:2

    Topics: Adult; Aged; Cardiovascular Diseases; Ethnicity; Factor V; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genetic Association Studies; Genotype; Humans; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Polymorphism, Single Nucleotide; Young Adult

2014
Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events.
    Journal of the American Heart Association, 2014, Jun-23, Volume: 3, Issue:3

    Topics: Adipokines; Aged; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Chitinase-3-Like Protein 1; Cholesterol, LDL; Female; Fibrinogen; Genome-Wide Association Study; Humans; Incidence; Intercellular Adhesion Molecule-1; Lectins; Middle Aged; Myocardial Infarction; Polymorphism, Single Nucleotide; Prospective Studies; Stroke

2014
Haemostatic factors, lipoproteins and long-term mortality in a multi-ethnic population of Gujarati, African-Caribbean and European origin.
    Atherosclerosis, 2014, Volume: 236, Issue:1

    Topics: Adult; Aged; Anthropometry; Antigens; Apolipoprotein A-I; Apolipoproteins B; Black People; Cardiovascular Diseases; Caribbean Region; Ethnicity; Europe; Factor VII; Female; Fibrinogen; Follow-Up Studies; Humans; India; Kaplan-Meier Estimate; London; Male; Middle Aged; Mortality; Proportional Hazards Models; Prospective Studies; Risk Factors; Sampling Studies; Thrombophilia; Vascular Stiffness; von Willebrand Factor; White People

2014
Plasma viscosity, functional fibrinogen, and platelet reactivity in vascular surgery patients.
    Clinical hemorheology and microcirculation, 2015, Volume: 61, Issue:3

    Topics: Aged; Blood Platelets; Blood Viscosity; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Humans; Male; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies

2015
[Detection of early markers of atherosclerosis in men with various levels of risk of cardiovascular complications].
    Kardiologiia, 2014, Volume: 54, Issue:6

    Topics: Adult; Ankle Brachial Index; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Carotid Arteries; Carotid Intima-Media Thickness; Early Diagnosis; Fibrinogen; Glucose; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Risk Assessment; Risk Factors; Tomography, Spiral Computed; Ultrasonography, Doppler, Duplex; Uric Acid

2014
Leukocyte telomere length and hemostatic factors in a South African cohort: the SABPA Study.
    Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:12

    Topics: Adult; Algorithms; Black People; Cardiovascular Diseases; Cohort Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Incidence; Leukocytes; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Software; South Africa; Telomere; von Willebrand Factor

2014
Novel locus for fibrinogen in 3' region of LEPR gene in island population of Vis (Croatia).
    Journal of human genetics, 2014, Volume: 59, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Croatia; Female; Fibrinogen; Gene Frequency; Genetics, Population; Haplotypes; Humans; Islands; Linkage Disequilibrium; Lipids; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Receptors, Leptin; Risk Factors; Waist Circumference; Young Adult

2014
Fibrin clot properties and haemostatic function in men and women with type 1 diabetes.
    Thrombosis and haemostasis, 2015, Volume: 113, Issue:2

    Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 1; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hyperglycemia; Male; Microcirculation; Middle Aged; Nephelometry and Turbidimetry; Permeability; Risk Factors; Thrombin; Thrombosis; Young Adult

2015
Subclinical hypothyroidism and cardiovascular risk.
    Clinical hemorheology and microcirculation, 2014, Volume: 58, Issue:1

    Topics: Adult; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Erythrocytes; Female; Fibrinogen; Healthy Volunteers; Homocysteine; Humans; Hypothyroidism; Immunoenzyme Techniques; Inflammation; Male; Middle Aged; Regression Analysis; Risk Factors; Thyrotropin; Viscosity

2014
Chronic pain, body mass index and cardiovascular disease risk factors: tests of moderation, unique and shared relationships in the Study of Women's Health Across the Nation (SWAN).
    Journal of behavioral medicine, 2015, Volume: 38, Issue:2

    Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Chronic Pain; Female; Fibrinogen; Humans; Lipoproteins, HDL; Middle Aged; Obesity; Risk Factors; Triglycerides; Women's Health

2015
Progression of cardiovascular risk factors in black Africans: 3 year follow up of the SABPA cohort study.
    Atherosclerosis, 2015, Volume: 238, Issue:1

    Topics: Adult; Black People; Blood Glucose; Cardiovascular Diseases; Cholesterol; Cohort Studies; Diastole; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; South Africa; Systole; Waist Circumference

2015
Association between salivary cotinine and cardiovascular biomarkers among nonsmokers and current smokers: cross-sectional study of 10,081 participants.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2014, Volume: 48, Issue:6

    Topics: Adolescent; Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cotinine; Cross-Sectional Studies; Female; Fibrinogen; Health Surveys; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Risk Factors; Saliva; Scotland; Smoking; Time Factors; Tobacco Smoke Pollution; Young Adult

2014
Cigarette smoking is associated with dose-dependent adverse effects on paraoxonase activity and fibrinogen in young women.
    Inhalation toxicology, 2014, Volume: 26, Issue:14

    Topics: Adult; Aryldialkylphosphatase; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Fibrinogen; Humans; Oxidative Stress; Risk Factors; Smoking; Young Adult

2014
sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study.
    Journal of diabetes and its complications, 2015, Volume: 29, Issue:2

    Topics: Atherosclerosis; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Female; Fibrinogen; gamma-Glutamyltransferase; Humans; Incidence; Inflammation Mediators; Male; Middle Aged; Models, Biological; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Risk Factors; Solubility; United States

2015
Influence of anti-VEGF about cardiovascular biomarkers in age related macular degeneration.
    The journal of nutrition, health & aging, 2015, Volume: 19, Issue:2

    Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Lipids; Macular Degeneration; Male; Middle Aged; Ranibizumab; Risk Factors; Vascular Endothelial Growth Factor A; Wet Macular Degeneration

2015
Prospective association of TV viewing with acute phase reactants and coagulation markers: English Longitudinal Study of Ageing.
    Atherosclerosis, 2015, Volume: 239, Issue:2

    Topics: Acute-Phase Reaction; Aged; Aging; Blood Coagulation; C-Reactive Protein; Cardiovascular Diseases; England; Exercise; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Leukocytes; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Risk Factors; Sedentary Behavior; Television

2015
Homocysteine influences blood clot properties alone and in combination with total fibrinogen but not with fibrinogen γ' in Africans.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2015, Volume: 26, Issue:4

    Topics: Black People; Blood Coagulation; Cardiovascular Diseases; Cross-Sectional Studies; Fibrin Clot Lysis Time; Fibrinogen; Fibrinogens, Abnormal; Genotype; Hemostasis; Homocysteine; Humans; Polymorphism, Single Nucleotide; Risk Factors

2015
Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State.
    Journal of atherosclerosis and thrombosis, 2015, Volume: 22, Issue:6

    Topics: Adult; Aged; Biomarkers; Body Mass Index; Cardiovascular Diseases; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Humans; Hypertension; Inflammation; Inflammation Mediators; Lipids; Male; Middle Aged; Prognosis; Thrombosis

2015
Markers of inflammation and mortality in a cohort of patients with alcohol dependence.
    Medicine, 2015, Volume: 94, Issue:10

    Topics: Adult; Alcoholism; Anemia; Cardiovascular Diseases; Cohort Studies; Erythrocyte Indices; Female; Ferritins; Fibrinogen; Humans; Inflammation; Liver Diseases, Alcoholic; Longitudinal Studies; Male

2015
Sleep and future cardiovascular risk: prospective analysis from the English Longitudinal Study of Ageing.
    Sleep medicine, 2015, Volume: 16, Issue:6

    Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; England; Female; Fibrinogen; Humans; Hypertension; Incidence; Inflammation; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Risk Factors; Sex Factors; Sleep Wake Disorders

2015
The association between fibrinogen reactivity to mental stress and high-sensitivity cardiac troponin T in healthy adults.
    Psychoneuroendocrinology, 2015, Volume: 59

    Topics: Aged; Biomarkers; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Stress, Psychological; Troponin T

2015
Correlates of serum hepcidin levels and its association with cardiovascular disease in an elderly general population.
    Clinical chemistry and laboratory medicine, 2016, Volume: 54, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Aging; Cardiovascular Diseases; Female; Ferritins; Fibrinogen; gamma-Glutamyltransferase; Hepcidins; Humans; Male; Middle Aged; Tandem Mass Spectrometry

2016
Long-term residential exposure to urban air pollution, and repeated measures of systemic blood markers of inflammation and coagulation.
    Occupational and environmental medicine, 2015, Volume: 72, Issue:9

    Topics: Aged; Air Pollutants; Air Pollution; Biomarkers; Blood Coagulation; C-Reactive Protein; Cardiovascular Diseases; Environmental Exposure; Female; Fibrinogen; Germany; Humans; Inflammation; Male; Middle Aged; Particulate Matter; Platelet Count; Prospective Studies; Residence Characteristics

2015
Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
    Lipids in health and disease, 2015, Aug-10, Volume: 14

    Topics: Cardiovascular Diseases; Cell Line, Tumor; Farnesyl-Diphosphate Farnesyltransferase; Fibrinogen; Genetic Association Studies; Humans; Models, Biological; Non-alcoholic Fatty Liver Disease; Oligonucleotide Array Sequence Analysis; Proteomics; Risk Factors; Signal Transduction; Up-Regulation

2015
New circulating biomarkers for predicting cardiovascular death in healthy population.
    Journal of cellular and molecular medicine, 2015, Volume: 19, Issue:10

    Topics: Aged; Biomarkers; Blood Proteins; Cardiovascular Diseases; Case-Control Studies; Female; Fibrinogen; Follow-Up Studies; Health; Humans; Male; Middle Aged; Vitamin D-Binding Protein

2015
Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes.
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2016, Volume: 25, Issue:1

    Topics: Adult; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cross-Sectional Studies; Female; Fibrinogen; Humans; Insulin Resistance; Phenotype; Polycystic Ovary Syndrome; Risk Assessment; Triglycerides; Young Adult

2016
Comparison of risk factors for cardiovascular disease in hemodialysis and peritoneal dialysis patients.
    Clinics (Sao Paulo, Brazil), 2015, Volume: 70, Issue:9

    Topics: Adult; Atherosclerosis; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Peritoneal Dialysis; Renal Dialysis; Risk Factors; Triglycerides

2015
Identification of ageing-associated naturally occurring peptides in human urine.
    Oncotarget, 2015, Oct-27, Volume: 6, Issue:33

    Topics: Adult; Aged; Aged, 80 and over; Aging; Cardiovascular Diseases; Collagen; Diabetes Mellitus; Female; Fibrinogen; Humans; Kidney Diseases; Male; Middle Aged; Peptides; Proteome; Uromodulin; Young Adult

2015
Roflumilast inhibits leukocyte-platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes.
    Journal of thrombosis and haemostasis : JTH, 2016, Volume: 14, Issue:1

    Topics: Aminopyridines; Animals; Benzamides; Blood Platelets; Cardiovascular Diseases; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Extracellular Traps; Fibrinogen; Humans; Leukocytes; Macrophage-1 Antigen; Mice; Microscopy, Confocal; Monocytes; Neutrophils; P-Selectin; Phosphatidylinositol 3-Kinases; Phosphodiesterase 4 Inhibitors; Phosphorylation; Platelet Adhesiveness; Pulmonary Disease, Chronic Obstructive; Risk; Thromboplastin; Thrombosis

2016
Relationship between visceral obesity and plasma fibrinogen in obese children.
    Journal of pediatric endocrinology & metabolism : JPEM, 2016, Volume: 29, Issue:3

    Topics: Adipose Tissue; Adolescent; Biomarkers; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Child; Cross-Sectional Studies; Female; Fibrinogen; Follow-Up Studies; Humans; Intra-Abdominal Fat; Male; Obesity, Abdominal; Prognosis; Risk Factors; Ultrasonography; Waist-Hip Ratio

2016
A Japanese cross-sectional multicentre study of biomarkers associated with cardiovascular disease in smokers and non-smokers.
    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2015, Volume: 20, Issue:6-7

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Asian People; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cotinine; Cross-Sectional Studies; Dinoprost; Female; Fibrinogen; Humans; Japan; Male; Middle Aged; Smoking; Thromboxane B2

2015
Hemorheological and Glycemic Parameters and HDL Cholesterol for the Prediction of Cardiovascular Events.
    Arquivos brasileiros de cardiologia, 2016, Volume: 106, Issue:1

    Topics: Aged; Biomarkers; Blood Glucose; Blood Sedimentation; Cardiovascular Diseases; Cholesterol, HDL; Coronary Disease; Female; Fibrinogen; Glycated Hemoglobin; Glycemic Index; Hemorheology; Humans; Male; Middle Aged; Outpatients; Predictive Value of Tests; Reproducibility of Results; Risk Factors; Statistics, Nonparametric

2016
Association of exposure to particulate matter (PM2.5) air pollution and biomarkers of cardiovascular disease risk in adult NHANES participants (2001-2008).
    International journal of hygiene and environmental health, 2016, Volume: 219, Issue:3

    Topics: Adult; Air Pollutants; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Environmental Exposure; Female; Fibrinogen; Homocysteine; Humans; Leukocyte Count; Male; Middle Aged; Nutrition Surveys; Ozone; Particulate Matter; Risk Factors; United States; Young Adult

2016
Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
    PloS one, 2016, Volume: 11, Issue:1

    Topics: Adult; Aged; Betaine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Choline; Female; Fibrinogen; Glomerular Filtration Rate; Humans; Inflammation; Interleukin-6; Kidney Transplantation; Longitudinal Studies; Male; Methylamines; Middle Aged; Multivariate Analysis; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Severity of Illness Index; Survival Analysis

2016
Evaluation of cardiovascular disease risk in women with surgically induced menopause.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016, Volume: 32, Issue:6

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrinogen; Growth Differentiation Factor 15; Humans; Hysterectomy; Menopause; Menopause, Premature; Middle Aged; Natriuretic Peptide, Brain; Ovariectomy; Risk; Serum Albumin; Serum Albumin, Human; Triglycerides

2016
Prospective evaluation of postimplantation syndrome evolution on patient outcomes after endovascular aneurysm repair for abdominal aortic aneurysm.
    Journal of vascular surgery, 2016, Volume: 63, Issue:5

    Topics: Aged; Aortic Aneurysm, Abdominal; Biomarkers; Blood Vessel Prosthesis Implantation; C-Reactive Protein; Cardiovascular Diseases; Elective Surgical Procedures; Endovascular Procedures; Female; Fibrinogen; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Leukocyte Count; Male; Middle Aged; Platelet Count; Prospective Studies; Risk Factors; Syndrome; Time Factors; Treatment Outcome

2016
Lack of association of plasma gamma prime (γ') fibrinogen with incident cardiovascular disease.
    Thrombosis research, 2016, Volume: 143

    Topics: Aged; Cardiovascular Diseases; Female; Fibrinogen; Fibrinogens, Abnormal; Hemostasis; Humans; Incidence; Male; Proportional Hazards Models; Risk Factors

2016
Atomic force microscopy as a tool to evaluate the risk of cardiovascular diseases in patients.
    Nature nanotechnology, 2016, Volume: 11, Issue:8

    Topics: Aged; Biomarkers; Blood Viscosity; Cardiovascular Diseases; Erythrocytes; Female; Fibrinogen; Hematologic Tests; Humans; Male; Microscopy, Atomic Force; Middle Aged; Protein Binding; Risk Assessment

2016
Cardiometabolic risk markers of normal weight and excess body weight in Brazilian adolescents.
    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 2016, Volume: 41, Issue:6

    Topics: Adolescent; Biomarkers; Blood Glucose; Blood Pressure; Body Weight; Brazil; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Exercise; Female; Fibrinogen; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Logistic Models; Male; Metabolic Syndrome; Overweight; Risk Factors; Socioeconomic Factors; Triglycerides; Tumor Necrosis Factor-alpha

2016
Elevated Serum Fibrinogen Is Associated With 12-Month Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention.
    Journal of the American College of Cardiology, 2016, 05-31, Volume: 67, Issue:21

    Topics: Aged; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Percutaneous Coronary Intervention; Postoperative Complications; Time Factors

2016
Haemostatic biomarkers are associated with long-term recurrent vascular events after ischaemic stroke.
    Thrombosis and haemostasis, 2016, 08-30, Volume: 116, Issue:3

    Topics: Aged; Biomarkers; Carboxypeptidase B2; Cardiovascular Diseases; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Recurrence; Stroke; Tissue Plasminogen Activator; von Willebrand Factor

2016
Participant-Reported Health Status Predicts Cardiovascular and All-Cause Mortality Independent of Established and Nontraditional Biomarkers: Evidence From a Representative US Sample.
    Journal of the American Heart Association, 2016, 08-29, Volume: 5, Issue:9

    Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; Cholesterol, LDL; Female; Fibrinogen; Health Status; Humans; Male; Middle Aged; Mortality; Nutrition Surveys; Patient Reported Outcome Measures; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Self Report; Serum Albumin; Triglycerides; Uric Acid

2016
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
    American journal of respiratory and critical care medicine, 2016, 09-01, Volume: 194, Issue:5

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Biomarkers; Bronchodilator Agents; Cardiovascular Diseases; Disease Progression; Drug Therapy, Combination; Fibrinogen; Forced Expiratory Volume; Humans; Muscarinic Antagonists; Phenotype; Precision Medicine; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Severity of Illness Index

2016
The interaction between systemic inflammation and psychosocial stress in the association with cardiac troponin elevation: A new approach to risk assessment and disease prevention.
    Preventive medicine, 2016, Volume: 93

    Topics: Biomarkers; Calcinosis; Cardiovascular Diseases; Cross-Sectional Studies; Fibrinogen; Humans; Inflammation; Risk Assessment; Stress, Psychological; Troponin T; United Kingdom

2016
Increased fibrinogen responses to psychophysiological stress predict future endothelial dysfunction implications for cardiovascular disease?
    Brain, behavior, and immunity, 2017, Volume: 60

    Topics: Adult; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Endothelium, Vascular; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Stress, Psychological; Tumor Necrosis Factor-alpha; Vasodilation

2017
Plasma and blood viscosity in the prediction of cardiovascular disease and mortality in the Scottish Heart Health Extended Cohort Study.
    European journal of preventive cardiology, 2017, Volume: 24, Issue:2

    Topics: Adult; Aged; Biomarkers; Blood Viscosity; Cardiovascular Diseases; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Multivariate Analysis; Plasma; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Scotland; Time Factors

2017
Role of T-Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV.
    Journal of the American Heart Association, 2016, 12-20, Volume: 5, Issue:12

    Topics: Adult; Blood Coagulation; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; CD8-Positive T-Lymphocytes; Cross-Sectional Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; HIV Infections; Humans; Hyperemia; Inflammation; Interleukin-6; Lipopolysaccharide Receptors; Lymphocyte Activation; Male; Microcirculation; Microvessels; Middle Aged; T-Lymphocytes; Tumor Necrosis Factor-alpha; Vasodilation

2016
A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin
    BioMed research international, 2016, Volume: 2016

    Topics: Abciximab; Animals; Antibodies, Monoclonal; Cardiovascular Diseases; Disease Models, Animal; Eptifibatide; Fibrinogen; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Integrin alpha2; Integrin beta3; Mice; Naphthalenes; Peptides; Platelet Aggregation; Rats; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine

2016
The relationship between smoking intensity and subclinical cardiovascular injury: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis, 2017, Volume: 258

    Topics: Aged; Aged, 80 and over; Biomarkers; Blood Coagulation; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cotinine; Cross-Sectional Studies; Cytokines; Early Diagnosis; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Homocysteine; Humans; Inflammation Mediators; Linear Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Risk Assessment; Risk Factors; Smoking; Troponin T; United States; Vascular Stiffness; Vasodilation

2017
Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease.
    The American journal of cardiology, 2008, Jun-15, Volume: 101, Issue:12

    Topics: Biomarkers; Cardiovascular Diseases; Cause of Death; Confidence Intervals; Female; Fibrinogen; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Ohio; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate

2008
Inflammation markers in individuals with history of mental health crisis.
    Inflammation, 2008, Volume: 31, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Female; Fibrinogen; Humans; Inflammation Mediators; Leukocyte Count; Male; Mental Disorders; Middle Aged; Risk Factors

2008
Vital exhaustion and cardiovascular disease: are circulating fibrinogen and D-dimer levels a plausible link?
    Stress (Amsterdam, Netherlands), 2008, Volume: 11, Issue:4

    Topics: Cardiovascular Diseases; Fatigue; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Stress, Psychological

2008
Overfatness, stunting and physical inactivity are determinants of plasminogen activator inhibitor-1activity, fibrinogen and thrombin-antithrombin complex in African adolescents.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2008, Volume: 19, Issue:5

    Topics: Adolescent; Age Factors; Antithrombins; Black People; C-Reactive Protein; Cardiovascular Diseases; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Male; Motor Activity; Obesity; Plasminogen Activator Inhibitor 1; Sex Factors; South Africa; Thrombin

2008
A priori-defined dietary patterns and markers of cardiovascular disease risk in the Multi-Ethnic Study of Atherosclerosis (MESA).
    The American journal of clinical nutrition, 2008, Volume: 88, Issue:1

    Topics: Aged; Aged, 80 and over; Atherosclerosis; Biomarkers; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery, Common; Diet; Diet Surveys; Ethnicity; Factor Analysis, Statistical; Feeding Behavior; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Linear Models; Male; Middle Aged; Nutrition Assessment; Risk Factors; Surveys and Questionnaires; Tunica Intima; United States

2008
The combined effect of albuminuria and inflammation on all-cause and cardiovascular mortality in nondiabetic persons.
    Journal of internal medicine, 2008, Volume: 264, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Biomarkers; Cardiovascular Diseases; Cause of Death; Creatinine; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Linear Models; Male; Middle Aged; Norway; Proportional Hazards Models; Prospective Studies

2008
[Relationship of fibrinogen with cardiovascular risk factors in healthy men from Maracaibo, Venezuela].
    Investigacion clinica, 2008, Volume: 49, Issue:3

    Topics: Adult; Aged; Cardiovascular Diseases; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Venezuela

2008
Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel.
    Journal of the American College of Cardiology, 2008, Sep-23, Volume: 52, Issue:13

    Topics: Aged; Body Mass Index; Cardiovascular Diseases; Clopidogrel; Diabetes Complications; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Ticlopidine

2008
The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes.
    Diabetes research and clinical practice, 2008, Volume: 82, Issue:3

    Topics: Adult; Albumins; Biomarkers; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Fibrinogen; Humans; Indians, North American; Inflammation; Microcirculation

2008
Relation of educational level to inflammation-sensitive biomarker level.
    The American journal of cardiology, 2008, Oct-15, Volume: 102, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cardiovascular Diseases; Educational Measurement; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Israel; Male; Middle Aged; Patient Education as Topic; Prevalence; Prognosis; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Socioeconomic Factors; Surveys and Questionnaires

2008
Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4.
    Kidney international. Supplement, 2008, Issue:111

    Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Kidney Diseases; Longitudinal Studies; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Factors; Severity of Illness Index

2008
Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension.
    Coronary artery disease, 2009, Volume: 20, Issue:1

    Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery Diseases; Female; Fibrinogen; Humans; Hypertension; Inflammation Mediators; Middle Aged; Odds Ratio; Postmenopause; Predictive Value of Tests; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Ultrasonography, Doppler, Color; Women's Health

2009
[Association between plasma fibrinogen concentration and ten-year change in blood pressure].
    Zhonghua yi xue za zhi, 2008, Aug-19, Volume: 88, Issue:32

    Topics: Adult; Blood Pressure; Cardiovascular Diseases; China; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Surveys and Questionnaires

2008
Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms.
    Journal of the American College of Cardiology, 2008, Dec-16, Volume: 52, Issue:25

    Topics: Adult; Alcohol Drinking; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Disease Progression; Female; Fibrinogen; Health Behavior; Humans; Hypertension; Inflammation; Male; Middle Aged; Motor Activity; Obesity; Odds Ratio; Prospective Studies; Psychological Tests; Psychometrics; Risk Factors; Smoking; Stress, Psychological; Surveys and Questionnaires; United Kingdom

2008
Diurnal and seasonal patterns in inflammation-sensitive biomarker level.
    The American journal of cardiology, 2009, Jan-15, Volume: 103, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cardiovascular Diseases; Circadian Rhythm; Educational Status; Female; Fibrinogen; Humans; Inflammation; Israel; Male; Middle Aged; Patient Education as Topic; Prevalence; Prognosis; Risk Factors; Seasons; Sensitivity and Specificity; Socioeconomic Factors

2009
Occupation and plasma fibrinogen in Japanese male and female workers: the Jichi Medical School Cohort study.
    Social science & medicine (1982), 2009, Volume: 68, Issue:6

    Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Health Behavior; Humans; Japan; Male; Menopause; Middle Aged; Occupations; Risk Factors; Sex Factors; Socioeconomic Factors

2009
[Novel risk factors for cardiovascular disease and tobacco smoke].
    Przeglad lekarski, 2008, Volume: 65, Issue:10

    Topics: Adult; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Causality; Comorbidity; Environmental Monitoring; Epidemiological Monitoring; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Smoking; Tobacco Smoke Pollution

2008
Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies.
    Statistics in medicine, 2009, Mar-30, Volume: 28, Issue:7

    Topics: Bias; Cardiovascular Diseases; Epidemiologic Studies; Fibrinogen; Meta-Analysis as Topic; Models, Statistical; Multivariate Analysis; Regression Analysis

2009
Multiple mechanisms affect the clopidogrel response.
    Journal of the American College of Cardiology, 2009, Mar-10, Volume: 53, Issue:10

    Topics: Biomarkers; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 Enzyme System; Diabetes Complications; Fibrinogen; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Ticlopidine

2009
NASH and cardiovascular biomarkers.
    Obesity (Silver Spring, Md.), 2009, Volume: 17, Issue:4

    Topics: Adiponectin; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fatty Liver; Fibrinogen; Humans; Intra-Abdominal Fat; Obesity; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Triglycerides

2009
Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: data from
    American heart journal, 2009, Volume: 157, Issue:4

    Topics: Cardiovascular Diseases; Cross-Sectional Studies; DNA; Ethnicity; Female; Fibrinogen; Gene Frequency; Genetic Variation; Humans; Intercellular Adhesion Molecule-1; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Morbidity; United States; Women's Health

2009
Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community.
    Journal of hypertension, 2009, Volume: 27, Issue:6

    Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Collagen; Collagen Type III; Cross-Sectional Studies; Data Collection; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Inflammation; Male; Matrix Metalloproteinase 9; Middle Aged; Natriuretic Peptide, Brain; Plasminogen Activator Inhibitor 1; Protein Precursors; Renin; Renin-Angiotensin System; Tissue Inhibitor of Metalloproteinase-1; Ventricular Remodeling

2009
Do inflammatory biomarkers add to the discrimination of cardiovascular disease after allowing for social deprivation? Results from a 10-year cohort study in Glasgow, Scotland.
    European heart journal, 2010, Volume: 31, Issue:21

    Topics: Adult; Analysis of Variance; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Interleukin-18; Interleukin-6; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors; Scotland; Socioeconomic Factors; Tumor Necrosis Factor-alpha

2010
Reverse causation in the association between C-reactive protein and fibrinogen levels and cognitive abilities in an aging sample.
    Psychosomatic medicine, 2009, Volume: 71, Issue:4

    Topics: Aged; Aging; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Causality; Cognition; Cohort Studies; Cross-Sectional Studies; Female; Fibrinogen; Health Status Indicators; Hemostasis; Humans; Inflammation; Intelligence; Male; Neuropsychological Tests; Predictive Value of Tests; Reaction Time; Risk Factors; Scotland

2009
Candidate genes for respiratory disease associated with markers of inflammation and endothelial dysfunction in elderly men.
    Atherosclerosis, 2009, Volume: 206, Issue:2

    Topics: Aged; Aging; Asthma; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Male; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive; Respiration Disorders; Vascular Cell Adhesion Molecule-1

2009
A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease.
    Proteomics, 2009, Volume: 9, Issue:11

    Topics: Adult; alpha 1-Antichymotrypsin; Analysis of Variance; Biomarkers; Blood Proteins; Cardiovascular Diseases; Chromatography, Liquid; Electrophoresis, Gel, Two-Dimensional; Female; Fibrinogen; Humans; Pre-Eclampsia; Pregnancy; Proteome; Proteomics; Tandem Mass Spectrometry

2009
Does fibrinogen add to prediction of cardiovascular disease? Results from the Scottish Heart Health Extended Cohort Study.
    British journal of haematology, 2009, Volume: 146, Issue:4

    Topics: Adult; Aged; Area Under Curve; Biomarkers; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Health Surveys; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Psychosocial Deprivation; Risk Assessment; Risk Factors; Scotland; Sex Factors

2009
Haemostatic and fibrinolytic factors in men with a small abdominal aortic aneurysm.
    The British journal of surgery, 2009, Volume: 96, Issue:8

    Topics: Aged; Antithrombin III; Aortic Aneurysm, Abdominal; Cardiovascular Diseases; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Male; Peptide Hydrolases; Regression Analysis; Risk Factors

2009
Chronic residential exposure to particulate matter air pollution and systemic inflammatory markers.
    Environmental health perspectives, 2009, Volume: 117, Issue:8

    Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Environmental Exposure; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Particulate Matter; Vehicle Emissions

2009
Alcohol consumption and cardiovascular risk factors in older lifelong wine drinkers: the Italian Longitudinal Study on Aging.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2010, Volume: 20, Issue:9

    Topics: Aged; Aged, 80 and over; Alcohol Drinking; Apolipoprotein A-I; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Fibrinogen; Humans; Insulin; Italy; Lipids; Logistic Models; Male; Risk Factors; Waist Circumference; Wine

2010
The relationship of the Fas 670 A/G gene polymorphism with cardiovascular risk factors in polycystic ovary syndrome (PCOS) patients.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2010, Volume: 26, Issue:3

    Topics: 17-alpha-Hydroxyprogesterone; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cholesterol; DNA; fas Receptor; Female; Fibrinogen; Genotype; Humans; Insulin; Polycystic Ovary Syndrome; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Testosterone; Triglycerides

2010
Dietary patterns are linked to cardiovascular risk factors but not to inflammatory markers in Alaska Eskimos.
    The Journal of nutrition, 2009, Volume: 139, Issue:12

    Topics: Adolescent; Adult; Alaska; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Feeding Behavior; Female; Fibrinogen; Humans; Inflammation; Inuit; Male; Risk Factors; Surveys and Questionnaires; Triglycerides

2009
Leukocyte count is associated with incidence of coronary events, but not with stroke: a prospective cohort study.
    Atherosclerosis, 2010, Volume: 209, Issue:2

    Topics: Adult; Cardiovascular Diseases; Coronary Disease; Female; Fibrinogen; Humans; Incidence; Leukocyte Count; Male; Middle Aged; Prospective Studies; Risk Factors; Sex Factors; Smoking; Stroke; Sweden

2010
Genetic cardiovascular risk factors and age-related macular degeneration.
    Acta ophthalmologica, 2011, Volume: 89, Issue:4

    Topics: Aged; Aged, 80 and over; Apolipoprotein E4; Cardiovascular Diseases; Case-Control Studies; Female; Fibrinogen; Genetic Markers; Genetic Predisposition to Disease; Genotype; Humans; Macular Degeneration; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Single-Blind Method; White People

2011
Patients with hypertension and the cardiometabolic syndrome: the potential impact of inflammatory biomarkers.
    Journal of clinical hypertension (Greenwich, Conn.), 2009, Volume: 11, Issue:11

    Topics: Biomarkers; Black or African American; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Hypertension; Inflammation; Interleukin-6; Metabolic Syndrome; Middle Aged; Risk Factors; Tumor Necrosis Factor-alpha

2009
Anthropometric indices as determinants of haemorheological cardiovascular disease risk factors in Nigerian adults living in a semi-urban community.
    Clinical hemorheology and microcirculation, 2009, Volume: 43, Issue:4

    Topics: Adult; Anthropometry; Blood Pressure; Body Composition; Body Mass Index; Cardiovascular Diseases; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Nigeria; Obesity; Regression Analysis; Risk Factors; Urban Population; Waist Circumference; Waist-Hip Ratio

2009
Common coding variants of the HNF1A gene are associated with multiple cardiovascular risk phenotypes in community-based samples of younger and older European-American adults: the Coronary Artery Risk Development in Young Adults Study and The Cardiovascula
    Circulation. Cardiovascular genetics, 2009, Volume: 2, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Black or African American; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Female; Fibrinogen; gamma-Glutamyltransferase; Genetic Predisposition to Disease; Genotype; Hepatocyte Nuclear Factor 1-alpha; Humans; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; White People

2009
Indices of obesity and cardiovascular risk factors in British women.
    Obesity facts, 2008, Volume: 1, Issue:4

    Topics: Adult; Aged; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Obesity; Prospective Studies; Risk Factors; Surveys and Questionnaires; Triglycerides; United Kingdom; Waist-Hip Ratio

2008
Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study.
    Annals of human genetics, 2010, Volume: 74, Issue:1

    Topics: Aged; Cardiovascular Diseases; Carotid Arteries; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Humans; Interleukin-6; Male; Models, Biological; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk; Stroke

2010
The role of the inflammatory markers ferritin, transferrin and fibrinogen in the relationship between major depression and cardiovascular disorders - The German Health Interview and Examination Survey.
    Acta psychiatrica Scandinavica, 2010, Volume: 121, Issue:2

    Topics: Aged; Cardiovascular Diseases; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Ferritins; Fibrinogen; Germany; Health Status; Humans; Interviews as Topic; Male; Severity of Illness Index; Social Class; Surveys and Questionnaires; Transferrin

2010
Gene polymorphisms in association with emerging cardiovascular risk markers in adult women.
    BMC medical genetics, 2010, Jan-15, Volume: 11

    Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Demography; Female; Fibrinogen; Genotype; Homocysteine; Humans; Linear Models; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Uric Acid

2010
Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?
    Journal of the American College of Cardiology, 2009, Dec-15, Volume: 54, Issue:25

    Topics: Aging; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Factor VII; Female; Fibrinogen; Humans; Insulin; Linear Models; Lipoproteins; Longitudinal Studies; Middle Aged; Perimenopause; Plasminogen Activator Inhibitor 1; Prospective Studies; Racial Groups; Risk Factors; Triglycerides; United States

2009
Menopause, age, and cardiovascular risk: a complex relationship.
    Journal of the American College of Cardiology, 2009, Dec-15, Volume: 54, Issue:25

    Topics: Aging; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Factor VII; Female; Fibrinogen; Humans; Insulin; Lipoproteins; Middle Aged; Perimenopause; Plasminogen Activator Inhibitor 1; Racial Groups; Risk Factors; Triglycerides

2009
Clinical and biochemical parameters related to cardiovascular disease after Helicobacter pylori eradication.
    International angiology : a journal of the International Union of Angiology, 2009, Volume: 28, Issue:6

    Topics: Anti-Bacterial Agents; Biomarkers; Blood Pressure; Body Mass Index; Breath Tests; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Middle Aged; Remission Induction; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

2009
Association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Psychosomatic medicine, 2010, Volume: 72, Issue:2

    Topics: Adaptation, Psychological; Adult; Aged; Aged, 80 and over; Atherosclerosis; Attitude to Health; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus; Ethnicity; Female; Fibrinogen; Health Behavior; Hemostasis; Humans; Hypertension; Inflammation; Interleukin-6; Male; Middle Aged; Personality; Risk Factors

2010
Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentrations in Taiwanese individuals.
    Clinical chemistry and laboratory medicine, 2010, Volume: 48, Issue:4

    Topics: Adult; Age Factors; Asian People; Blood Glucose; Cardiovascular Diseases; Female; Fibrinogen; Genotype; Humans; Male; Matrix Metalloproteinase 9; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Smoking; Taiwan

2010
Association of lipid and inflammatory markers with C-reactive protein in cardiovascular risk assessment for primary prevention.
    Clinical laboratory, 2009, Volume: 55, Issue:11-12

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Odds Ratio; Primary Prevention; Risk Factors; Serum Amyloid A Protein

2009
[Inflammation markers and endothelial disfunction in children with type 1 diabetes].
    Medicina, 2010, Volume: 70, Issue:1

    Topics: Adolescent; Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Child; Diabetes Mellitus, Type 1; Diabetic Angiopathies; E-Selectin; Endothelium, Vascular; Female; Fibrinogen; Glycated Hemoglobin; Humans; Inflammation; Male; Vascular Cell Adhesion Molecule-1

2010
Fibrinogen assays for cardiovascular risk assessment.
    Clinical chemistry, 2010, Volume: 56, Issue:5

    Topics: Cardiovascular Diseases; Fibrinogen; Risk Assessment

2010
Gamma' fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease.
    Clinical chemistry, 2010, Volume: 56, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Cardiovascular Diseases; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Limit of Detection; Male; Middle Aged; Risk Factors; ROC Curve

2010
Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA.
    The American journal of cardiology, 2010, May-01, Volume: 105, Issue:9

    Topics: Adult; Aged; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Homocysteine; Humans; Incidence; Leukocyte Count; Lipoproteins; Male; Middle Aged; Platelet Count; Prognosis; Reference Values; Retrospective Studies; Risk Assessment; Risk Factors; United States

2010
Effects of long-term hormone replacement therapy: results from a cohort study.
    Journal of endocrinological investigation, 2011, Volume: 34, Issue:3

    Topics: Adult; Aged; Antithrombin III; Cardiovascular Diseases; Cholesterol; Cohort Studies; Female; Fibrinogen; Hormone Replacement Therapy; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Postmenopause; Risk Assessment; Time Factors

2011
Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
    Thrombosis research, 2010, Volume: 126, Issue:1

    Topics: Adult; Aged; Blood Coagulation Tests; Cardiovascular Diseases; Case-Control Studies; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Inflammation; Male; Middle Aged; Permeability; Plasminogen Activator Inhibitor 1; Thrombosis; Tissue Plasminogen Activator; Young Adult

2010
Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey.
    BMJ (Clinical research ed.), 2010, May-27, Volume: 340

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Cross-Sectional Studies; Dental Care; Female; Fibrinogen; Health Surveys; Humans; Infections; Male; Middle Aged; Patient Acceptance of Health Care; Periodontitis; Prevalence; Risk Factors; Scotland; Toothbrushing

2010
Haemorheologic and fibrinolytic activity in Nigerian HIV infected patients.
    African health sciences, 2008, Volume: 8, Issue:4

    Topics: Blood Viscosity; Cardiovascular Diseases; Case-Control Studies; Fibrinogen; Fibrinolysis; Hematocrit; Hemorheology; HIV Infections; HIV-1; Humans; Risk Factors; Serum Globulins

2008
Objectively measured secondhand smoke exposure and risk of cardiovascular disease: what is the mediating role of inflammatory and hemostatic factors?
    Journal of the American College of Cardiology, 2010, Jun-29, Volume: 56, Issue:1

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cotinine; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Inflammation; Male; Middle Aged; Saliva; Tobacco Smoke Pollution

2010
Prevention: Reducing the risk of CVD in patients with periodontitis.
    Nature reviews. Cardiology, 2010, Volume: 7, Issue:9

    Topics: C-Reactive Protein; Cardiovascular Diseases; Chronic Periodontitis; Fibrinogen; Humans; Inflammation; Lipid Metabolism; Oral Hygiene; Risk Factors

2010
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
    Thrombosis and haemostasis, 2010, Volume: 104, Issue:6

    Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aspirin; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrinogen; Germany; Humans; Inflammation Mediators; Leukocyte Count; Linear Models; Logistic Models; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome

2010
Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe).
    Blood, 2011, Jan-06, Volume: 117, Issue:1

    Topics: Adult; Aged; Black or African American; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; White People

2011
Effect of blood sample type on the measurement of advanced oxidation protein products as a biomarker of inflammation and oxidative stress in hemodialysis patients.
    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2011, Volume: 16, Issue:2

    Topics: Biomarkers; Blood Specimen Collection; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Peroxidase; Renal Dialysis; Tumor Necrosis Factor-alpha

2011
Glycemic and lipidic profile in diabetic patients undergoing dialysis.
    Arquivos brasileiros de endocrinologia e metabologia, 2010, Volume: 54, Issue:9

    Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Diabetic Nephropathies; Epidemiologic Methods; Female; Fibrinogen; Glycated Hemoglobin; Humans; Lipids; Male; Middle Aged; Patient Care Team; Peritoneal Dialysis; Renal Dialysis

2010
Masked hypertension unfavourably affects haemostasis parameters.
    Blood pressure, 2011, Volume: 20, Issue:4

    Topics: Antigens; Blood Pressure; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Hemostasis; Humans; Hypertension; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Thrombomodulin; Tissue Plasminogen Activator

2011
Prevalence of low ankle-brachial index, elevated plasma fibrinogen and CRP across Framingham risk categories: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    Atherosclerosis, 2011, Volume: 216, Issue:1

    Topics: Adult; Aged; Ankle Brachial Index; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Nutrition Surveys; Peripheral Vascular Diseases; Prevalence; Risk Assessment; Risk Factors; Time Factors; United States; Up-Regulation

2011
Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City Heart Study.
    European journal of preventive cardiology, 2012, Volume: 19, Issue:1

    Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; Denmark; Female; Fibrinogen; Health Surveys; Heart Rate; Humans; Inflammation Mediators; Linear Models; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors

2012
Childhood intelligence and midlife inflammatory and hemostatic biomarkers: the National Child Development Study (1958) cohort.
    Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 2011, Volume: 30, Issue:6

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Child; Child Development; Cognition; Cohort Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Intelligence; Male; Middle Aged; Prospective Studies; Risk Factors; Social Class; Tissue Plasminogen Activator; United Kingdom; von Willebrand Factor

2011
Effects of obstructive sleep apnea and its treatment on cardiovascular risk in CAD patients.
    Respiratory medicine, 2011, Volume: 105, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Continuous Positive Airway Pressure; Cross-Sectional Studies; Endothelin-1; Female; Fibrinogen; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Polysomnography; Sleep Apnea, Obstructive

2011
Age as a modulator of inflammatory cardiovascular risk factors.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:9

    Topics: Age Factors; Biomarkers; Black or African American; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Phospholipases A2; Risk Factors; Serum Amyloid A Protein; Serum Amyloid P-Component; White People

2011
Correlation of atherogenetic biomarkers and estradiol changes in postmenopause.
    Georgian medical news, 2011, Issue:195

    Topics: Adult; Age Factors; Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Catalase; Cholesterol; Cholesterol, LDL; Estradiol; Estrogens; Female; Fibrinogen; Glutathione Reductase; Humans; Middle Aged; Postmenopause; Risk Factors; Superoxide Dismutase; Triglycerides

2011
Plasma adrenomedullin level is related to a single nucleotide polymorphism in the adrenomedullin gene.
    European journal of endocrinology, 2011, Volume: 165, Issue:4

    Topics: Adrenomedullin; Adult; Age Factors; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Gene Frequency; Genotype; Haplotypes; Hong Kong; Humans; Interleukin-6; Male; Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Risk Factors; Sex Factors

2011
Fibrinogen concentration and its role in CVD risk in black South Africans--effect of urbanisation.
    Thrombosis and haemostasis, 2011, Volume: 106, Issue:3

    Topics: Adult; Biomarkers; Black People; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Prognosis; Risk; Rural Population; South Africa; Urbanization

2011
Significant inverse association of marine n-3 fatty acids with plasma fibrinogen levels in Japanese in Japan but not in whites or Japanese Americans.
    European journal of clinical nutrition, 2012, Volume: 66, Issue:3

    Topics: Adult; Asian People; Cardiovascular Diseases; Cross-Sectional Studies; Diet; Dietary Fats; Fatty Acids, Omega-3; Fibrinogen; Fish Oils; Hawaii; Humans; Japan; Linear Models; Male; Middle Aged; Pennsylvania; Risk Factors; White People

2012
Elevated plasma factor VIII and von Willebrand factor in women with type 2 diabetes: inflammatory reaction, endothelial perturbation or else?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:7

    Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Diabetes Mellitus, Type 2; Endothelium, Vascular; Factor VIII; Female; Fibrinogen; Humans; Inflammation; Middle Aged; Thrombomodulin; Tunica Intima; Ultrasonography, Doppler, Color; von Willebrand Factor

2011
Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2011, Volume: 42, Issue:6

    Topics: Aged; Angioplasty; Cardiovascular Diseases; Factor V; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Intermittent Claudication; Ischemia; Leg; Lupus Coagulation Inhibitor; Male; Peripheral Arterial Disease; Proportional Hazards Models; Risk Factors; Stents; Thrombophilia; Thrombosis

2011
Plasma fibrinogen: a possible link between job stress and cardiovascular disease among Chinese workers.
    American journal of industrial medicine, 2012, Volume: 55, Issue:2

    Topics: Adaptation, Psychological; Adult; Cardiovascular Diseases; China; Confidence Intervals; Female; Fibrinogen; Humans; Linear Models; Male; Occupational Diseases; Occupational Exposure; Odds Ratio; Psychometrics; Risk Assessment; Stress, Psychological

2012
Geographic variation in cardiovascular inflammation among healthy women in the Women's Health Study.
    PloS one, 2011, Volume: 6, Issue:11

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Geography; Humans; Inflammation; Intercellular Adhesion Molecule-1; Middle Aged; Prevalence; Risk Factors; United States; Women's Health

2011
Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children.
    HIV medicine, 2012, Volume: 13, Issue:5

    Topics: Adolescent; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cell Adhesion Molecules; Chemokine CCL2; Child; Cohort Studies; E-Selectin; Female; Fibrinogen; HIV Infections; HIV-1; Humans; Hyperlipidemias; Interleukin-6; Male; Multivariate Analysis; P-Selectin; Risk Factors; Virus Replication

2012
Incremental value of biochemical and echocardiographic measures in prediction of ischemic stroke: the Strong Heart Study.
    Stroke, 2012, Volume: 43, Issue:3

    Topics: Aged; Albuminuria; Brain Ischemia; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Creatinine; Data Interpretation, Statistical; Echocardiography; Female; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Heart; Heart Atria; Humans; Indians, North American; Kidney Diseases; Male; Middle Aged; Risk Factors; Stroke

2012
Changes in cardiovascular risk factors and inflammatory markers of young, healthy, men after six weeks of moderate or high intensity resistance training.
    The Journal of sports medicine and physical fitness, 2011, Volume: 51, Issue:4

    Topics: Adult; Apolipoproteins A; Apolipoproteins B; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Fibrinogen; Humans; Interleukin-1; Interleukin-6; Lipoprotein Lipase; Male; Random Allocation; Resistance Training; Risk Factors; Triglycerides; Waist-Hip Ratio; Young Adult

2011
Erythrocyte deformability dependence on band 3 protein in an in-vitro model of hyperfibrinogenemia.
    Clinical hemorheology and microcirculation, 2012, Volume: 50, Issue:3

    Topics: Anion Exchange Protein 1, Erythrocyte; Cardiovascular Diseases; Erythrocyte Deformability; Erythrocyte Membrane; Erythrocytes; Fibrinogen; Humans; Male; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Signal Transduction

2012
Effects of oral estradiol and levonorgestrel on cardiovascular risk markers in postmenopausal women.
    Archives of gynecology and obstetrics, 2012, Volume: 285, Issue:6

    Topics: Aged; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Levonorgestrel; Middle Aged; Partial Thromboplastin Time; Postmenopause; Prothrombin Time; Randomized Controlled Trials as Topic; Risk; Triglycerides

2012
Aronia melanocarpa extract suppresses the biotoxicity of homocysteine and its metabolite on the hemostatic activity of fibrinogen and plasma.
    Nutrition (Burbank, Los Angeles County, Calif.), 2012, Volume: 28, Issue:7-8

    Topics: Adult; Anticoagulants; Antioxidants; Blood Coagulation; Cardiovascular Diseases; Coagulants; Dietary Supplements; Fibrinogen; Fruit; Homocysteine; Humans; Hyperhomocysteinemia; Models, Biological; Oxidative Stress; Photinia; Plant Extracts; Poland; Polymerization; Resveratrol; Stilbenes

2012
[Prevalence of obesity and cardiovascular risk in the general population of a health area in Extremadura (Spain): the Hermex study].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2012, Volume: 59, Issue:3

    Topics: Adult; Aged; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Comorbidity; Cross-Sectional Studies; Female; Fibrinogen; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Ischemia; Obesity; Overweight; Prevalence; Risk Factors; Sampling Studies; Smoking; Spain; Waist Circumference

2012
Cardiovascular inflammation in healthy women: multilevel associations with state-level prosperity, productivity and income inequality.
    BMC public health, 2012, Mar-20, Volume: 12

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Intercellular Adhesion Molecule-1; Middle Aged; Social Class; Women's Health

2012
Exposure to polycyclic aromatic hydrocarbons and serum inflammatory markers of cardiovascular disease.
    Environmental research, 2012, Volume: 117

    Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Female; Fibrinogen; Fluorenes; Homocysteine; Humans; Leukocyte Count; Linear Models; Male; Middle Aged; Naphthalenes; Phenanthrenes; Polycyclic Aromatic Hydrocarbons; Pyrenes; United States

2012
Endogenous oestradiol as a positive correlate of plasma fibrinogen among older postmenopausal women: a population-based study (the Three-City cohort study).
    Clinical endocrinology, 2012, Volume: 77, Issue:6

    Topics: Aged; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Estradiol; Female; Fibrinogen; Gonadal Steroid Hormones; Humans; Overweight; Postmenopause; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone

2012
The polyphenol-rich extracts from black chokeberry and grape seeds impair changes in the platelet adhesion and aggregation induced by a model of hyperhomocysteinemia.
    European journal of nutrition, 2013, Volume: 52, Issue:3

    Topics: Adult; Antioxidants; Blood Platelets; Cardiovascular Diseases; Collagen; Dietary Supplements; Fibrinogen; Fruit; Grape Seed Extract; Homocysteine; Humans; Hyperhomocysteinemia; Photinia; Plant Extracts; Platelet Activation; Platelet Aggregation Inhibitors; Polyphenols; Seeds; Superoxides; Vitis; Young Adult

2013
T-wave amplitude is related to physical fitness status.
    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2012, Volume: 17, Issue:3

    Topics: Adult; Age Factors; Aged; Analysis of Variance; Biomarkers; Blood Chemical Analysis; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Electrocardiography; Exercise Test; Female; Fibrinogen; Heart Rate; Humans; Israel; Linear Models; Male; Middle Aged; Multivariate Analysis; Physical Examination; Physical Fitness; Predictive Value of Tests; Reference Values; Risk Assessment; Sex Factors; Young Adult

2012
Prognostic markers in young patients with premature coronary heart disease.
    Atherosclerosis, 2012, Volume: 224, Issue:1

    Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Prognosis; Recurrence; Regression Analysis; Risk Factors; Survival Analysis; von Willebrand Factor

2012
Effects of cold air on cardiovascular disease risk factors in rat.
    International journal of environmental research and public health, 2012, Volume: 9, Issue:7

    Topics: Animals; Blood Pressure; Blood Viscosity; Body Weight; Cardiovascular Diseases; Cold Temperature; Fibrinogen; Heart Rate; Lipids; Male; Myocardium; Myoglobin; Rats; Rats, Wistar; Risk Factors; Troponin T; Vasoconstrictor Agents

2012
Seasonal variation in cardiovascular disease risk factors in a subarctic population: the Tromsø Study 1979-2008.
    Journal of epidemiology and community health, 2013, Volume: 67, Issue:2

    Topics: Adult; Aged; Blood Pressure; Body Mass Index; Body Weight; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Female; Fibrinogen; Heart Rate; Humans; Incidence; Male; Middle Aged; Norway; Population Surveillance; Risk Factors; Seasons; Time Factors; Triglycerides

2013
Patients with prostate cancer treated by ADT have significantly higher fibrinogenemia than healthy control.
    World journal of urology, 2013, Volume: 31, Issue:2

    Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Fibrinogen; Gonadotropin-Releasing Hormone; Humans; Insulin Resistance; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Testosterone; Triglycerides

2013
The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women.
    Gene, 2012, Oct-25, Volume: 508, Issue:2

    Topics: Alu Elements; Body Mass Index; Cardiovascular Diseases; Estrogen Receptor beta; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Middle Aged; Polymorphism, Genetic; Postmenopause; Prognosis; Risk Factors

2012
Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans.
    Vascular health and risk management, 2012, Volume: 6

    Topics: Antibodies, Bacterial; Biomarkers; Black People; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Chi-Square Distribution; Cross-Sectional Studies; Democratic Republic of the Congo; Female; Fibrinogen; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hemodynamics; Humans; Incidence; Lipids; Logistic Models; Male; Multivariate Analysis; Odds Ratio; Prospective Studies; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Uric Acid; Waist Circumference

2012
C-reactive protein, fibrinogen, and cardiovascular disease prediction.
    The New England journal of medicine, 2012, Oct-04, Volume: 367, Issue:14

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Humans; Lipids; Male; Mass Screening; Middle Aged; Practice Guidelines as Topic; Prognosis; Proportional Hazards Models; Risk Factors

2012
Cardiometabolic risk in adolescents: associations with physical activity, fitness, and sleep.
    Annals of behavioral medicine : a publication of the Society of Behavioral Medicine, 2013, Volume: 45, Issue:1

    Topics: Adolescent; Adolescent Behavior; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Depression; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Metabolic Syndrome; Models, Psychological; Motor Activity; Physical Fitness; Psychiatric Status Rating Scales; Risk Factors; Sleep Initiation and Maintenance Disorders

2013
13-year long-term associations between changes in traditional cardiovascular risk factors and changes in fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
    Atherosclerosis, 2013, Volume: 226, Issue:1

    Topics: Adolescent; Adult; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Prospective Studies; Risk Factors; Time Factors; Young Adult

2013
Evidence of a synergistic association between heart rate, inflammation, and cardiovascular mortality in patients undergoing coronary angiography.
    European heart journal, 2013, Volume: 34, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Coronary Angiography; Female; Fibrinogen; Heart Rate; Humans; Interleukin-6; Kaplan-Meier Estimate; Male; Middle Aged; Neutrophils; Prospective Studies; Serum Amyloid A Protein; Young Adult

2013
Artificial cold air increases the cardiovascular risks in spontaneously hypertensive rats.
    International journal of environmental research and public health, 2012, Sep-04, Volume: 9, Issue:9

    Topics: Angiotensin II; Animals; Blood Chemical Analysis; Blood Pressure; Blood Viscosity; Body Weight; Cardiovascular Diseases; Cold Temperature; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Epinephrine; Fibrinogen; Heart Rate; Lipids; Male; Norepinephrine; Rats; Rats, Inbred SHR; Risk Factors; Vasoconstrictor Agents

2012
C-reactive protein, fibrinogen, and cardiovascular risk.
    The New England journal of medicine, 2013, 01-03, Volume: 368, Issue:1

    Topics: C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male

2013
C-reactive protein, fibrinogen, and cardiovascular risk.
    The New England journal of medicine, 2013, 01-03, Volume: 368, Issue:1

    Topics: C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male

2013
C-reactive protein, fibrinogen, and cardiovascular risk.
    The New England journal of medicine, 2013, 01-03, Volume: 368, Issue:1

    Topics: C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male

2013
C-reactive protein, fibrinogen, and cardiovascular risk.
    The New England journal of medicine, 2013, 01-03, Volume: 368, Issue:1

    Topics: C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male

2013
Association of optimism with cardiometabolic risk in adolescents.
    The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2013, Volume: 52, Issue:4

    Topics: Biomarkers; Black or African American; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Character; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Insulin; Interleukin-6; Lipids; Massachusetts; Motivation; Personality Inventory; Puberty; Risk Factors; Smoking; White People

2013
Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors.
    Clinical biochemistry, 2002, Volume: 35, Issue:4

    Topics: Adipose Tissue; Adult; Aged; Body Composition; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Fibrinogen; Glucose; Homocysteine; Humans; Insulin Resistance; Leptin; Male; Middle Aged; Obesity; Risk Factors; Triglycerides; von Willebrand Factor

2002
Periodontitis as a risk factor for cardiovascular disease.
    The journal of contemporary dental practice, 2000, Feb-15, Volume: 1, Issue:2

    Topics: Cardiovascular Diseases; Cytokines; Endotoxins; Fibrinogen; Humans; Inflammation Mediators; Periodontitis; Platelet Aggregation; Risk Factors; Streptococcus sanguis

2000
Variables associated with fibrinogen in a population-based study: interaction between smoking and age on fibrinogen concentration.
    European journal of epidemiology, 2001, Volume: 17, Issue:10

    Topics: Adult; Age Factors; Aged; Alcohol Drinking; Analysis of Variance; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Linear Models; Male; Middle Aged; Risk Factors; Sex Factors; Smoking; Spain; Statistics, Nonparametric; Surveys and Questionnaires

2001
Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:11

    Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Arteriosclerosis; Blood Glucose; Blood Pressure; Body Constitution; Body Mass Index; Cardiovascular Diseases; Carotid Arteries; Cholesterol; Cushing Syndrome; Diabetes Mellitus, Type 2; Diastole; Fasting; Female; Fibrinogen; Glucose Intolerance; Humans; Hyperlipidemias; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged; Risk Factors; Systole; Triglycerides; Ultrasonography

2002
Prevalence and concomitants of glucose intolerance in European obese children and adolescents.
    Diabetes care, 2003, Volume: 26, Issue:1

    Topics: Adolescent; Birth Weight; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Child; Cohort Studies; Diabetes Mellitus; Female; Fibrinogen; Glucose Intolerance; Humans; Insulin Resistance; Italy; Lipids; Male; Obesity; Prevalence; Puberty; Risk Factors; Uric Acid

2003
Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.
    Circulation, 2003, Jan-07, Volume: 107, Issue:1

    Topics: Aged; alpha-2-Antiplasmin; Biomarkers; Blood Coagulation Factors; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Creatinine; Cross-Sectional Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Humans; Inflammation; Interleukin-6; Male; Prospective Studies; Renal Insufficiency; Risk Factors

2003
Non-linear models for the relation between cardiovascular risk factors and intake of wine, beer and spirits.
    Statistics in medicine, 2003, Feb-15, Volume: 22, Issue:3

    Topics: Adult; Alcohol Drinking; Alcoholic Beverages; Beer; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Female; Fibrinogen; Humans; Male; Middle Aged; Models, Cardiovascular; Nonlinear Dynamics; Wine

2003
Drink to your health?
    Scientific American, 2003, Volume: 288, Issue:2

    Topics: Alcohol Drinking; Beer; Blood Coagulation; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Ethanol; Fibrinogen; Health Promotion; Humans; Insulin Resistance; Wine

2003
[Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
    Minerva ginecologica, 2003, Volume: 55, Issue:1

    Topics: Administration, Cutaneous; Antithrombin III; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Depression; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Follow-Up Studies; Hot Flashes; Humans; Hyperlipidemias; Hysterectomy; Italy; Lipids; Middle Aged; Ovariectomy; Platelet Count; Prospective Studies; Risk Factors; Tamoxifen; Triglycerides

2003
Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study.
    American heart journal, 2003, Volume: 145, Issue:3

    Topics: Cardiovascular Diseases; Echocardiography; Fibrinogen; Heart Diseases; Humans; Hypertrophy, Left Ventricular; Indians, North American; Longitudinal Studies; Risk Factors; Ventricular Dysfunction, Left

2003
Re: "Increased fibrinogen levels among South Asians versus Whites in the United Kingdom are not explained by common polymorphisms".
    American journal of epidemiology, 2003, Apr-01, Volume: 157, Issue:7

    Topics: Asian People; Cardiovascular Diseases; Fibrinogen; Humans; Risk Factors; United Kingdom; White People

2003
Endothelial function and coagulant factors in growth hormone-treated hypopituitary adults receiving desmopressin.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:5

    Topics: Administration, Intranasal; Adult; Arteriosclerosis; Blood Coagulation Factors; Brachial Artery; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Deamino Arginine Vasopressin; Endothelium, Vascular; Factor VIII; Fibrinogen; Human Growth Hormone; Humans; Hypopituitarism; Insulin-Like Growth Factor I; Middle Aged; Triglycerides; Vasodilation; von Willebrand Factor

2003
Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States.
    Annals of internal medicine, 2003, Jun-03, Volume: 138, Issue:11

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cotinine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Odds Ratio; Smoking; United States

2003
Summaries for patients. Associations between smoking and newer risk factors for cardiovascular disease.
    Annals of internal medicine, 2003, Jun-03, Volume: 138, Issue:11

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Smoking; United States

2003
[Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
    Orvosi hetilap, 2003, Jun-01, Volume: 144, Issue:22

    Topics: Adult; Aged; Alcoholism; Blood Viscosity; Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Diabetes Complications; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hyperlipidemias; Male; Middle Aged; Plasma; Risk Factors; Smoking; Stroke

2003
Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure.
    Journal of internal medicine, 2003, Volume: 254, Issue:2

    Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Dialysis; Risk Factors

2003
Does sticky blood predict a sticky end? Associations of blood viscosity, haematocrit and fibrinogen with mortality in the West of Scotland.
    British journal of haematology, 2003, Volume: 122, Issue:4

    Topics: Adult; Blood Viscosity; Cardiovascular Diseases; Female; Fibrinogen; Follow-Up Studies; Health Surveys; Hematocrit; Humans; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Scotland; Smoking

2003
Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status.
    Journal of epidemiology and community health, 2003, Volume: 57, Issue:9

    Topics: Acute-Phase Proteins; Age Factors; Aged; Biomarkers; Body Constitution; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Fibrinogen; Finland; Humans; Inflammation; Male; Middle Aged; Risk Factors; Serum Amyloid A Protein; Smoking; Social Class; Socioeconomic Factors

2003
C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community.
    Clinical science (London, England : 1979), 2004, Volume: 106, Issue:2

    Topics: Adult; Antibodies, Bacterial; Antibodies, Viral; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Carotid Arteries; Chlamydophila pneumoniae; Cohort Studies; Cytomegalovirus; Female; Fibrinogen; Helicobacter pylori; Humans; Immunoglobulin G; Inflammation; Kidney Diseases; Male; Middle Aged; Native Hawaiian or Other Pacific Islander; Northern Territory; Serum Albumin; Tunica Intima

2004
Fibrinogen concentration in acute myocardial infarction; comparison of the clot density determination of fibrinogen with the erythrocyte sedimentation rate.
    A.M.A. archives of internal medicine, 1954, Volume: 93, Issue:2

    Topics: Anterior Wall Myocardial Infarction; Blood Sedimentation; Cardiovascular Diseases; Fibrinogen; Hematologic Tests; Humans; Myocardial Infarction

1954
Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjects.
    Cerebrovascular diseases (Basel, Switzerland), 2003, Volume: 16, Issue:4

    Topics: Adult; Aged; Cardiovascular Diseases; Carotid Arteries; Female; Fibrinogen; Humans; Male; Middle Aged; Polymorphism, Genetic; Reference Values; Risk Factors; Tunica Intima

2003
The clot-density method of determination of fibrinogen in acute myocardial infarction.
    Bulletin of the New York Academy of Medicine, 1956, Volume: 32, Issue:3

    Topics: Anterior Wall Myocardial Infarction; Cardiovascular Diseases; Coagulants; Fibrinogen; Humans; Myocardial Infarction

1956
Plasma fibrinogen and erythrocyte sedimentation rate in myocardial infarction.
    Acta medica Scandinavica, 1957, Jan-15, Volume: 156, Issue:5

    Topics: Blood Sedimentation; Cardiovascular Diseases; Fibrinogen; Hematologic Tests; Humans; Myocardial Infarction; Plasma

1957
Clinical evaluation of plasma fibrinogen determination in cases of myocardial infarction.
    The Journal of the American Osteopathic Association, 1959, Volume: 58, Issue:6

    Topics: Cardiovascular Diseases; Fibrinogen; Humans; Myocardial Infarction

1959
[Clinical significance of fibrinogen test in myocardial infarction and stenocardia].
    Terapevticheskii arkhiv, 1958, Volume: 30, Issue:12

    Topics: Angina Pectoris; Cardiovascular Diseases; Coagulants; Fibrinogen; Humans; Myocardial Infarction

1958
[DIAGNOSTIC VALUE OF THE DETERMINATION OF BLOOD FIBRINOGEN IN MYOCARDIAL INFARCTION AND ARTERIAL THROMBOSIS].
    Sovetskaia meditsina, 1964, Volume: 27

    Topics: Cardiovascular Diseases; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Thrombosis

1964
[IS THERE A RELATIONSHIP BETWEEN THE CHOLESTEROL AND FIBRINOGEN CONTENT OF THE BLOOD?].
    Cardiologia, 1965, Volume: 46

    Topics: Adolescent; Cardiovascular Diseases; Child; Cholesterol; Fibrinogen; Geriatrics; Humans; Neoplasms

1965
Leisure time, occupational and household physical activity, and risk factors for cardiovascular disease in working men and women: the WOLF study.
    Scandinavian journal of public health, 2003, Volume: 31, Issue:5

    Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol, HDL; Exercise; Female; Fibrinogen; Humans; Leisure Activities; Male; Middle Aged; Occupations; Prevalence; Risk Factors; Sex Distribution; Surveys and Questionnaires; Sweden

2003
Cardiovascular risk of young growth-hormone-deficient adolescents. Differences in growth-hormone-treated and untreated patients.
    Hormone research, 2003, Volume: 60, Issue:6

    Topics: Adolescent; Cardiovascular Diseases; Child; Cholesterol, HDL; Cholesterol, LDL; Dietary Fats; Eating; Fasting; Female; Fibrinogen; Folic Acid; Homocysteine; Hormone Replacement Therapy; Human Growth Hormone; Humans; Male; Plasminogen Activator Inhibitor 1; Postprandial Period; Risk Assessment; Time Factors; Triglycerides; Vitamin B 12

2003
Effects of chronic alcohol consumption on lipid levels, inflammatory and haemostatic factors in the general population: the 'ATTICA' Study.
    European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 2003, Volume: 10, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Apolipoprotein A-I; Apolipoproteins B; Arteriosclerosis; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Ethanol; Female; Fibrinogen; Greece; Hemostasis; Humans; Leukocyte Count; Lipids; Male; Middle Aged; Multivariate Analysis; Peptide Fragments; Risk Factors

2003
Inflammation-sensitive plasma proteins and incidence of myocardial infarction in men with low cardiovascular risk.
    Arteriosclerosis, thrombosis, and vascular biology, 2003, Volume: 23, Issue:12

    Topics: Acute-Phase Proteins; alpha 1-Antitrypsin; Cardiovascular Diseases; Ceruloplasmin; Fibrinogen; Haptoglobins; Humans; Incidence; Inflammation; Male; Middle Aged; Myocardial Infarction; Orosomucoid; Risk Factors

2003
Periodontal disease and biomarkers related to cardiovascular disease.
    Journal of dental research, 2004, Volume: 83, Issue:2

    Topics: Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Antigens, CD; Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Cross-Sectional Studies; Factor VII; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Motor Activity; Periodontal Diseases; Platelet Aggregation Inhibitors; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Smoking; Tissue Plasminogen Activator; von Willebrand Factor

2004
Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study.
    The American journal of medicine, 2004, Feb-01, Volume: 116, Issue:3

    Topics: Adult; Arteriosclerosis; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Greece; Health Surveys; Homocysteine; Humans; Inflammation Mediators; Leukocyte Count; Lipoproteins, LDL; Male; Middle Aged; Multivariate Analysis; Risk Factors; Tobacco Smoke Pollution

2004
Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation.
    Clinical transplantation, 2004, Volume: 18, Issue:2

    Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Creatinine; Female; Fibrinogen; Homocysteine; Humans; Inflammation Mediators; Kidney Transplantation; Male; Middle Aged; N-Acetylneuraminic Acid; Risk Factors

2004
Third generation oral contraceptive use and cardiovascular risk factors.
    Atherosclerosis, 2004, Volume: 172, Issue:2

    Topics: Adult; Blood Viscosity; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Synthetic; Desogestrel; Female; Fibrinogen; Humans; Norpregnenes; Risk Factors; Smoking

2004
Alcohol consumption and its relation to cardiovascular risk factors in Germany.
    European journal of clinical nutrition, 2004, Volume: 58, Issue:4

    Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Analysis of Variance; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Germany; Health Surveys; Homocysteine; Humans; Lipids; Male; Middle Aged; Risk Factors; Sex Distribution; Smoking; Social Class

2004
Organizational instability and cardiovascular risk factors in white-collar employees: an analysis of correlates of structural instability of workplace organization on risk factors for coronary heart disease in a sample of 3,904 white collar employees in t
    European journal of public health, 2004, Volume: 14, Issue:1

    Topics: Adult; Cardiovascular Diseases; Cholesterol; Employment; Fibrinogen; Humans; Middle Aged; Risk Factors; Sweden; Triglycerides; Workplace

2004
Plasma fibrinogen and its association with cardiovascular risk factors in apparently healthy Japanese subjects.
    Heart and vessels, 2004, Volume: 19, Issue:3

    Topics: Adult; Arteriosclerosis; Asian People; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Japan; Male; Regression Analysis; Risk Factors

2004
Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:8

    Topics: Adult; alpha 1-Antitrypsin; Biomarkers; Blood Proteins; Body Mass Index; Cardiovascular Diseases; Ceruloplasmin; Cohort Studies; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Hypertension; Incidence; Inflammation; Male; Middle Aged; Motor Activity; Myocardial Infarction; Obesity; Orosomucoid; Predictive Value of Tests; Proportional Hazards Models; Smoking; Stroke; Sweden

2004
Interindividual variation in the response by fibrinogen, C-reactive protein and interleukin-6 to yellow fever vaccination.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:5

    Topics: C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Genetic Variation; Homozygote; Humans; Inflammation; Interleukin-6; Vaccination; Yellow Fever Vaccine

2004
Periodontal disease, but not edentulism, is independently associated with increased plasma fibrinogen levels. Results from a population-based study.
    Thrombosis and haemostasis, 2004, Volume: 92, Issue:2

    Topics: Adult; Age Factors; Aged; Alcohol Drinking; Body Mass Index; Cardiovascular Diseases; Cholesterol, LDL; Female; Fibrinogen; Humans; Logistic Models; Male; Middle Aged; Mouth, Edentulous; Odds Ratio; Periodontal Diseases; Sex Factors; Time Factors

2004
[Relationship between cholesterol and fibrinogen in two populations of different geographical location of Catalonia].
    Revista clinica espanola, 2004, Volume: 204, Issue:8

    Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Female; Fibrinogen; Geography; Humans; Male; Middle Aged; Prevalence; Spain

2004
C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:10

    Topics: Aged; Biomarkers; Blood Coagulation Tests; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Fasting; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Odds Ratio; Predictive Value of Tests

2004
Blood fluidity, fibrinogen, and cardiovascular risk factors of occlusive arterial disease: results of the Aachen study.
    Clinical hemorheology and microcirculation, 2004, Volume: 31, Issue:3

    Topics: Blood Viscosity; Cardiovascular Diseases; Case-Control Studies; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Prevalence; Risk Factors; Sex Factors

2004
Classical and "non-classical" cardiovascular risk factors in Tunisian patients with end stage renal disease: prevalence and association with cardiovascular events.
    Clinical laboratory, 2004, Volume: 50, Issue:7-8

    Topics: Adult; Age Factors; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Fluorescence Polarization Immunoassay; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Lipoprotein(a); Male; Risk Factors; Tunisia

2004
Omega-3 polyunsaturated fatty acids decrease plasma lipoprotein(a) levels in hypertensive subjects.
    Clinical nutrition (Edinburgh, Scotland), 2004, Volume: 23, Issue:5

    Topics: Adult; Aged; Cardiovascular Diseases; Dose-Response Relationship, Drug; Fatty Acids, Omega-3; Female; Fibrinogen; Humans; Hypertension; Lipoprotein(a); Male; Middle Aged; Time Factors

2004
Evidence for association between endothelial nitric oxide synthase gene polymorphism (G894T) and inflammatory markers: the ATTICA study.
    American heart journal, 2004, Volume: 148, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Cross-Sectional Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Leukocyte Count; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Point Mutation; Polymorphism, Genetic; Serum Amyloid A Protein

2004
Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:10

    Topics: Adolescent; Apolipoproteins B; Arginine; Blood Glucose; Body Height; Cardiovascular Diseases; Carotid Arteries; Child; Child, Preschool; Cholesterol, LDL; Echocardiography, Doppler; Exercise; Female; Fibrinogen; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Infant; Insulin; Leptin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Risk Factors; Triglycerides

2004
Correlation between some metabolic markers of vascular risk and carotid artery intima-media thickness in postmenopausal women.
    Maturitas, 2004, Oct-15, Volume: 49, Issue:2

    Topics: Adult; Aging; Analysis of Variance; Biomarkers; Body Mass Index; Cardiovascular Diseases; Carotid Arteries; Female; Fibrinogen; Humans; Insulin; Lipids; Lipoproteins; Middle Aged; Multivariate Analysis; Patient Selection; Postmenopause; Regression Analysis; Risk Factors; Tunica Intima; Tunica Media

2004
Subjective health and fibrinogen in a healthy Chinese cohort.
    British journal of health psychology, 2004, Volume: 9, Issue:Pt 4

    Topics: Adult; Aged; Blood Pressure; Cardiovascular Diseases; China; Cohort Studies; Cross-Sectional Studies; Fibrinogen; Health Status; Humans; Mass Screening; Middle Aged; Surveys and Questionnaires

2004
The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardiovascular disease: the ATTICA Study.
    Preventive medicine, 2005, Volume: 40, Issue:4

    Topics: Adult; Biomarkers; Blood Coagulation Tests; Blood Glucose; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Exercise; Female; Fibrinogen; Humans; Interleukin-6; Leisure Activities; Leukocyte Count; Life Style; Male; Middle Aged; Multivariate Analysis; Nutrition Surveys; Regression Analysis; Risk Factors; Serum Amyloid A Protein; Surveys and Questionnaires; Tumor Necrosis Factor-alpha

2005
Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study.
    Journal of exposure analysis and environmental epidemiology, 2005, Volume: 15, Issue:4

    Topics: Air Pollutants; Carbon Monoxide; Cardiovascular Diseases; Dust; Environmental Monitoring; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Nitrogen Dioxide; Ozone; Regression Analysis; Sulfur Dioxide; von Willebrand Factor

2005
The factor VII activating protease G511E (Marburg) variant and cardiovascular risk.
    Thrombosis and haemostasis, 2004, Volume: 92, Issue:5

    Topics: Alleles; Cardiovascular Diseases; Cholesterol; Fibrinogen; Genotype; Hemostasis; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Probability; Prospective Studies; Risk Factors; Serine Endopeptidases; Triglycerides; United Kingdom

2004
Plasma fibrinogen and its correlates in adult Saudi population.
    Saudi medical journal, 2004, Volume: 25, Issue:11

    Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Cluster Analysis; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Reference Values; Risk Factors; Sex Factors; Statistics as Topic

2004
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper.
    Circulation, 2004, Dec-21, Volume: 110, Issue:25

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Female; Fibrinogen; Humans; Hyperhomocysteinemia; Inflammation; Leukocyte Count; Male; Prospective Studies; Public Health Practice; Risk; Risk Factors

2004
No effect of polymorphisms in prothrombotic genes on the risk of myocardial infarction in young adults without cardiovascular risk factors.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:1

    Topics: Blood Platelets; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; DNA; Factor V; Factor VII; Factor XIII; Family Health; Fibrinogen; Humans; Integrin alpha2beta1; Integrin beta3; Myocardial Infarction; Odds Ratio; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prothrombin; Risk; Risk Factors; Thrombosis

2005
Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.
    Diabetologia, 2005, Volume: 48, Issue:3

    Topics: Aged; Albuminuria; Biomarkers; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibrinogen; Follow-Up Studies; Humans; Italy; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Regression Analysis; Risk; Time Factors

2005
Genetic determination of acute phase reactant levels: the strong heart study.
    Human heredity, 2004, Volume: 58, Issue:2

    Topics: Aged; Analysis of Variance; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Humans; Likelihood Functions; Middle Aged; Models, Biological; Myocardium; Plasminogen Activator Inhibitor 1

2004
Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women.
    Diabetes, 2005, Volume: 54, Issue:3

    Topics: Adipose Tissue; Aged; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Insulin Resistance; Interleukin-6; Lipids; Middle Aged; Obesity; Postmenopause; Risk

2005
Genetic variation in the fibrinogen gene cluster.
    Thrombosis and haemostasis, 2005, Volume: 93, Issue:3

    Topics: Cardiovascular Diseases; Fibrinogen; Genetic Variation; Humans; Multigene Family; Risk Factors

2005
Fibrinogen and cigarette smoking in men and women in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population.
    European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 2005, Volume: 12, Issue:2

    Topics: Age Distribution; Aged; Body Mass Index; Cardiovascular Diseases; Confounding Factors, Epidemiologic; Cross-Sectional Studies; Europe; Female; Fibrinogen; Health Surveys; Humans; Incidence; Life Style; Male; Middle Aged; Risk Assessment; Severity of Illness Index; Sex Distribution; Smoking; Smoking Cessation; Survival Analysis

2005
Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation.
    Clinical science (London, England : 1979), 2005, Volume: 109, Issue:2

    Topics: Adult; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, LDL; Fibrinogen; Humans; Interleukin-6; Linear Models; Male; Middle Aged; Pulse; Risk Factors; Smoking; Spondylitis, Ankylosing

2005
Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies.
    Ophthalmology, 2005, Volume: 112, Issue:4

    Topics: Aged; Aged, 80 and over; Arterioles; Blood Pressure; Cardiovascular Diseases; Carotid Stenosis; Coronary Artery Disease; Cross-Sectional Studies; Embolism; Female; Fibrinogen; Humans; Hypertension; Lipoprotein(a); Male; Meta-Analysis as Topic; Middle Aged; Retinal Artery; Retinal Vein Occlusion; Risk Factors

2005
Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.
    European heart journal, 2005, Volume: 26, Issue:17

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Hemostasis; Humans; Inflammation Mediators; Leukocyte Count; Male; Middle Aged; Prospective Studies; Risk Factors; Smoking; Smoking Cessation

2005
An association between the methylenetetrahydrofolate reductase (MTHFR) C677T mutation and inflammation markers related to cardiovascular disease.
    International journal of cardiology, 2005, Apr-28, Volume: 100, Issue:3

    Topics: C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Polymorphism, Genetic; Serum Amyloid A Protein

2005
The influence of type 2 diabetes on fibrin structure and function.
    Diabetologia, 2005, Volume: 48, Issue:6

    Topics: Blood Coagulation; Body Mass Index; Body Size; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Factor XIII; Female; Fibrin; Fibrinogen; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Reference Values; Risk Factors

2005
Genetic and environmental origins of the association between birth weight and cardiovascular risk factors.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:6

    Topics: Birth Weight; Cardiovascular Diseases; Environmental Exposure; Fibrinogen; Genetic Predisposition to Disease; Humans; Hypertension; Risk Factors; Twin Studies as Topic

2005
[Cardiovascular risk factors in dialyzed patients].
    Polskie Archiwum Medycyny Wewnetrznej, 2004, Volume: 112, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Blood Pressure; C-Reactive Protein; Calcium; Cardiovascular Diseases; Female; Fibrinogen; Hemodialysis, Home; Humans; Hyperlipidemias; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Myocardial Ischemia; Peritoneal Dialysis; Phosphates; Poland; Retrospective Studies; Risk Factors; Time Factors

2004
Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey.
    PLoS medicine, 2005, Volume: 2, Issue:6

    Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Nutrition Surveys; Risk Factors; Risk Reduction Behavior; Serum Albumin; Smoking; Smoking Cessation; United States

2005
Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 46, Issue:1

    Topics: Adult; Aged; Alleles; Cardiovascular Diseases; Cohort Studies; Comorbidity; Diabetes Mellitus; Ethnicity; Female; Fibrinogen; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Polymorphism, Genetic; Renal Dialysis; Risk; Smoking

2005
Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study.
    Atherosclerosis, 2006, Volume: 185, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anxiety; Biomarkers; Blood Coagulation; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Leukocyte Count; Male; Middle Aged; Risk Factors; Tumor Necrosis Factor-alpha

2006
Opposite effect of negative and positive affect on stress procoagulant reactivity.
    Physiology & behavior, 2005, Sep-15, Volume: 86, Issue:1-2

    Topics: Adult; Affect; Blood Coagulation; Blood Coagulation Factors; Blood Pressure; Cardiovascular Diseases; Demography; Fibrinogen; Heart Rate; Hemostasis; Humans; Hydrocortisone; Life Style; Male; Middle Aged; Psychological Tests; Social Support; Statistics, Nonparametric; Stress, Psychological; von Willebrand Factor

2005
Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program.
    Diabetes care, 2005, Volume: 28, Issue:10

    Topics: C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Intolerance; Homeostasis; Humans; Lipoproteins; Male; Middle Aged; Regression Analysis; Risk Factors; Tissue Plasminogen Activator; Triglycerides

2005
Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study).
    The American journal of cardiology, 2005, Nov-01, Volume: 96, Issue:9

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Blood Viscosity; Cardiovascular Diseases; Centrifugation; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prognosis; Prospective Studies; Prothrombin; Risk Factors; Time Factors; Tissue Polypeptide Antigen; von Willebrand Factor

2005
[Explosion of cardiovascular risks in family practice].
    MMW Fortschritte der Medizin, 2005, Oct-20, Volume: 147, Issue:42

    Topics: Adolescent; Adult; Aged; Animals; Cardiovascular Diseases; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Diet; Erectile Dysfunction; Family Practice; Female; Fibrinogen; Fishes; Germany; Humans; Hyperlipidemias; Hypertension; Male; Meta-Analysis as Topic; Middle Aged; Prospective Studies; Risk Factors; Smoking

2005
Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM.
    International journal of cardiology, 2006, Jan-04, Volume: 106, Issue:1

    Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male; Prevalence; Risk Factors

2006
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study.
    Stroke, 2006, Volume: 37, Issue:2

    Topics: Aged; Analysis of Variance; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Cardiovascular System; Carotid Arteries; Carotid Artery Diseases; Chlamydophila pneumoniae; Cytomegalovirus; Disease Progression; Echocardiography, Doppler; Female; Fibrinogen; Follow-Up Studies; Helicobacter pylori; Humans; Immunoglobulin G; Infections; Inflammation; Lipids; Male; Middle Aged; Risk Factors; Sex Factors; Stroke; Time Factors; Tunica Intima; Tunica Media; Ultrasonography

2006
Epidemiological evidence for an association between habitual tea consumption and markers of chronic inflammation.
    Atherosclerosis, 2006, Volume: 189, Issue:2

    Topics: Adult; Belgium; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Feeding Behavior; Fibrinogen; Haptoglobins; Humans; Inflammation; Male; Middle Aged; Prevalence; Serum Amyloid A Protein; Surveys and Questionnaires; Tea

2006
Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
    Medical science monitor : international medical journal of experimental and clinical research, 2006, Volume: 12, Issue:2

    Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Renal Dialysis; Reproducibility of Results; von Willebrand Factor

2006
Metabolic syndrome and the risk of stroke in middle-aged men.
    Stroke, 2006, Volume: 37, Issue:3

    Topics: Adult; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Diabetes Complications; Fibrinogen; Finland; Follow-Up Studies; Humans; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Risk; Risk Factors; Smoking; Stroke; Time Factors

2006
Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease.
    Journal of vascular surgery, 2006, Volume: 43, Issue:3

    Topics: Aged; alpha-2-Antiplasmin; Aortic Aneurysm, Abdominal; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Forced Expiratory Volume; Hemostasis; Humans; Inflammation; Lung; Male; Pulmonary Disease, Chronic Obstructive; Smoking; Spirometry; Surveys and Questionnaires; Ultrasonography; Vital Capacity

2006
Factors associated with occurrence of the intraleft atrial nonsmoke spontaneous individual contrast phenomenon after a Valsalva maneuver during transesophageal echocardiography.
    Ultrasound in medicine & biology, 2006, Volume: 32, Issue:3

    Topics: Age Factors; Aged; Artifacts; Body Height; Cardiovascular Diseases; Echocardiography, Transesophageal; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Atria; Hematocrit; Humans; Logistic Models; Male; Middle Aged; Pulmonary Veins; Smoking; Valsalva Maneuver

2006
The association of markers of inflammation with weight change in older adults: the Cardiovascular Health Study.
    International journal of obesity (2005), 2006, Volume: 30, Issue:9

    Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Factor VIII; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Leukocyte Count; Male; Platelet Count; Weight Gain; Weight Loss

2006
Plasma fibrinogen levels and cardiovascular risk factors in Japanese schoolchildren.
    Journal of epidemiology, 2006, Volume: 16, Issue:2

    Topics: Adolescent; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Child; Cholesterol; Female; Fibrinogen; Glycated Hemoglobin; Humans; Japan; Male; Risk Factors

2006
The association of oestrogen receptor alpha-haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study.
    European heart journal, 2006, Volume: 27, Issue:13

    Topics: Aged; Cardiovascular Diseases; Cholesterol, HDL; Enzyme-Linked Immunosorbent Assay; Estrogen Receptor alpha; Female; Fibrinogen; Genotype; Haplotypes; Hormone Replacement Therapy; Humans; Insulin Resistance; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Social Class; Waist-Hip Ratio

2006
Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women.
    JAMA, 2006, Mar-22, Volume: 295, Issue:12

    Topics: Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Creatinine; Cross-Sectional Studies; Exercise; Female; Fibrinogen; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Lipoproteins; Middle Aged; Overweight; Risk Factors

2006
Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
    Circulation, 2006, Apr-11, Volume: 113, Issue:14

    Topics: Adult; Aged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Progression; Female; Fibrinogen; Glucose Tolerance Test; Humans; Incidence; Male; Middle Aged; Plasminogen Activator Inhibitor 1

2006
Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk.
    Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:6

    Topics: Aged; Base Sequence; Blood Proteins; Cardiovascular Diseases; Chromosome Mapping; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Hemostatics; Humans; Linkage Disequilibrium; Male; Middle Aged; Molecular Sequence Data; Multigene Family; Plasminogen Activators; Polymorphism, Single Nucleotide; Thrombosis

2006
Randomised by (your) god: robust inference from an observational study design.
    Journal of epidemiology and community health, 2006, Volume: 60, Issue:5

    Topics: Aged; Alcohol Drinking; Cardiovascular Diseases; Cholesterol; Epidemiologic Research Design; Female; Fibrinogen; Genetic Predisposition to Disease; Heredity; Humans; Male; Middle Aged; Neural Tube Defects; Risk

2006
Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB-455 G/A polymorphism.
    Atherosclerosis, 2007, Volume: 191, Issue:2

    Topics: Adenine; Adult; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Fasting; Female; Fibrinogen; France; Gene Frequency; Genetic Predisposition to Disease; Genotype; Guanine; Homeostasis; Humans; Immunoenzyme Techniques; Insulin; Male; Metabolic Syndrome; Middle Aged; Polymorphism, Single Nucleotide; Reference Values; Risk Factors

2007
Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:6

    Topics: Adolescent; Adult; Black or African American; Blood Coagulation Tests; Cardiovascular Diseases; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Humans; Immunoassay; Linkage Disequilibrium; Phenotype; Polymorphism, Single Nucleotide; Reproducibility of Results; White People

2006
Increased cardiovascular risk markers in obesity are associated with body adiposity: role of leptin.
    Thrombosis and haemostasis, 2006, Volume: 95, Issue:6

    Topics: Adiposity; Adult; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Insulin Resistance; Leptin; Male; Middle Aged; Obesity; Risk Factors; Sex Factors; von Willebrand Factor

2006
Which thyroid-stimulating hormone level should be sought in hypothyroid patients under L-thyroxine replacement therapy?
    International journal of clinical practice, 2006, Volume: 60, Issue:6

    Topics: C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Fibrin Fibrinogen Degradation Products; Fibrinogen; Homocysteine; Humans; Hypothyroidism; Middle Aged; Risk Factors; Thyrotropin; Thyroxine

2006
Obesity, inflammatory markers and cardiovascular disease: distinguishing causality from confounding.
    Journal of human hypertension, 2006, Volume: 20, Issue:11

    Topics: Biomarkers; Black People; C-Reactive Protein; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Confounding Factors, Epidemiologic; Female; Fibrinogen; Humans; Inflammation Mediators; Insulin Resistance; Leptin; Obesity; White People

2006
Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
    Circulation, 2006, Aug-01, Volume: 114, Issue:5

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Immunoassay; Middle Aged; Odds Ratio; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Thrombosis

2006
Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries.
    Journal of the American College of Cardiology, 2006, Aug-01, Volume: 48, Issue:3

    Topics: Aged; Cardiovascular Diseases; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Fibrinogen; Humans; Linear Models; Lipoprotein(a); Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Retrospective Studies; Tunica Media; Ultrasonography, Interventional

2006
Hemorheological parameters and aging.
    Clinical hemorheology and microcirculation, 2006, Volume: 35, Issue:1-2

    Topics: Adult; Aged; Aging; Blood Viscosity; Cardiovascular Diseases; Cerebrovascular Disorders; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Risk Factors

2006
Recognizing the dental-medical symbiosis: back to basic sciences.
    Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995), 2006, Volume: 27, Issue:7

    Topics: Atherosclerosis; Bacterial Physiological Phenomena; Biological Science Disciplines; C-Reactive Protein; Cardiovascular Diseases; Causality; Fibrinogen; Focal Infection, Dental; Heat-Shock Proteins; Humans; Inflammation; Interleukin-6; Periodontal Diseases; Risk Factors; Tumor Necrosis Factor-alpha; Tunica Intima

2006
Transgenic flavonoid tomato intake reduces C-reactive protein in human C-reactive protein transgenic mice more than wild-type tomato.
    The Journal of nutrition, 2006, Volume: 136, Issue:9

    Topics: Alanine Transaminase; Animals; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Diet; E-Selectin; Fenofibrate; Fibrinogen; Flavonoids; Fruit; Humans; Mice; Mice, Transgenic; Plants, Genetically Modified; Risk Factors; Solanum lycopersicum

2006
Abundance of intrinsic disorder in protein associated with cardiovascular disease.
    Biochemistry, 2006, Sep-05, Volume: 45, Issue:35

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiovascular Diseases; Computer Simulation; Cyclic Nucleotide Phosphodiesterases, Type 4; Databases, Protein; Fibrinogen; Hirudins; Humans; Models, Molecular; Protein Conformation; Protein Structure, Tertiary; Proteins; Sequence Analysis, Protein; Structure-Activity Relationship; Thrombin

2006
Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
    Clinical endocrinology, 2006, Volume: 65, Issue:4

    Topics: Adiponectin; Adult; Apolipoproteins B; Apoprotein(a); Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Female; Fibrinogen; Homocysteine; Humans; Hyperthyroidism; Hypothyroidism; Insulin Resistance; Lipoprotein(a); Male; Middle Aged; Multivariate Analysis; Risk Factors

2006
Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients.
    Prilozi, 2006, Volume: 27, Issue:1

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; Female; Fibrinogen; Humans; Inflammation; Kaplan-Meier Estimate; Male; Middle Aged; Renal Dialysis; Risk Factors; Serum Albumin

2006
Independent association of matrix metalloproteinase-10, cardiovascular risk factors and subclinical atherosclerosis.
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:1

    Topics: C-Reactive Protein; Cardiovascular Diseases; Carotid Artery Diseases; Carotid Artery, Common; Female; Fibrinogen; Humans; Interleukin-6; Linear Models; Logistic Models; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 10; Matrix Metalloproteinase 9; Middle Aged; Odds Ratio; Risk Factors; Severity of Illness Index; Tunica Intima; Tunica Media; Ultrasonography; von Willebrand Factor

2007
Vascular phenotype and subclinical inflammation in diabetic Asian Indians without overt cardiovascular disease.
    Diabetes research and clinical practice, 2007, Volume: 76, Issue:3

    Topics: Adult; Aged; Anthropometry; Asian People; C-Reactive Protein; Cardiovascular Diseases; Carotid Arteries; Diabetes Mellitus, Type 2; Electrocardiography; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Netherlands; Phenotype; Suriname

2007
Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
    European heart journal, 2006, Volume: 27, Issue:24

    Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Stenosis; Disease-Free Survival; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors

2006
Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies.
    International journal of epidemiology, 2006, Volume: 35, Issue:6

    Topics: Adult; Age Factors; Bias; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Meta-Analysis as Topic; Prospective Studies; Regression Analysis; Risk Factors; Sex Factors; Smoking; Time Factors

2006
The relationship between circulating fibrinogen and lipoprotein (a) levels in patients with primary dyslipidemia.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2007, Volume: 13, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Data Interpretation, Statistical; Dyslipidemias; Female; Fibrinogen; Humans; Lipoprotein(a); Male; Middle Aged; Retrospective Studies; Sex Factors; Smoking

2007
Long-term change in cholesterol in relation to inflammation-sensitive plasma proteins: a longitudinal study.
    Annals of epidemiology, 2007, Volume: 17, Issue:1

    Topics: Acute-Phase Proteins; Adult; alpha 1-Antitrypsin; Biomarkers; Cardiovascular Diseases; Ceruloplasmin; Cholesterol; Fibrinogen; Haptoglobins; Humans; Hypercholesterolemia; Hypertriglyceridemia; Inflammation; Longitudinal Studies; Male; Mass Screening; Middle Aged; Orosomucoid; Risk Factors; Triglycerides

2007
[Postprandial glycemia in diabetes patients: assessing this indicator].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:12 Pt 1

    Topics: Administration, Inhalation; Administration, Oral; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Postprandial Period; Pregnancy; Pregnancy in Diabetics; Risk Factors; Time Factors; Tumor Necrosis Factor-alpha

2006
Plasma viscosity and related cardiovascular risk factors in a Spanish Mediterranean population.
    Thrombosis research, 2007, Volume: 120, Issue:4

    Topics: Adult; Aged; Biomarkers; Blood Glucose; Blood Viscosity; Cardiovascular Diseases; Cholesterol; Female; Fibrinogen; Humans; Male; Mediterranean Region; Middle Aged; Population Groups; Risk Factors; Spain; Triglycerides

2007
Inflammation biomarkers and near-term death in older men.
    American journal of epidemiology, 2007, Mar-15, Volume: 165, Issue:6

    Topics: Age Distribution; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Complications; Epidemiologic Studies; Female; Fibrinogen; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Inflammation; Male; Middle Aged; Obesity; Population Surveillance; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Factors; Sex Distribution; Smoking; Time Factors; United States

2007
Early-life and adult socioeconomic status and inflammatory risk markers in adulthood.
    European journal of epidemiology, 2007, Volume: 22, Issue:1

    Topics: Biomarkers; Black or African American; C-Reactive Protein; Cardiovascular Diseases; Child; Educational Status; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Prospective Studies; Residence Characteristics; Risk; Social Class; von Willebrand Factor; White People

2007
The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease.
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:6

    Topics: alpha-2-Antiplasmin; Blood Coagulation; Cardiovascular Diseases; Fibrin; Fibrinogen; Hemolysis; Humans; In Vitro Techniques; Kinetics; Models, Cardiovascular; Nephelometry and Turbidimetry; Peptide Fragments; Plasminogen; Recombinant Proteins; Tissue Plasminogen Activator

2007
Exposure to secondhand smoke and biomarkers of cardiovascular disease risk in never-smoking adults.
    Circulation, 2007, Feb-27, Volume: 115, Issue:8

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cotinine; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Leukocyte Count; Male; Middle Aged; Risk Factors; Tobacco Smoke Pollution

2007
[Determining factors of cardiac biomarkers in hemodialysed diabetic and non-diabetic patients].
    Orvosi hetilap, 2007, Mar-18, Volume: 148, Issue:11

    Topics: Adult; Aged; Biomarkers; Body Water; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Diabetes Complications; Female; Fibrinogen; Humans; Kidney Failure, Chronic; Linear Models; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Peptide Fragments; Renal Dialysis; Retrospective Studies; Troponin T

2007
The impact of living donor kidney transplantation on markers of cardiovascular risk in chronic kidney disease patients.
    Blood purification, 2007, Volume: 25, Issue:3

    Topics: Adult; Biomarkers; Calcium; Cardiovascular Diseases; Comorbidity; Female; Fibrinogen; Follow-Up Studies; Glomerular Filtration Rate; Heart Ventricles; Hematocrit; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Middle Aged; Organ Size; Postoperative Complications; Prospective Studies; Risk Factors; Treatment Outcome

2007
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study.
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:6

    Topics: Aged; Aging; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cohort Studies; Factor VIII; Female; Fibrinogen; Hemostasis; Homocysteine; Humans; Inflammation Mediators; Interleukin-6; Leukocyte Count; Lipoprotein(a); Male; Prospective Studies; Risk Factors

2007
Variation in blood levels of inflammatory markers related and unrelated to smoking cessation in women.
    Preventive cardiology, 2007,Spring, Volume: 10, Issue:2

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; CD40 Ligand; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation Mediators; Intercellular Adhesion Molecule-1; Leukocyte Count; Middle Aged; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Smoking; Smoking Cessation

2007
sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2008, Volume: 18, Issue:3

    Topics: Adolescent; Adult; Anthropometry; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Female; Fibrinogen; Humans; Insulin Resistance; Lipids; Middle Aged; Obesity; P-Selectin; Plasminogen Activator Inhibitor 1; Platelet Activation; Regression Analysis; Risk Factors; Solubility; von Willebrand Factor

2008
Hemostatic factors in Australian Aboriginal and Torres Strait Islander populations.
    Metabolism: clinical and experimental, 2007, Volume: 56, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthropometry; Australia; Blood Glucose; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Factor VII; Female; Fibrinogen; Humans; Male; Middle Aged; Native Hawaiian or Other Pacific Islander; Triglycerides

2007
Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes.
    Diabetes research and clinical practice, 2007, Volume: 78, Issue:2

    Topics: Aged; Ankle; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glycated Hemoglobin; Humans; Italy; Logistic Models; Male; Middle Aged; Peripheral Vascular Diseases; Prevalence; Pulse; Risk Factors; Smoking

2007
Cardiovascular fitness and vascular inflammatory markers after acute aerobic exercise.
    International journal of sport nutrition and exercise metabolism, 2007, Volume: 17, Issue:2

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Exercise; Fibrinogen; Health Status; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Oxygen Consumption; Physical Fitness; Risk Factors; Time Factors

2007
Socioeconomic status as an independent predictor of physiological biomarkers of cardiovascular disease: evidence from NHANES.
    Preventive medicine, 2007, Volume: 45, Issue:1

    Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Educational Status; Female; Fibrinogen; Homocysteine; Humans; Income; Lipoproteins, HDL; Logistic Models; Male; Middle Aged; Nutrition Surveys; Risk Factors; Social Class; Stress, Psychological; United States

2007
Fibrinogen induces endothelial cell permeability.
    Molecular and cellular biochemistry, 2008, Volume: 307, Issue:1-2

    Topics: Actins; Albumins; Animals; Capillary Permeability; Cardiovascular Diseases; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Extracellular Signal-Regulated MAP Kinases; Fibrinogen; Flavonoids; Humans; Integrin beta1; Intercellular Adhesion Molecule-1; Rats

2008
Relationship of fibrinogen with arterial stiffness and wave reflections.
    Journal of hypertension, 2007, Volume: 25, Issue:10

    Topics: Adult; Arteries; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Elasticity; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Pulse; Risk Factors

2007
Serum markers of cardiovascular risk in patients with acromegaly before and after six months of treatment with octreotide LAR.
    Pituitary, 2008, Volume: 11, Issue:1

    Topics: Acromegaly; Adult; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Delayed-Action Preparations; Factor VIII; Fibrinogen; Human Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Lipids; Longitudinal Studies; Middle Aged; Natriuretic Peptide, Brain; Octreotide; Peptide Fragments; Time Factors; Treatment Outcome

2008
Heritability of clot formation, morphology, and lysis: the EuroCLOT study.
    Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:12

    Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Cardiovascular Diseases; Europe; Female; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Genetic Variation; Humans; Male; Metabolic Syndrome; Middle Aged; Nephelometry and Turbidimetry; Pedigree; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombosis; Time Factors

2007
Acute effects of walking on inflammatory and cardiovascular risk in sedentary post-menopausal women.
    Journal of sports sciences, 2008, Feb-01, Volume: 26, Issue:3

    Topics: C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Inflammation; Middle Aged; Postmenopause; Triglycerides; United Kingdom; Walking

2008
Psychosocial job characteristics and plasma fibrinogen in Japanese male and female workers: the Jichi Medical School cohort study.
    Atherosclerosis, 2008, Volume: 198, Issue:2

    Topics: Adult; Aged; Asian People; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Humans; Japan; Job Description; Male; Middle Aged; Occupations; Stress, Psychological; Workload; Workplace

2008
Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes.
    The aging male : the official journal of the International Society for the Study of the Aging Male, 2007, Volume: 10, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Comorbidity; Diabetes Mellitus, Type 2; Fibrinogen; Glycated Hemoglobin; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Triglycerides

2007
An extension of the regression of offspring on mid-parent to test for association and estimate locus-specific heritability: the revised ROMP method.
    Annals of human genetics, 2008, Volume: 72, Issue:Pt 1

    Topics: Cardiovascular Diseases; Computer Simulation; Fibrinogen; Humans; Korea; Multigene Family; Nuclear Family; Parents; Polymorphism, Genetic; Quantitative Trait Loci; Regression Analysis; Research Design

2008
Cardiovascular risk factors in obese women and their first-degree relatives.
    Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2007, Volume: 7, Issue:4

    Topics: Adult; Aged; Anthropometry; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Family; Female; Fibrinogen; Genetic Predisposition to Disease; Heart Rate; Humans; Insulin; Linear Models; Lipids; Male; Middle Aged; Obesity; Risk Factors; Triglycerides; Turkey

2007
Blood fibrinogen in myocardial infarction.
    Archives of internal medicine (Chicago, Ill. : 1908), 1948, Volume: 82, Issue:5

    Topics: Blood; Cardiovascular Diseases; Fibrinogen; Heart; Humans; Infarction; Myocardial Infarction

1948
The relation of leptin and insulin with obesity-related cardiovascular risk factors in US adults.
    Atherosclerosis, 2008, Volume: 200, Issue:1

    Topics: Adult; Aged; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Insulin; Leptin; Male; Middle Aged; Nutrition Surveys; Obesity; Risk Factors; Sex Factors; United States

2008
Higher levels of inflammation factors and greater insulin resistance are independently associated with higher heart rate and lower heart rate variability in normoglycemic older individuals: the Cardiovascular Health Study.
    Journal of the American Geriatrics Society, 2008, Volume: 56, Issue:2

    Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Electrocardiography, Ambulatory; Female; Fibrinogen; Heart Rate; Humans; Inflammation Mediators; Insulin Resistance; Interleukin-6; Male; Risk Factors

2008
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.
    The American journal of medicine, 2008, Volume: 121, Issue:1

    Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cerebrospinal Fluid Proteins; Cystatin C; Cystatins; Female; Fibrinogen; Follow-Up Studies; Humans; Incidence; Interleukin-6; Male; Multivariate Analysis; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Prospective Studies; Risk Factors; ROC Curve; Time Factors

2008
Participation of IIb-IIIa glycoprotein in spontaneous platelet aggregation.
    Bulletin of experimental biology and medicine, 2007, Volume: 143, Issue:4

    Topics: Antibodies, Monoclonal; Aspirin; Blood Platelets; Cardiovascular Diseases; Fibrinogen; Humans; Mutation; Peptide Fragments; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Protein Binding; von Willebrand Factor

2007
Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:2

    Topics: Age Factors; Aged; Black or African American; Brain Ischemia; Cardiovascular Diseases; Carotid Artery Diseases; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Male; Myocardial Infarction; Polymorphism, Single Nucleotide; Population Surveillance; Proportional Hazards Models; Prospective Studies; Reproducibility of Results; Risk Assessment; Risk Factors; Sex Factors; Stroke; United States; White People

2008
Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction.
    Journal of thrombosis and haemostasis : JTH, 2008, Volume: 6, Issue:5

    Topics: Adult; Aged; Blood Coagulation Factors; Cardiovascular Diseases; Cohort Studies; DNA Mutational Analysis; Fibrinogen; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Recurrence; Risk Factors

2008
Determinants of the erythrocyte sedimentation rate in the era of microinflammation: excluding subjects with elevated C-reactive protein levels.
    American journal of clinical pathology, 2008, Volume: 129, Issue:3

    Topics: Adult; Age Factors; Blood Sedimentation; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Globulins; Hemoglobins; Humans; Inflammation; Male; Risk Factors; Sex Factors; Triglycerides

2008
Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
    Renal failure, 2008, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Confidence Intervals; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Probability; Reference Values; Risk Factors; Severity of Illness Index; Statistics, Nonparametric

2008
Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity.
    Brain, behavior, and immunity, 2008, Volume: 22, Issue:6

    Topics: Adult; Biomarkers; Blood Coagulation; Cardiovascular Diseases; Fasting; Female; Fibrinogen; Humans; Inflammation; Insulin; Insulin Resistance; Male; Risk Factors; Sex Factors; Sleep Wake Disorders; Surveys and Questionnaires

2008
Effects of socioeconomic position on inflammatory and hemostatic markers: a life-course analysis in the 1958 British birth cohort.
    American journal of epidemiology, 2008, Jun-01, Volume: 167, Issue:11

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; England; Female; Fibrinogen; Humans; Male; Middle Aged; Regression Analysis; Social Class; Tissue Plasminogen Activator; von Willebrand Factor

2008
NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.
    Obesity (Silver Spring, Md.), 2008, Volume: 16, Issue:6

    Topics: Adiponectin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Fatty Liver; Fibrinogen; Humans; Inflammation; Insulin Resistance; Intra-Abdominal Fat; Linear Models; Male; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Risk Factors; Triglycerides

2008
Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study.
    British journal of haematology, 2008, Volume: 141, Issue:6

    Topics: Adult; Age Factors; Alcohol Drinking; Blood Viscosity; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Cytokines; Female; Fibrinogen; Humans; Inflammation Mediators; Male; Middle Aged; Poverty; Risk Factors; Scotland; Sex Factors; Smoking

2008
Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:9

    Topics: Aged; Alcohol Drinking; Blood Pressure; Cardiovascular Diseases; Creatinine; Female; Fibrinogen; Follow-Up Studies; Glomerular Filtration Rate; Health Surveys; Humans; Linear Models; Male; Middle Aged; Norway; Renal Insufficiency, Chronic; Risk Factors; Sex Factors; Smoking

2008
Inflammation and cardiovascular events in individuals with and without chronic kidney disease.
    Kidney international, 2008, Volume: 73, Issue:12

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Female; Fibrinogen; Humans; Inflammation; Kidney Diseases; Leukocyte Count; Male; Middle Aged; Risk Factors; Serum Albumin

2008
Refining exposure definitions for studies of periodontal disease and systemic disease associations.
    Community dentistry and oral epidemiology, 2008, Volume: 36, Issue:6

    Topics: Adult; Aged; Cardiovascular Diseases; Carotid Artery, Common; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Middle Aged; Models, Statistical; Periodontal Attachment Loss; Periodontal Diseases; Periodontal Pocket; Research Design; Risk Factors; Tooth Loss; Tunica Intima; Tunica Media; Young Adult

2008
[Significance of the laboratory diagnosis of hypercoagulability].
    Folia haematologica (Leipzig, Germany : 1928), 1984, Volume: 111, Issue:4

    Topics: Blood Coagulation Tests; Cardiovascular Diseases; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Neoplasms; Partial Thromboplastin Time; Platelet Count; Postoperative Complications; Pregnancy; Pregnancy Complications, Hematologic; Thrombosis

1984
Prognostic value of fibrinogen level in geriatric patients.
    Lancet (London, England), 1981, Apr-25, Volume: 1, Issue:8226

    Topics: Aged; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Prognosis; Time Factors

1981
Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A.
    Seminars in thrombosis and hemostasis, 1984, Volume: 10, Issue:4

    Topics: Blood Coagulation Tests; Cardiovascular Diseases; Evaluation Studies as Topic; Fibrinogen; Fibrinopeptide A; Humans; Immunoenzyme Techniques; Neoplasms; Radioimmunoassay; Reference Values; Thrombosis

1984
Increased ristocetin-cofactor in acute myocardial infarction: a component of the acute phase reaction.
    Thrombosis and haemostasis, 1980, Feb-29, Volume: 43, Issue:1

    Topics: Adolescent; Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Factor VIII; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Pregnancy; von Willebrand Factor

1980
[Blood viscosimetric factors in cardiovascular pathology].
    Minerva cardioangiologica, 1980, Volume: 28, Issue:9

    Topics: Angina Pectoris; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Viscosity; Cardiovascular Diseases; Diabetic Angiopathies; Fibrinogen; Hematocrit; Humans; Leg; Myocardial Infarction; Vascular Diseases

1980
Plasma fibrinogen as cardiovascular risk factor.
    Diabetologia, 1995, Volume: 38, Issue:5

    Topics: Biomarkers; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Norway; Prospective Studies; Sex Characteristics; Sweden; Triglycerides

1995
Raised plasma fibrinogen concentrations in subjects attending a metabolic ward--relation to family history and vascular risk factors.
    Thrombosis and haemostasis, 1995, Volume: 73, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Family; Female; Fibrinogen; Humans; Male; Middle Aged; Polymorphism, Genetic; Risk Factors

1995
Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease.
    Lancet (London, England), 1994, Feb-19, Volume: 343, Issue:8895

    Topics: Acute-Phase Proteins; Aged; Antigens; Cardiovascular Diseases; Factor VII; Female; Fibrinogen; Humans; Leukocyte Count; Male; Neutrophils; Periodicity; Regression Analysis; Respiratory Tract Infections; Risk Factors; Seasons; United Kingdom

1994
Vitamin C and vascular disease.
    BMJ (Clinical research ed.), 1995, Jun-17, Volume: 310, Issue:6994

    Topics: Acute-Phase Proteins; Ascorbic Acid; Cardiovascular Diseases; Factor VII; Fibrinogen; Humans

1995
Hemostatic concomitants of syndrome X.
    Medical hypotheses, 1995, Volume: 44, Issue:3

    Topics: Animals; Antigens; Blood Platelets; Cardiovascular Diseases; Epoprostenol; Factor VII; Fibrinogen; Hemostasis; Humans; Insulin Resistance; Microvascular Angina; Models, Biological; Models, Cardiovascular; Plasminogen Activator Inhibitor 1; Risk Factors

1995
Complement components and fibrinogen: correlations and association with previous myocardial infarction.
    Cardiology, 1995, Volume: 86, Issue:3

    Topics: Adult; Antithrombin III; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Complement System Proteins; Confounding Factors, Epidemiologic; Fibrinogen; Humans; Lipids; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Protein C; Protein S; Radioimmunoassay; Risk Factors; Tissue Plasminogen Activator

1995
Associations between plasma fibrinogen levels and cardiovascular risk factors in hypertensive men.
    Journal of cardiovascular risk, 1994, Volume: 1, Issue:4

    Topics: Adolescent; Adult; Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cross-Sectional Studies; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Risk Factors; Smoking; Triglycerides

1994
[Fibrinogen and factor VII in women with dyslipidemia. The preliminary results of the Bellvitge-Costa de Ponent Study. The Bellvitge Study Group].
    Medicina clinica, 1995, Jul-01, Volume: 105, Issue:5

    Topics: Adult; Aged; Cardiovascular Diseases; Cross-Sectional Studies; Factor VII; Female; Fibrinogen; Humans; Hyperlipidemias; Middle Aged; Prospective Studies; Risk Factors; Spain; Statistics, Nonparametric

1995
Associations between serum ferritin and cardiovascular risk factors in healthy young men. A cross sectional study.
    European journal of clinical nutrition, 1995, Volume: 49, Issue:6

    Topics: Adult; Analysis of Variance; Blood Pressure; Body Constitution; Cardiovascular Diseases; Cholesterol, HDL; Confounding Factors, Epidemiologic; Cross-Sectional Studies; Ferritins; Fibrinogen; Humans; Male; Middle Aged; Predictive Value of Tests; Reference Values; Regression Analysis; Risk Factors

1995
Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors.
    Arteriosclerosis, thrombosis, and vascular biology, 1995, Volume: 15, Issue:9

    Topics: Adult; Aorta; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Carotid Arteries; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Femoral Artery; Fibrinogen; Humans; Male; Middle Aged; Regression Analysis; Risk Factors; Smoking; Triglycerides; Ultrasonography

1995
Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study.
    Arteriosclerosis, thrombosis, and vascular biology, 1995, Volume: 15, Issue:9

    Topics: Aged; Aged, 80 and over; Blood Pressure; Cardiovascular Diseases; Carotid Stenosis; Cohort Studies; Factor VII; Factor VIII; Fibrinogen; Humans; Multivariate Analysis; Prospective Studies; Regression Analysis; Risk Factors

1995
Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease.
    BMJ (Clinical research ed.), 1995, Jun-17, Volume: 310, Issue:6994

    Topics: Aged; Antioxidants; Ascorbic Acid; C-Reactive Protein; Cardiovascular Diseases; Common Cold; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Longitudinal Studies; Male; Risk Factors; Seasons

1995
Proceedings from the 2nd International Symposium on Fibrinogen and Cardiovascular Disease. Edinburgh, Scotland, 1-2 November 1994.
    European heart journal, 1995, Volume: 16 Suppl A

    Topics: Animals; Cardiovascular Diseases; Fibrinogen; Humans

1995
Fibrinogen and cardiovascular disease: historical introduction.
    European heart journal, 1995, Volume: 16 Suppl A

    Topics: Cardiovascular Diseases; Europe; Fibrinogen; History, 19th Century; History, 20th Century; Humans; United States

1995
Relation of plasma coagulation factor VII and fibrinogen to carotid artery intima-media thickness.
    Thrombosis and haemostasis, 1994, Volume: 72, Issue:2

    Topics: Adult; Alleles; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Carotid Arteries; Cholesterol; Cross-Sectional Studies; Factor VII; Female; Fibrinogen; Gene Frequency; Humans; Male; Middle Aged; Multivariate Analysis; Muscle, Smooth, Vascular; Polymorphism, Genetic; Risk Factors; Smoking; Ultrasonography

1994
Royal College of Physicians of Edinburgh 2nd International Symposium on Fibrinogen and Cardiovascular Disease. 1-2 November 1994. Abstracts.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1994, Volume: 5 Suppl 2

    Topics: Animals; Cardiovascular Diseases; Fibrinogen; Humans

1994
Laboratory methods and quality assurance in the Cardiovascular Health Study.
    Clinical chemistry, 1995, Volume: 41, Issue:2

    Topics: Aged; Blood Glucose; Blood Specimen Collection; Cardiovascular Diseases; Chemistry, Clinical; Factor VII; Factor VIII; Fibrinogen; Humans; Insulin; Quality Control; Regression Analysis; Triglycerides

1995
Why is plasma fibrinogen a cardiovascular risk factor?
    Thrombosis and haemostasis, 1994, Volume: 72, Issue:4

    Topics: Cardiovascular Diseases; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gels; Humans; Risk Factors

1994
Plasma fibrinogen and other cardiovascular risk factors in urban American Indian smokers.
    Ethnicity & disease, 1993,Fall, Volume: 3, Issue:4

    Topics: Adolescent; Adult; Aged; Black People; Blood Pressure; Body Constitution; Body Weight; Cardiovascular Diseases; Cholesterol; Female; Fibrinogen; Humans; Indians, North American; Male; Middle Aged; Obesity; Smoking; Surveys and Questionnaires; United States; White People

1993
Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic disease.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1994, Volume: 5, Issue:6

    Topics: Aged; Arteriosclerosis; Blood Pressure; Body Constitution; Cardiovascular Diseases; Carotid Arteries; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Peptide Fragments; Prothrombin; Risk Factors; Smoking; Ultrasonography

1994
Longitudinal associations between plasma viscosity and cardiovascular risk factors in a middle-aged French population.
    Atherosclerosis, 1993, Volume: 104, Issue:1-2

    Topics: Age Factors; Blood Pressure; Blood Viscosity; Body Mass Index; Cardiovascular Diseases; Female; Fibrinogen; France; gamma-Glutamyltransferase; Hemoglobins; Humans; Lipoproteins; Longitudinal Studies; Male; Menopause; Middle Aged; Risk Factors; Smoking

1993
Reduced fetal growth increases risk of cardiovascular disease.
    Health reports, 1994, Volume: 6, Issue:1

    Topics: Adult; Birth Weight; Cardiovascular Diseases; Cerebrovascular Disorders; Confounding Factors, Epidemiologic; Embryonic and Fetal Development; England; Female; Fibrinogen; Follow-Up Studies; Growth; Humans; Hypertension; Infant; Infant, Low Birth Weight; Infant, Newborn; Male; Middle Aged; Risk Factors

1994
Relationship between plasma essential fatty acids and smoking, serum lipids, blood pressure and haemostatic and rheological factors.
    Prostaglandins, leukotrienes, and essential fatty acids, 1994, Volume: 51, Issue:2

    Topics: Aged; Arachidonic Acid; Blood Pressure; Blood Viscosity; Cardiovascular Diseases; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Essential; Female; Fibrinogen; Hemostasis; Humans; Lipid Peroxides; Male; Middle Aged; Rheology; Risk Factors; Smoking; Triglycerides

1994
Association between fibrinogen and other risk factors for cardiovascular disease in men and women. Results from the Göteborg MONICA survey 1985.
    Annals of epidemiology, 1994, Volume: 4, Issue:5

    Topics: Adult; Age Factors; Analysis of Variance; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Risk Factors; Sex Factors; Smoking; Sweden; Triglycerides

1994
Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution.
    Thrombosis research, 1994, Aug-01, Volume: 75, Issue:3

    Topics: Adult; Blood Coagulation; Blood Proteins; Blood Viscosity; Body Constitution; Cardiovascular Diseases; Factor VII; Female; Fibrinogen; Fibrinolysis; Hematocrit; Hemorheology; Humans; Lipids; Obesity; Premenopause; Risk Factors

1994
Fibrinogen, a vascular risk factor: a simple marker or a real cause of vascular lesion?
    Thrombosis research, 1994, Aug-01, Volume: 75, Issue:3

    Topics: Adolescent; Adult; Biomarkers; Carcinoma, Hepatocellular; Cardiovascular Diseases; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Growth Inhibitors; Humans; Interleukin-6; Leukemia Inhibitory Factor; Liver; Liver Neoplasms; Lymphokines; Oncostatin M; Peptides; Recombinant Proteins; Risk Factors; Tumor Cells, Cultured

1994
Does weight loss reduce plasma fibrinogen?
    British heart journal, 1993, Volume: 70, Issue:2

    Topics: Cardiovascular Diseases; Clinical Trials as Topic; Fibrinogen; Humans; Risk Factors; Weight Loss

1993
Prothrombin fragment F1 + 2: correlations with cardiovascular risk factors.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1994, Volume: 5, Issue:3

    Topics: Adult; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Exercise; Factor VII; Female; Fibrinogen; Humans; Male; Middle Aged; Obesity; Peptide Fragments; Prothrombin; Risk Factors; Smoking

1994
Evaluation of cardiovascular risk factors in overweight and obese subjects.
    International angiology : a journal of the International Union of Angiology, 1994, Volume: 13, Issue:1

    Topics: Adult; Anthropometry; Apolipoprotein A-I; Apolipoproteins B; Blood Glucose; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Factor VII; Female; Fibrinogen; Humans; Male; Obesity; Plasminogen; Risk Factors; Triglycerides

1994
Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor.
    Thrombosis and haemostasis, 1994, Volume: 71, Issue:5

    Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Enzyme Activation; Female; Fibrinogen; Humans; Male; Mass Screening; Middle Aged; Regression Analysis; Risk Factors; Thrombin

1994
Plasma fibrinogen and physiological aging.
    Aging (Milan, Italy), 1993, Volume: 5, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Aging; Blood Chemical Analysis; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Middle Aged; Reference Values; Risk Factors; Sex Characteristics

1993
[Plasma fibrinogen and cardiovascular risk factors. The experience of the Integrated Community Control Project on Chronic Degenerative Diseases in the Health District of Sezze--Di.S.Co. The Research Group].
    Recenti progressi in medicina, 1994, Volume: 85, Issue:3

    Topics: Adult; Age Distribution; Aged; Arteriosclerosis; Cardiovascular Diseases; Chronic Disease; Female; Fibrinogen; Humans; Italy; Linear Models; Male; Middle Aged; Risk Factors; Sex Distribution

1994
Fibrinogen and viscosity: risk factors for cardiovascular events.
    Comprehensive therapy, 1994, Volume: 20, Issue:3

    Topics: Arterial Occlusive Diseases; Arteriosclerosis; Blood Viscosity; Cardiovascular Diseases; Cerebrovascular Disorders; Fibrinogen; Humans; Myocardial Ischemia; Risk Factors

1994
Fibrinogen and factor VII in male neonates.
    Thrombosis research, 1994, Feb-15, Volume: 73, Issue:3-4

    Topics: Birth Weight; Cardiovascular Diseases; Disease Susceptibility; Embryonic and Fetal Development; Factor VII; Fetal Blood; Fibrinogen; Gestational Age; Humans; Infant, Newborn; Male; Organ Size; Placenta; Prognosis; Sex Factors

1994
Risk factors for cardiovascular disease in IDDM. A study of identical twins.
    Diabetes, 1994, Volume: 43, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Alcohol Drinking; Apolipoproteins; Blood Glucose; Cardiovascular Diseases; Cholesterol; Creatinine; Diabetes Mellitus, Type 1; Diseases in Twins; Factor VII; Female; Fibrinogen; Glycated Hemoglobin; Humans; Lipoproteins; Male; Middle Aged; Risk Factors; Smoking; Triglycerides; Twins, Monozygotic

1994
Plasma fibrinogen in relation to serum insulin, smoking habits and adipose tissue fatty acids in healthy men.
    European journal of clinical investigation, 1994, Volume: 24, Issue:2

    Topics: Adipose Tissue; Adult; Cardiovascular Diseases; Fatty Acids; Fibrinogen; Humans; Insulin; Male; Risk Factors; Smoking

1994
Inheritance conjointly contributing to fibrinolysis and hyperlipidemia.
    Metabolism: clinical and experimental, 1993, Volume: 42, Issue:11

    Topics: Adult; alpha-2-Antiplasmin; Cardiovascular Diseases; Fasting; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Lipids; Lipoproteins; Male; Middle Aged; Plasminogen; Plasminogen Inactivators; Prospective Studies; Regression Analysis; Tissue Plasminogen Activator

1993
Fibrinogen and cardiovascular risk.
    Annals of internal medicine, 1993, Dec-15, Volume: 119, Issue:12

    Topics: Cardiovascular Diseases; Fibrinogen; Humans; Risk Factors

1993
Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1993, Volume: 13, Issue:12

    Topics: Arteriosclerosis; Cardiovascular Diseases; Carotid Artery Diseases; Factor VII; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Prospective Studies; Racial Groups; Risk Factors; Smoking; Ultrasonography; von Willebrand Factor

1993
Routine measurement of fibrinogen concentration.
    BMJ (Clinical research ed.), 1993, Oct-09, Volume: 307, Issue:6909

    Topics: Cardiovascular Diseases; Fibrinogen; Hematologic Tests; Humans; Risk Factors

1993
Plasma fibrinogen: levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    American journal of epidemiology, 1993, Dec-15, Volume: 138, Issue:12

    Topics: Adolescent; Adult; Body Mass Index; Cardiovascular Diseases; Female; Fibrinogen; Humans; Life Style; Male; Multivariate Analysis; Reference Values; Regression Analysis; Risk Factors; Socioeconomic Factors; Stress, Physiological

1993
Fibrinogen plasma levels as a marker of thrombin activation in diabetes.
    Diabetes, 1994, Volume: 43, Issue:3

    Topics: Adult; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glycated Hemoglobin; Heparin; Humans; Male; Prothrombin; Regression Analysis; Risk Factors; Thrombin

1994
Lipoprotein (a) in a randomly selected 25-64 year old population: the Northern Sweden Monica Study.
    Journal of clinical epidemiology, 1993, Volume: 46, Issue:7

    Topics: Adult; Aged; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Life Style; Lipoprotein(a); Male; Menopause; Middle Aged; Regression Analysis; Risk Factors; Sweden

1993
Fibrinogen as a cardiovascular risk factor in Spanish children and adolescents. The Niño Jesus Group.
    American heart journal, 1993, Volume: 126, Issue:2

    Topics: Adolescent; Age Factors; Cardiovascular Diseases; Child; Child, Preschool; Cross-Sectional Studies; Female; Fibrinogen; Humans; Lipids; Male; Risk Factors; Sex Factors; Smoking; Spain

1993
Passage of the menopause is followed by haemostatic changes.
    Maturitas, 1993, Volume: 17, Issue:1

    Topics: Adult; Antithrombin III; Cardiovascular Diseases; Female; Fibrinogen; Hemostasis; Humans; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Protein C; Risk Factors; Tissue Plasminogen Activator

1993
Reduced plasma fibrinogen, serum peroxides, lipids, and apolipoproteins after a 3-week vegetarian diet.
    Plant foods for human nutrition (Dordrecht, Netherlands), 1993, Volume: 43, Issue:1

    Topics: Apolipoproteins; Body Weight; Cardiovascular Diseases; Cholesterol; Diet, Vegetarian; Female; Fibrinogen; Fibromyalgia; Humans; Lipids; Male; Middle Aged; Peroxides; Risk Factors; Triglycerides; Walking

1993
Plasma fibrinogen and its correlates in children from a biracial community: the Bogalusa Heart Study.
    Pediatric research, 1993, Volume: 33, Issue:4 Pt 1

    Topics: Adolescent; Age Factors; Black People; Blood Pressure; Cardiovascular Diseases; Child; Child, Preschool; Female; Fibrinogen; Humans; Leukocyte Count; Lipoproteins; Louisiana; Male; Reference Values; Risk Factors; Sex Factors; Skinfold Thickness; White People

1993
Fibrinogen: A new cardiovascular risk factor?
    Canadian family physician Medecin de famille canadien, 1993, Volume: 39

    Topics: Blood Coagulation Disorders; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Risk Factors

1993
Relation of fibrinogen to lifestyles and to cardiovascular risk factors in a working population.
    International journal of epidemiology, 1995, Volume: 24, Issue:5

    Topics: Adult; Analysis of Variance; Apolipoproteins B; Belgium; Cardiovascular Diseases; Cross-Sectional Studies; Fibrinogen; Humans; Life Style; Linear Models; Male; Middle Aged; Occupational Health; Risk Factors

1995
Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects--evidence against a modulating role for insulin.
    Diabetologia, 1995, Volume: 38, Issue:9

    Topics: Adult; Aged; Albuminuria; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Factor VII; Fasting; Female; Fibrinogen; Humans; Insulin; Lipids; Male; Middle Aged; Proinsulin; Protein Precursors; Reference Values; Risk Factors; Triglycerides

1995
'Silent' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese.
    Arteriosclerosis, thrombosis, and vascular biology, 1996, Volume: 16, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation Disorders; Brain Ischemia; Cardiovascular Diseases; Cerebral Infarction; Comorbidity; Dementia, Multi-Infarct; Disease Susceptibility; Endothelium, Vascular; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Japan; Lipids; Lipoprotein(a); Magnetic Resonance Imaging; Male; Middle Aged; Prevalence; Risk Factors; Smoking; Thrombomodulin; von Willebrand Factor

1996
Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus.
    Atherosclerosis, 1996, Volume: 120, Issue:1-2

    Topics: Aged; alpha-2-Antiplasmin; Antithrombin III; Blood Coagulation Disorders; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Susceptibility; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Japan; Lipoprotein(a); Male; Middle Aged; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator

1996
Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators.
    American journal of epidemiology, 1996, Apr-01, Volume: 143, Issue:7

    Topics: Age Distribution; Aged; Aged, 80 and over; Analysis of Variance; Cardiovascular Diseases; Cohort Studies; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Linear Models; Logistic Models; Male; Prevalence; Risk Factors; Sex Distribution; United States

1996
Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1996, Volume: 27, Issue:6

    Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Factor VII; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Plasminogen Activator Inhibitor 1; Renal Dialysis; Risk Factors; Tissue Plasminogen Activator

1996
Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome.
    American journal of respiratory and critical care medicine, 1996, Volume: 153, Issue:6 Pt 1

    Topics: Adult; Aged; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Middle Aged; Nose; Positive-Pressure Respiration; Predictive Value of Tests; Risk Factors; Sleep Apnea Syndromes; Syndrome

1996
Distribution of blood viscosity values and biochemical correlates in healthy adults.
    Clinical chemistry, 1996, Volume: 42, Issue:8 Pt 1

    Topics: Adult; Blood Proteins; Blood Viscosity; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrinogen; Humans; Lipids; Male; Middle Aged; Reference Values; Risk Factors; Sex Characteristics; Triglycerides

1996
Long-term influence of fibrinogen on initial and recurrent cardiovascular events in men and women.
    The American journal of cardiology, 1996, Jul-01, Volume: 78, Issue:1

    Topics: Age Factors; Aged; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Follow-Up Studies; Humans; Incidence; Male; Massachusetts; Middle Aged; Proportional Hazards Models; Recurrence; Risk Factors; Sex Factors; Time Factors

1996
Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program.
    Diabetes care, 1996, Volume: 19, Issue:6

    Topics: Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Blood Glucose; Cardiovascular Diseases; Cholesterol; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus; Fibrinogen; Glucose Intolerance; Glucose Tolerance Test; Hawaii; Humans; Insulin; Male; Prevalence; Reference Values; Risk Factors; Smoking; Surveys and Questionnaires; Triglycerides

1996
Influence of smoking on the survival rate of diabetic patients requiring hemodialysis.
    Diabetes care, 1996, Volume: 19, Issue:6

    Topics: Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prevalence; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Smoking; Survival Rate; Time Factors; Triglycerides

1996
Fish oil may be an antidote for the cardiovascular risk of smoking.
    Medical hypotheses, 1996, Volume: 46, Issue:4

    Topics: Antidotes; Arrhythmias, Cardiac; Arteriosclerosis; Blood Viscosity; Cardiovascular Diseases; Fibrinogen; Fish Oils; Humans; Models, Biological; Nicotine; Risk Factors; Smoking; Thrombosis; Vasoconstriction

1996
Considerations about plasma fibrinogen concentration and the cardiovascular risk: combined evidence from the GRIPS and ECAT studies. Goettingen Risk Incidence and Prevalence Study. European Concerted Action on Thrombosis and Disabilities.
    The American journal of cardiology, 1996, Aug-01, Volume: 78, Issue:3

    Topics: Adult; Cardiovascular Diseases; Cohort Studies; Fibrinogen; Humans; Male; Middle Aged; Risk Factors

1996
Relationship between job stress and plasma fibrinolytic activity in male Japanese workers.
    International archives of occupational and environmental health, 1996, Volume: 68, Issue:5

    Topics: Adult; Blood Coagulation; Cardiovascular Diseases; Data Collection; Fibrinogen; Humans; Japan; Male; Middle Aged; Plasminogen; Regression Analysis; Risk Factors; Stress, Psychological; Workplace

1996
Inter-relationships of plasma fibrinogen, low-density lipoprotein cholesterol, cigarette smoking and the prevalence of cardiovascular disease.
    Journal of cardiovascular risk, 1996, Volume: 3, Issue:3

    Topics: Aged; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Odds Ratio; Prevalence; Risk Factors; Smoking

1996
Fibrinogen and the albumin-globulin ratio in essential hypertension: relations to plasma renin system activity.
    Journal of human hypertension, 1996, Volume: 10, Issue:2

    Topics: Adult; Albumins; Analysis of Variance; Cardiovascular Diseases; Case-Control Studies; Female; Fibrinogen; Globulins; Humans; Hypertension; Male; Regression Analysis; Renin-Angiotensin System; Risk Factors

1996
Determinants of lipoprotein(a) levels in a middle-aged working population.
    European heart journal, 1996, Volume: 17, Issue:12

    Topics: Adult; Analysis of Variance; Apolipoproteins B; Belgium; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Health Surveys; Humans; Industry; Lipoproteins; Male; Middle Aged; Multivariate Analysis; Risk Factors

1996
Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men.
    Stroke, 1996, Volume: 27, Issue:12

    Topics: Aged; Aged, 80 and over; Alleles; Apolipoprotein E4; Apolipoproteins E; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Cognition Disorders; Cohort Studies; Comorbidity; Diabetes Mellitus, Type 1; Disease Susceptibility; Fibrinogen; Humans; Male; Netherlands; Odds Ratio; Risk Factors

1996
Hemorheological profile in patients with cardiovascular risk factors.
    Haemostasis, 1996, Volume: 26 Suppl 4

    Topics: Adolescent; Adult; Blood Viscosity; Cardiovascular Diseases; Child; Child, Preschool; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Heterozygote; Humans; Hyperlipoproteinemia Type II; Hypertension; Male; Risk Factors; Sex Factors

1996
Plasma fibrinogen in Israeli Moslem and Jewish school-children: distribution and relation to other cardiovascular risk factors. The Petah Tikva project.
    Israel journal of medical sciences, 1996, Volume: 32, Issue:12

    Topics: Adolescent; Age Distribution; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Child; Cholesterol, HDL; Cross-Sectional Studies; Female; Fibrinogen; Humans; Islam; Israel; Jews; Male; Risk Factors; Sex Distribution; Students

1996
Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1997, Volume: 12, Issue:1

    Topics: Adult; Aged; Alleles; Blood Coagulation Disorders; Cardiovascular Diseases; Environment; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genotype; Humans; Kidney Transplantation; Male; Middle Aged; Peptide Fragments; Prothrombin; Risk Factors

1997
Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population.
    Circulation, 1997, Feb-18, Volume: 95, Issue:4

    Topics: Apolipoproteins B; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Factor VII; Female; Fibrinogen; Humans; Hypobetalipoproteinemias; Longitudinal Studies; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Risk Factors; Smoking; Tissue Plasminogen Activator; Triglycerides; von Willebrand Factor

1997
Fibrinogen and cardiovascular disease.
    Journal of clinical pathology, 1997, Volume: 50, Issue:1

    Topics: Cardiovascular Diseases; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Myocardial Ischemia; Prospective Studies; Risk Factors

1997
Exercise intensity and subclinical cardiovascular disease in the elderly. The Cardiovascular Health Study.
    American journal of epidemiology, 1997, Jun-01, Volume: 145, Issue:11

    Topics: Aged; Cardiovascular Diseases; Cross-Sectional Studies; Energy Metabolism; Exercise; Female; Fibrinogen; Humans; Insulin; Life Style; Longitudinal Studies; Male; Prevalence; Risk Factors

1997
Plasma fibrinogen concentration in a Chinese population.
    Atherosclerosis, 1997, Volume: 131, Issue:2

    Topics: Adolescent; Adult; Aged; Asian People; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Male; Middle Aged; Prevalence; Risk Factors; Triglycerides

1997
Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
    Diabetologia, 1997, Volume: 40, Issue:6

    Topics: Adult; Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Europe; Female; Fibrinogen; Glycated Hemoglobin; Humans; Male; Risk Factors; Smoking; Triglycerides; von Willebrand Factor

1997
The effects of genotype and infant weight on adult plasma levels of fibrinogen, factor VII, and LDL cholesterol are additive.
    Journal of medical genetics, 1997, Volume: 34, Issue:7

    Topics: Adult; Alleles; Apolipoproteins E; Birth Weight; Cardiovascular Diseases; Cholesterol, LDL; Factor VII; Female; Fibrinogen; Genotype; Humans; Infant; Male; Polymorphism, Genetic; Risk Factors

1997
Proinsulin, intact insulin, and fibrinolytic variables and fibrinogen in healthy subjects. A population study.
    Diabetes care, 1997, Volume: 20, Issue:8

    Topics: Adult; Aged; Cardiovascular Diseases; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Fibrinolysis; Glucose Intolerance; Humans; Hyperinsulinism; Insulin; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Proinsulin; Random Allocation; Risk Factors; Sweden; Tissue Plasminogen Activator

1997
Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.
    Circulation, 1997, Sep-02, Volume: 96, Issue:5

    Topics: Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Count; Platelet Glycoprotein GPIb-IX Complex; Polymorphism, Genetic; Risk Factors

1997
Cognitive function, vascular risk factors and education. A cross-sectional study based on a cohort of 70-year-old men.
    Journal of internal medicine, 1997, Volume: 242, Issue:4

    Topics: Aged; Cardiovascular Diseases; Cognition; Cross-Sectional Studies; Diabetes Complications; Educational Status; Fibrinogen; Humans; Hyperlipidemias; Male; Obesity; Psychometrics; Risk Factors; Smoking

1997
Seasonal variations of rheological and hemostatic parameters and acute-phase reactants in young, healthy subjects.
    Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:11

    Topics: Acute-Phase Proteins; Adult; Blood Proteins; Blood Viscosity; Cardiovascular Diseases; Erythrocyte Indices; Female; Fibrinogen; Hemostasis; Humans; Hydrocortisone; Leukocyte Count; Lipids; Male; Plasminogen Activator Inhibitor 1; Reference Values; Risk Factors; Seasons

1997
Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
    Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:11

    Topics: Angioplasty, Balloon; Antithrombin III; Arterial Occlusive Diseases; Biomarkers; Blood Coagulation Tests; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Creatinine; Diabetes Mellitus; Female; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hyperlipidemias; Lipids; Male; Metabolic Clearance Rate; Peptide Fragments; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Popliteal Artery; Prospective Studies; Prothrombin; Recurrence; Risk; Risk Factors; Smoking; Thrombin; Thrombophilia; Tissue Plasminogen Activator; Treatment Failure; Ultrasonography, Doppler, Color; von Willebrand Factor

1997
[Chronic metabolic syndrome: a predictive model of risk of macrovascular events?].
    Atencion primaria, 1997, Sep-15, Volume: 20, Issue:4

    Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Chronic Disease; Female; Fibrinogen; Humans; Logistic Models; Male; Microvascular Angina; Middle Aged; Prognosis; Random Allocation; Risk Factors

1997
Fibrinogen, plasminogen activator inhibitor-1, and carotid intima-media wall thickness in the NHLBI Family Heart Study.
    Thrombosis and haemostasis, 1998, Volume: 79, Issue:2

    Topics: Aged; Cardiovascular Diseases; Carotid Arteries; Female; Fibrinogen; Humans; Hyperplasia; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Tunica Intima; Tunica Media

1998
Elevated plasma fibrinogen: cause or consequence of cardiovascular disease?
    Arteriosclerosis, thrombosis, and vascular biology, 1998, Volume: 18, Issue:4

    Topics: Aged; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cross-Sectional Studies; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Smoking

1998
Cardiovascular disease, fibrinogen and the acute phase response: associations with lipids and blood pressure in patients with chronic renal disease.
    Atherosclerosis, 1998, Volume: 137, Issue:1

    Topics: Acute-Phase Reaction; Adult; Age Factors; Aged; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, VLDL; Cross-Sectional Studies; Data Interpretation, Statistical; Diastole; Female; Fibrinogen; Humans; Hypertension; Interleukin-6; Kidney Failure, Chronic; Leukocyte Count; Lipids; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Platelet Count; Prospective Studies; Proteinuria; Renal Dialysis; Serum Albumin; Sex Factors; Smoking; Systole

1998
Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1998, Volume: 116, Issue:5

    Topics: Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Macular Degeneration; Male; Middle Aged; New South Wales; Risk Factors; Smoking

1998
[Prevalence of obesity and its relationship with cardiovascular risk in the general population of Albacete].
    Atencion primaria, 1998, Mar-15, Volume: 21, Issue:4

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Body Weight; Cardiovascular Diseases; Cross-Over Studies; Data Interpretation, Statistical; Diabetes Complications; Female; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Obesity; Risk Factors; Sex Factors; Spain

1998
The alpha fibrinogen T/A312 polymorphism in the ECTIM study.
    Thrombosis and haemostasis, 1998, Volume: 79, Issue:5

    Topics: Cardiovascular Diseases; Fibrinogen; Humans; Polymorphism, Genetic; Risk Factors

1998
Cardiovascular risk factors in relation to cigarette smoking: a population-based survey among Asians in Singapore.
    Atherosclerosis, 1998, Volume: 137, Issue:2

    Topics: Adult; Aged; Antioxidants; Body Mass Index; Cardiovascular Diseases; Ethnicity; Fibrinogen; Humans; Insulin; Lipids; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prevalence; Random Allocation; Reactive Oxygen Species; Retrospective Studies; Risk Factors; Singapore; Smoking; Surveys and Questionnaires

1998
Cardiorespiratory fitness and cardiovascular disease risk factors in postmenopausal women.
    Medicine and science in sports and exercise, 1998, Volume: 30, Issue:6

    Topics: Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Lipids; Middle Aged; Physical Fitness; Postmenopause; Risk Factors

1998
Haemostatic profile of the San (Bushmen) relocated to Schmidtsdrif.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1998, Volume: 88, Issue:6

    Topics: Adult; Black People; Blood Coagulation Factors; Cardiovascular Diseases; Cross-Sectional Studies; Feeding Behavior; Female; Fibrinogen; Hemostasis; Humans; Male; Namibia; Partial Thromboplastin Time; Prothrombin Time; Risk Factors; South Africa; Thrombin Time; Urbanization

1998
A possible connection between furnace dust exposure, plasma fibrinogen levels and cardiovascular disease.
    Scandinavian journal of work, environment & health, 1998, Volume: 24, Issue:3

    Topics: Alloys; Biomarkers; Cardiovascular Diseases; Dust; Environmental Monitoring; Epidemiological Monitoring; Fibrinogen; Humans; Inhalation Exposure; Iron; Manganese; Occupational Diseases; Particle Size; Risk Factors; Silicon; Sweden

1998
Risk factors for cardiovascular disease in patients with functioning kidney grafts.
    Transplantation proceedings, 1998, Volume: 30, Issue:5

    Topics: Blood Glucose; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Kidney Transplantation; Male; Middle Aged; Obesity; Postoperative Complications; Retrospective Studies; Risk Factors; Smoking; Triglycerides

1998
Hemostasis in normotensive and hypertensive men: results of the PROCAM study. The prospective cardiovascular Münster study.
    Journal of hypertension, 1998, Volume: 16, Issue:7

    Topics: Adult; Antithrombin III; Blood Pressure; Cardiovascular Diseases; Factor VII; Fibrinogen; Germany; Hemostasis; Humans; Hypertension; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Protein C; Reference Values; Risk Factors; Serum Globulins; von Willebrand Factor

1998
Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Thrombosis and haemostasis, 1998, Volume: 80, Issue:5

    Topics: Alcohol Drinking; Cardiovascular Diseases; Comorbidity; Factor VII; Fibrinogen; France; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Northern Ireland; Obesity; Plasminogen Activator Inhibitor 1; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires

1998
Social network in relation to plasma fibrinogen.
    Journal of biosocial science, 1997, Volume: 29, Issue:2

    Topics: Cardiovascular Diseases; Fibrinogen; Finland; Health Status; Humans; Male; Middle Aged; Risk Factors; Sampling Studies; Smoking; Social Support; Surveys and Questionnaires

1997
Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinoma.
    Cancer, 1999, Jan-01, Volume: 85, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antithrombin III; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Enzyme Inhibitors; Estrogen Antagonists; Fadrozole; Female; Fibrinogen; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Postmenopause; Protein C; Protein S; Risk Factors; Triglycerides

1999
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.
    Kidney international, 1999, Volume: 55, Issue:2

    Topics: Acute-Phase Reaction; Adult; Aged; Aged, 80 and over; Apolipoproteins; Cardiovascular Diseases; Female; Fibrinogen; Humans; Inflammation; Lipids; Lipoprotein(a); Male; Middle Aged; Prospective Studies; Reference Values; Renal Dialysis; Risk Factors; Serum Albumin

1999
Cardiovascular risk profile after simultaneous pancreas and kidney transplantation.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1998, Volume: 106, Issue:6

    Topics: Adult; Blood Viscosity; Cardiovascular Diseases; Cholesterol, LDL; Cross-Sectional Studies; Female; Fibrinogen; Graft Rejection; Hemorheology; Humans; Hypertension; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Risk Factors; Triglycerides

1998
Antiplasmin correlates to arterial reactivity in a healthy population of 35-year-old men and women.
    Journal of internal medicine, 1999, Volume: 245, Issue:1

    Topics: Adult; alpha-2-Antiplasmin; Antifibrinolytic Agents; Brachial Artery; Cardiovascular Diseases; Endothelium, Vascular; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Male; Nitroglycerin; Plasminogen Activator Inhibitor 1; Random Allocation; Reference Values; Regression Analysis; Risk Factors; Sweden; Vasodilation; Vasodilator Agents; von Willebrand Factor

1999
Fibrinogen: a possible link between alcohol consumption and cardiovascular disease? DESIR Study Group.
    Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:4

    Topics: Adult; Alcohol Drinking; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; France; Humans; Male; Middle Aged; Smoking

1999
Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle advice.
    International angiology : a journal of the International Union of Angiology, 1998, Volume: 17, Issue:4

    Topics: Body Weight; Cardiovascular Diseases; Clofibric Acid; Female; Fibric Acids; Fibrinogen; Humans; Hyperlipidemias; Hypolipidemic Agents; Life Style; Lipoproteins; Liver Function Tests; Male; Middle Aged; Retrospective Studies; Risk Factors

1998
The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction.
    Diabetologia, 1999, Volume: 42, Issue:5

    Topics: Animals; Blood Glucose; Cachexia; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Fibrinogen; Glycated Hemoglobin; Hepatomegaly; Hyperinsulinism; Islets of Langerhans; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Nicotinic Acids; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Risk Factors; Tetrahydronaphthalenes; Transcription Factors

1999
Increasing plasma fibrinogen, but unchanged levels of intraplatelet cyclic nucleotides, plasma endothelin-1, factor VII, and neopterin during cholesterol lowering with fluvastatin.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1999, Volume: 10, Issue:3

    Topics: Aged; Anticholesteremic Agents; Blood Platelets; Cardiovascular Diseases; Cholesterol; Endothelin-1; Factor VII; Fatty Acids, Monounsaturated; Female; Fibrinogen; Fluvastatin; Humans; Hypercholesterolemia; Indoles; Male; Middle Aged; Neopterin; Nucleotides, Cyclic

1999
The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study.
    Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:7

    Topics: Aged; Cardiovascular Diseases; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Male; Multivariate Analysis; Risk Factors

1999
The effect of short-term cold exposure on risk factors for cardiovascular disease.
    Thrombosis research, 1999, Jul-15, Volume: 95, Issue:2

    Topics: Adult; Blood Cell Count; Blood Coagulation; Cardiovascular Diseases; Cell Differentiation; Cold Temperature; Cytokines; Environmental Exposure; Fibrinogen; Fibrinolytic Agents; Hematocrit; Humans; Inflammation; Male; Norway; Pain Measurement; Plasminogen Activator Inhibitor 1; Risk Factors; Self-Assessment; Serine Proteinase Inhibitors; Thromboplastin; Thromboxane B2; Tissue Plasminogen Activator

1999
Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1999, Volume: 34, Issue:3

    Topics: Adult; Aged; Cardiovascular Diseases; Cross-Sectional Studies; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Kidney Failure, Chronic; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Middle Aged; Plasminogen Activator Inhibitor 1; Renal Dialysis; Risk Factors; Smoking; Tissue Plasminogen Activator

1999
Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives--a preliminary report.
    Thrombosis and haemostasis, 1999, Volume: 82, Issue:3

    Topics: Adult; Cardiovascular Diseases; Contraceptives, Oral; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Middle Aged; Risk Factors; Smoking

1999
Fibrinogen and factor VII levels are related to adiposity but not to fetal growth or social class in children aged 10-11 years.
    American journal of epidemiology, 1999, Oct-01, Volume: 150, Issue:7

    Topics: Adipose Tissue; Age Factors; Birth Weight; Body Constitution; Cardiovascular Diseases; Child; Embryonic and Fetal Development; England; Exercise; Factor VII; Female; Fibrinogen; Humans; Male; Obesity; Sex Factors; Social Class; Wales

1999
Plasma fibrinogen and other cardiovascular disease risk factors and cataract.
    Ophthalmic epidemiology, 1999, Volume: 6, Issue:4

    Topics: Aged; Aged, 80 and over; Body Mass Index; Cardiovascular Diseases; Cataract; Cross-Sectional Studies; Female; Fibrinogen; Humans; Incidence; Lipids; Male; Middle Aged; New South Wales; Odds Ratio; Retrospective Studies; Risk Factors; Sex Factors; Surveys and Questionnaires; Survival Rate

1999
Haemostatic parameters related to lipids and adhesion molecules.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1999, Volume: 10, Issue:8

    Topics: Adult; Age Factors; Antigens; beta-Thromboglobulin; Biomarkers; Blood Coagulation Factors; Cardiovascular Diseases; Cholesterol; Female; Fibrinogen; Hemostatics; Humans; Leukocyte Count; Lipids; Male; P-Selectin; Plasminogen Activator Inhibitor 1; Premenopause; Risk Factors; Smoking; Tissue Plasminogen Activator; Vascular Cell Adhesion Molecule-1

1999
Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen.
    American journal of epidemiology, 2000, Feb-01, Volume: 151, Issue:3

    Topics: Adolescent; Adult; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cross-Sectional Studies; Female; Fibrinogen; Health Status; Humans; Male; Middle Aged; Periodontal Index; Risk Factors

2000
Investigation of factors which might indicate susceptibility to particulate air pollution.
    Occupational and environmental medicine, 2000, Volume: 57, Issue:1

    Topics: Aged; Air Pollutants; Air Pollution; Cardiovascular Diseases; Cohort Studies; Disease Susceptibility; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Risk Factors; Scotland

2000
The Pl(A2) allele and cardiovascular disease: the pro(33) and con.
    The Journal of clinical investigation, 2000, Volume: 105, Issue:6

    Topics: Alleles; Amino Acid Substitution; Antigens, Human Platelet; Cardiovascular Diseases; Cell Adhesion Molecules; Clot Retraction; Fibrinogen; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Genetic Predisposition to Disease; Humans; Male; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Point Mutation; Polymorphism, Genetic; Protein Isoforms; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Risk Factors

2000
Relationship between apolipoprotein E polymorphism, postprandial hyperlipemia and hemostatic variables in patients with combined hyperlipemia.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2000, Volume: 10, Issue:1

    Topics: Adult; Apolipoproteins; Apolipoproteins E; Area Under Curve; Blood Glucose; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Factor VII; Female; Fibrinogen; Genotype; Hemostasis; Humans; Hyperlipidemias; Insulin; Linear Models; Male; Middle Aged; Polymorphism, Genetic; Postprandial Period; Triglycerides

2000
Birthweight and social deprivation: influences on serum lipids and fibrinogen.
    Acta paediatrica (Oslo, Norway : 1992), 2000, Volume: 89, Issue:6

    Topics: Adolescent; Birth Weight; Cardiovascular Diseases; Child; Female; Fibrinogen; Humans; Linear Models; Lipids; Male; Poverty; Risk Factors

2000
Inverse association of physical fitness with plasma fibrinogen level in children: the Columbia University BioMarkers Study.
    American journal of epidemiology, 2000, Aug-01, Volume: 152, Issue:3

    Topics: Adult; Alleles; Biomarkers; Body Mass Index; Cardiovascular Diseases; Child; Child, Preschool; Ethnicity; Female; Fibrinogen; Heart Rate; Humans; Linear Models; Male; Physical Fitness; Risk Factors; Surveys and Questionnaires

2000
Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factors.
    Arteriosclerosis, thrombosis, and vascular biology, 2000, Volume: 20, Issue:9

    Topics: Age Factors; Biomarkers; Carboxypeptidase B2; Carboxypeptidases; Cardiovascular Diseases; Environment; Female; Fibrinogen; Hemostasis; Hormones; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Sex Factors

2000
Untreated growth hormone deficiency explains premature mortality in patients with hypopituitarism.
    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 1998, Volume: 8 Suppl A

    Topics: Cardiovascular Diseases; Fibrinogen; Human Growth Hormone; Humans; Hyperlipidemias; Hypertension; Hypopituitarism; Insulin; Insulin Resistance; Obesity; Plasminogen Activator Inhibitor 1; Quality of Life; Recombinant Proteins

1998
Job strain and risk indicators for cardiovascular disease in young female nurses.
    Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 2000, Volume: 19, Issue:5

    Topics: Adult; Body Mass Index; Cardiovascular Diseases; Female; Fibrinogen; Humans; Job Satisfaction; Lipoproteins; Middle Aged; Nurses; Risk Factors; Social Support; Stress, Psychological; Workload

2000
Cardiovascular disease in South Asians.
    Lancet (London, England), 2000, Sep-23, Volume: 356, Issue:9235

    Topics: Asia; Canada; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Fibrinogen; Glucose Intolerance; Humans; Insulin Resistance; Lipoprotein(a); Plasminogen Inactivators; Syndrome; Triglycerides

2000
Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population.
    Circulation, 2000, Oct-03, Volume: 102, Issue:14

    Topics: Biomarkers; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Prognosis; Risk Factors

2000
Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: association with cardiovascular events.
    Thrombosis and haemostasis, 2000, Volume: 84, Issue:4

    Topics: Adult; Arterioles; Blood Coagulation; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Middle Aged; Nephrosclerosis; Risk

2000
Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.
    American journal of epidemiology, 2000, Nov-15, Volume: 152, Issue:10

    Topics: Aged; Aged, 80 and over; Antigens; Blood Coagulation; Cardiovascular Diseases; Cluster Analysis; Factor Analysis, Statistical; Factor VII; Female; Fibrinogen; Fibrinolysis; Humans; Inflammation; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors

2000
Serum carotenoids and markers of inflammation in nonsmokers.
    American journal of epidemiology, 2000, Dec-01, Volume: 152, Issue:11

    Topics: Acute-Phase Proteins; Adult; beta Carotene; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Carotenoids; Cross-Sectional Studies; Effect Modifier, Epidemiologic; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Risk

2000
Increased plasma fibrinogen level and future risk of coronary artery disease after repair of abdominal aortic aneurysm.
    Journal of the American College of Surgeons, 2000, Volume: 191, Issue:6

    Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Analysis of Variance; Aortic Aneurysm, Abdominal; Cardiovascular Diseases; Cause of Death; Cerebrovascular Disorders; Coronary Disease; Female; Fibrinogen; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Prognosis; Proportional Hazards Models; Renal Insufficiency; Retrospective Studies; Risk Factors; Smoking; Survival Analysis

2000
Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: a community with high prevalence of Type 2 diabetes mellitus and impaired glucose tolerance.
    Diabetic medicine : a journal of the British Diabetic Association, 2000, Volume: 17, Issue:11

    Topics: Adult; Age Factors; Aged; Asian People; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Confidence Intervals; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Glucose Intolerance; Hong Kong; Humans; Hypertension; Male; Middle Aged; Obesity; Prevalence; Risk Factors; Sex Factors; Triglycerides

2000
Association between physical activity and markers of inflammation in a healthy elderly population.
    American journal of epidemiology, 2001, Feb-01, Volume: 153, Issue:3

    Topics: Aged; Analysis of Variance; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Factor VIII; Female; Fibrinogen; Humans; Inflammation; Leukocyte Count; Male; Physical Exertion; Sex Factors; Smoking

2001
Hyperfibrinogenemia in patients of diabetes mellitus in relation to glycemic control and urinary albumin excretion rate.
    The Journal of the Association of Physicians of India, 2001, Volume: 49

    Topics: Age Factors; Albuminuria; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors

2001
Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: a long-term cohort study.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:3

    Topics: Adult; alpha 1-Antitrypsin; Cardiovascular Diseases; Ceruloplasmin; Cohort Studies; Fibrinogen; Follow-Up Studies; Haptoglobins; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Orosomucoid; Survival Rate; Sweden; Time Factors

2001
Ethnic differences in fibrinogen levels: the role of environmental factors and the beta-fibrinogen gene.
    American journal of epidemiology, 2001, Apr-15, Volume: 153, Issue:8

    Topics: Adult; Black People; Cardiovascular Diseases; England; Environment; Female; Fibrinogen; Gene Frequency; Humans; Indians, North American; Life Style; Male; Middle Aged; Smoking; White People

2001
Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:5

    Topics: Adolescent; Adult; Cardiovascular Diseases; Cohort Studies; Female; Fibrinogen; Growth Hormone; Hormone Replacement Therapy; Human Growth Hormone; Humans; Lipids; Male; Prospective Studies; Risk Factors; Time Factors; Ventricular Function, Left

2001
Hyperlipidaemia and cardiovascular disease.
    Current opinion in lipidology, 2001, Volume: 12, Issue:3

    Topics: Cardiovascular Diseases; Clinical Trials as Topic; Fibrinogen; Follow-Up Studies; Humans; Hyperlipidemias; Lipoproteins, LDL; Multicenter Studies as Topic; Risk

2001
APOC3, CETP, fibrinogen, and MTHFR are genetic determinants of carotid intima-media thickness in healthy men (the Stanislas cohort).
    Clinical genetics, 2001, Volume: 59, Issue:5

    Topics: Adult; Alleles; Apolipoprotein C-III; Apolipoproteins C; Cardiovascular Diseases; Carotid Arteries; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cohort Studies; DNA; Female; Fibrinogen; Gene Frequency; Genes; Genetic Markers; Glycoproteins; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Tunica Intima; Tunica Media; Ultrasonography

2001
Association between job strain status and cardiovascular risk in a population of Taiwanese white-collar workers.
    Japanese circulation journal, 2001, Volume: 65, Issue:6

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Data Collection; Female; Fibrinogen; Humans; Male; Middle Aged; Occupational Diseases; Risk Factors; Stress, Physiological; Taiwan

2001
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis.
    Rheumatology (Oxford, England), 2001, Volume: 40, Issue:6

    Topics: Adult; Aged; Arthritis, Rheumatoid; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Middle Aged; Prevalence; Risk Factors; von Willebrand Factor

2001
Air pollution and blood markers of cardiovascular risk.
    Environmental health perspectives, 2001, Volume: 109 Suppl 3

    Topics: Adult; Aged; Air Pollution; Biomarkers; Cardiovascular Diseases; Female; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Particle Size; Platelet Count; Risk Assessment

2001
Parameters of childhood obesity and their relationship to cardiovascular risk factors in healthy prepubescent children.
    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 2001, Volume: 25, Issue:6

    Topics: Anthropometry; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Child; Child, Preschool; Cross-Sectional Studies; Female; Fibrinogen; Humans; Lipids; Male; Obesity; Risk Factors; Sex Factors

2001
Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study.
    Circulation, 2001, Jul-10, Volume: 104, Issue:2

    Topics: Adenosine Diphosphate; Alleles; Antigens, Human Platelet; Cardiovascular Diseases; Epinephrine; Epitopes; Female; Fibrinogen; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Genetic Testing; Genotype; Homozygote; Humans; Integrin beta3; Male; Middle Aged; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Risk Factors; Vasoconstrictor Agents; von Willebrand Factor

2001
Plasma ascorbic acid and risk of heart disease and cancer.
    Lancet (London, England), 2001, Jun-30, Volume: 357, Issue:9274

    Topics: Ascorbic Acid; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Humans; Neoplasms; Risk Factors

2001
Chlamydia pneumonia seropositivity correlates with serum fibrinogen and lipoprotein a levels: any role in atherosclerosis?
    Endocrine journal, 2001, Volume: 48, Issue:2

    Topics: Aged; Antibodies, Bacterial; Arteriosclerosis; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery Diseases; Chlamydophila pneumoniae; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Humans; Immunoglobulin G; Lipoprotein(a); Male; Middle Aged; Risk Factors; Sex Factors; Triglycerides

2001
Cardiovascular risk factors associated with insulin resistance cluster in families with early-onset coronary heart disease.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:8

    Topics: Adult; Age of Onset; Aged; Arteriosclerosis; Cardiovascular Diseases; Cholesterol, HDL; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Insulin Resistance; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Risk Factors; Triglycerides

2001
Effect of smoking reduction and cessation on cardiovascular risk factors.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2001, Volume: 3, Issue:3

    Topics: Adult; Cardiovascular Diseases; Cotinine; Female; Fibrinogen; Hematocrit; Hemoglobins; Humans; Lipoproteins, HDL; Male; Nicotine; Retrospective Studies; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Triglycerides

2001
Associations between homocysteine and coagulation factors--a cross-sectional study in two populations of central Europe.
    Thrombosis research, 2001, Aug-15, Volume: 103, Issue:4

    Topics: Blood Coagulation Factors; Cardiovascular Diseases; Cross-Sectional Studies; Europe; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostatics; Homocysteine; Humans; Linear Models; Male; Middle Aged; Risk Factors

2001
Fibrinogen, lipoprotein (a) and lipids in patients with erectile dysfunction. A preliminary study.
    International angiology : a journal of the International Union of Angiology, 2001, Volume: 20, Issue:3

    Topics: Aged; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Erectile Dysfunction; Fibrinogen; Humans; Lipids; Lipoprotein(a); Male; Middle Aged; Risk Factors; Smoking

2001
[APOC3, CETP, beta-fibrinogen and MTHFR are genetic determinants of carotid intim-media thickness (Stanislas cohort)].
    Archives des maladies du coeur et des vaisseaux, 2001, Volume: 94, Issue:8

    Topics: Adult; Apolipoproteins C; Cardiovascular Diseases; Carotid Arteries; Cohort Studies; Female; Fibrinogen; Genetic Markers; Humans; Male; Middle Aged; Polymorphism, Genetic; Risk Factors; Tunica Intima

2001
Variability in fibrinogen measurements: an obstacle to cardiovascular risk stratification.
    Atherosclerosis, 2001, Volume: 159, Issue:1

    Topics: Adult; Aged; Cardiovascular Diseases; Female; Fibrinogen; Humans; Male; Middle Aged; Reproducibility of Results; Risk Factors

2001
[Fibrinogen: a cardiovascular risk factor].
    Presse medicale (Paris, France : 1983), 2000, Nov-13, Volume: 29, Issue:34

    Topics: Adult; Aged; Aortic Diseases; Arteriosclerosis; Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Humans; Leg; Life Style; Male; Pregnancy; Prospective Studies; Risk; Risk Factors; Smoking; Stroke

2000
Monitoring of cardiovascular risk factors in the diabetic clinics of an Italian region: the MOFRAD study.
    Diabetes, nutrition & metabolism, 2001, Volume: 14, Issue:4

    Topics: Adult; Aged; Ambulatory Care Facilities; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Italy; Lipoproteins, HDL; Male; Middle Aged; Obesity; Risk Factors; Sex Characteristics; Smoking; Triglycerides

2001
Patients on peritoneal dialysis but not on hemodialysis have elevated concentration and activity of thrombin-activatable fibrinolysis inhibitor.
    Thrombosis research, 2001, Nov-15, Volume: 104, Issue:4

    Topics: Adult; Aged; Carboxypeptidase B2; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Female; Fibrinogen; Humans; Male; Middle Aged; Peritoneal Dialysis; Renal Dialysis; Risk Factors; Triglycerides

2001
Obesity in African women in the North West Province, South Africa is associated with an increased risk of non-communicable diseases: the THUSA study. Transition and Health during Urbanisation of South Africans.
    The British journal of nutrition, 2001, Volume: 86, Issue:6

    Topics: Adolescent; Adult; Aged; Anthropometry; Black People; Blood Glucose; Blood Pressure; Body Constitution; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Insulin; Lipids; Middle Aged; Obesity; Risk Factors; Skinfold Thickness; South Africa

2001
Fibrinogen and thrombophilia.
    Clinical laboratory science : journal of the American Society for Medical Technology, 2001,Fall, Volume: 14, Issue:4

    Topics: Cardiovascular Diseases; Fibrinogen; Humans; Predictive Value of Tests; Risk Factors; Thrombophilia

2001
Multivariate analysis of relationships between insulin sensitivity and blood rheology: is plasma viscosity a marker of insulin resistance?
    Clinical hemorheology and microcirculation, 2001, Volume: 25, Issue:3-4

    Topics: Adult; Biomarkers; Blood Glucose; Blood Viscosity; Cardiovascular Diseases; Erythrocyte Aggregation; Fasting; Female; Fibrinogen; Glucose Tolerance Test; Hemorheology; Homeostasis; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Lipids; Male; Multivariate Analysis; Risk Factors

2001
Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk.
    Journal of clinical pathology, 2002, Volume: 55, Issue:4

    Topics: Acute-Phase Reaction; Adolescent; Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Creatine Kinase; Exercise; Fibrinogen; Humans; Lipoprotein(a); Male; Military Personnel; Risk Assessment; Serum Albumin

2002
Impaired fibrinolysis in premenopausal women and age-matched men with Type 2 diabetes mellitus: a pilot study.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2002, Volume: 50, Issue:2

    Topics: Adult; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Fibrinolysis; Humans; Male; Pilot Projects; Plasminogen Activator Inhibitor 1; Premenopause; Serum Globulins; Sex Characteristics; Tissue Plasminogen Activator

2002
The relationship between attendance at religious services and cardiovascular inflammatory markers.
    International journal of psychiatry in medicine, 2001, Volume: 31, Issue:4

    Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Inflammation Mediators; Leukocyte Count; Male; Middle Aged; Religion

2001
Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy.
    Journal of acquired immune deficiency syndromes (1999), 2002, Apr-15, Volume: 29, Issue:5

    Topics: Adipose Tissue; Adult; Antiretroviral Therapy, Highly Active; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; HIV Infections; HIV Protease Inhibitors; Humans; Insulin Resistance; Lipids; Lipodystrophy; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors

2002
A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women.
    Fertility and sterility, 2002, Volume: 77, Issue:5

    Topics: Administration, Cutaneous; Aged; Antioxidants; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Endothelin-1; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Lipids; Middle Aged; Norpregnenes; Postmenopause; Risk Factors

2002
Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients.
    Stroke, 2002, Volume: 33, Issue:7

    Topics: Aged; Anticoagulants; Biomarkers; Brain; Brain Ischemia; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Disease-Free Survival; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Inflammation; Magnetic Resonance Imaging; Male; Multivariate Analysis; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Assessment; Stroke; Time; Tomography, X-Ray Computed; Treatment Outcome

2002
Exercise fitness, cardiac work and blood viscosity factors in patients and normals.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1976, Volume: 8, Issue:2

    Topics: Adult; Aged; Blood Viscosity; Cardiac Output; Cardiovascular Diseases; Cholesterol; Erythrocyte Aggregation; Fibrinogen; Heart; Heart Function Tests; Humans; Middle Aged; Physical Exertion; Physical Fitness; Rheology; Serum Albumin

1976
Effect of stress and anxiety on thrombus formation and blood viscosity factors.
    Bibliotheca haematologica, 1975, Issue:41

    Topics: Adult; Anxiety; Blood Coagulation; Blood Group Antigens; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cell Aggregation; Female; Fibrinogen; Humans; Male; Middle Aged; Serum Albumin; Stress, Psychological

1975
[Fibrinogen seen as an independent cardiovascular factor from the molecular aspect].
    Casopis lekaru ceskych, 1992, Dec-04, Volume: 131, Issue:24-25

    Topics: Cardiovascular Diseases; Fibrinogen; Humans; Risk Factors

1992
Plasma fibrinogen levels, leucocyte and platelet counts in male Zimbabwean hypertensives.
    The Central African journal of medicine, 1992, Volume: 38, Issue:12

    Topics: Adult; Black People; Cardiovascular Diseases; Fibrinogen; Humans; Hypertension; Leukocyte Count; Male; Middle Aged; Platelet Count; Risk Factors; Sampling Studies; Zimbabwe

1992
Hemostatic factors according to menopausal status and use of hormone replacement therapy.
    Annals of epidemiology, 1992, Volume: 2, Issue:4

    Topics: Antithrombin III; Blood Coagulation Factors; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Fibrinogen; Hemostasis; Humans; Menopause; Middle Aged; Plasminogen; Postmenopause; Premenopause; Risk Factors

1992
Update on fibrinogen as a cardiovascular risk factor.
    Annals of epidemiology, 1992, Volume: 2, Issue:4

    Topics: Age Factors; Aged; Arteriosclerosis; Cardiovascular Diseases; Cerebrovascular Disorders; Cohort Studies; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors; Sex Factors

1992
Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Annals of epidemiology, 1992, Volume: 2, Issue:4

    Topics: Antithrombin III; Black People; Blood Coagulation Factors; Cardiovascular Diseases; Factor VII; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Protein C; Risk Factors; von Willebrand Factor

1992
The distribution of coagulation factors VII and VIII and fibrinogen in adults over 65 years. Results from the Cardiovascular Health Study.
    Annals of epidemiology, 1992, Volume: 2, Issue:4

    Topics: Age Factors; Aged; Black People; Cardiovascular Diseases; Cohort Studies; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged; Risk Factors

1992
The association of waist-hip ratio and risk factors for development of IDDM complications in an IDDM adult population.
    Diabetes research and clinical practice, 1992, Volume: 17, Issue:2

    Topics: Abdomen; Adipose Tissue; Adolescent; Adult; Age Factors; Aged; Blood Pressure; Body Weight; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Fibrinogen; Hip; Humans; Insulin Resistance; Lipids; Lipoproteins; Male; Middle Aged; Multivariate Analysis; Risk Factors; Triglycerides

1992
Evidence of decreased fibrinolytic activity in hypertensive premenopausal women.
    Scandinavian journal of clinical and laboratory investigation, 1992, Volume: 52, Issue:4

    Topics: Adult; Cardiovascular Diseases; Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Hypertension; Menstruation; Plasminogen Activator Inhibitor 1; Risk Factors; Smoking

1992
Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity.
    Thrombosis and haemostasis, 1992, Oct-05, Volume: 68, Issue:4

    Topics: Adult; Cardiovascular Diseases; Cholesterol; Factor VII; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Male; Middle Aged; Obesity, Morbid; Plasminogen Activator Inhibitor 1; Risk Factors; Weight Loss

1992
Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors.
    Annals of internal medicine, 1992, Sep-01, Volume: 117, Issue:5

    Topics: Aged; Blood Viscosity; Brain Ischemia; Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Odds Ratio; Prognosis; Risk Factors

1992
Plasma viscosity, fibrinogen, white cell count, and cardiovascular risk factors.
    Circulation, 1992, Volume: 85, Issue:5

    Topics: Blood Viscosity; Cardiovascular Diseases; Fibrinogen; Humans; Leukocyte Count; Risk Factors

1992
Early growth and clotting factors in adult life.
    BMJ (Clinical research ed.), 1992, Apr-18, Volume: 304, Issue:6833

    Topics: Adult; Cardiovascular Diseases; Factor VII; Fibrinogen; Growth; Humans; Infant; Male

1992
Fibrinogen: the plot thickens.
    Journal of clinical epidemiology, 1992, Volume: 45, Issue:5

    Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Fibrinogen; Humans; Myocardial Infarction; Platelet Aggregation; Risk Factors

1992
[Improvement of hemorheology with ginkgo biloba extract. Decreasing a cardiovascular risk factor].
    Fortschritte der Medizin, 1992, May-10, Volume: 110, Issue:13

    Topics: Aged; Blood Viscosity; Cardiovascular Diseases; Female; Fibrinogen; Ginkgo biloba; Humans; Male; Middle Aged; Plant Extracts; Prospective Studies; Rheology; Risk Factors

1992
Seasonal variations in fibrinogen concentrations among elderly people.
    Lancet (London, England), 1991, Jul-06, Volume: 338, Issue:8758

    Topics: Aged; Aged, 80 and over; Blood Viscosity; Body Temperature; Cardiovascular Diseases; Cholesterol, HDL; Female; Fibrinogen; Humans; Male; Seasons; Temperature

1991
Antithrombin III and arterial disease.
    Lancet (London, England), 1991, Oct-05, Volume: 338, Issue:8771

    Topics: Adult; Antithrombin III; Cardiovascular Diseases; Factor VII; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Survival Rate

1991
[When will fibrinogen screening become available?].
    Deutsche medizinische Wochenschrift (1946), 1991, Dec-06, Volume: 116, Issue:49

    Topics: Animals; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Rabbits; Risk Factors

1991
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors.
    Atherosclerosis, 1991, Volume: 91, Issue:3

    Topics: Body Constitution; Cardiovascular Diseases; Coronary Disease; Factor VII; Female; Fibrinogen; Humans; Life Style; Lipids; Male; Middle Aged; Prospective Studies; Racial Groups; Risk Factors; Sex Factors; Smoking

1991
Social class and cardiovascular risk factors in Danish men.
    Scandinavian journal of social medicine, 1991, Volume: 19, Issue:2

    Topics: Adult; Alcohol Drinking; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Denmark; Exercise; Fibrinogen; Humans; Incidence; Male; Middle Aged; Physical Fitness; Risk Factors; Smoking; Social Class; Social Support; Work Schedule Tolerance

1991
Fibrinogen.
    BMJ (Clinical research ed.), 1991, Sep-14, Volume: 303, Issue:6803

    Topics: Cardiovascular Diseases; Fibrinogen; Humans; Risk Factors

1991
Cardiovascular risk factors in young snuff-users and cigarette smokers.
    Journal of internal medicine, 1991, Volume: 230, Issue:1

    Topics: Adult; Alcohol Drinking; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Coffee; Fibrinogen; Humans; Insulin; Male; Plants, Toxic; Smoking; Tobacco, Smokeless

1991
[Evaluation of various hemorheological parameters in nonagenarians: evidence of an increase of fibrinogen].
    Bollettino della Societa italiana di biologia sperimentale, 1990, Volume: 66, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Blood Viscosity; Cardiovascular Diseases; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Humans; Male; Rheology; Risk Factors

1990
Bishop lecture. Contribution of the Framingham Study to preventive cardiology.
    Journal of the American College of Cardiology, 1990, Volume: 15, Issue:1

    Topics: Blood Glucose; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Cholesterol; Electrocardiography; Fibrinogen; Humans; Life Style; Massachusetts; Myocardial Infarction; Prospective Studies; Risk Factors

1990
Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease.
    Journal of internal medicine, 1990, Volume: 227, Issue:4

    Topics: Anthropometry; Blood Pressure; Body Composition; Cardiovascular Diseases; Fibrinogen; Glucose; Humans; Hypertension; Insulin; Lipids; Male; Middle Aged; Plasminogen Inactivators; Risk Factors

1990
Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men.
    BMJ (Clinical research ed.), 1990, Mar-10, Volume: 300, Issue:6725

    Topics: Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus; Exercise; Family Characteristics; Fibrinogen; Humans; Leisure Activities; Male; Middle Aged; Risk Factors; Smoking; Social Class; Social Support; Socioeconomic Factors; Stress, Psychological; Sweden

1990
Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience.
    American heart journal, 1990, Volume: 120, Issue:3

    Topics: Aged; Arteriosclerosis; Blood Coagulation; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Female; Fibrinogen; Follow-Up Studies; Glucose; Glucose Tolerance Test; Humans; Incidence; Male; Middle Aged; Risk Factors

1990
Hemostatic variables in Japanese and Caucasian men. Plasma fibrinogen, factor VIIc, factor VIIIc, and von Willebrand factor and their relations to cardiovascular disease risk factors.
    American journal of epidemiology, 1989, Volume: 130, Issue:5

    Topics: Adult; Asian; Asian People; Blood Coagulation Factors; Cardiovascular Diseases; Cross-Cultural Comparison; Data Interpretation, Statistical; Factor VII; Factor VIII; Fibrinogen; Humans; Japan; Male; Middle Aged; Minnesota; Prevalence; Risk Factors; von Willebrand Factor; White People

1989
[Fibrinogen and factor VII: 2 risk factors for arterial thrombosis].
    Presse medicale (Paris, France : 1983), 1989, Apr-22, Volume: 18, Issue:16

    Topics: Cardiovascular Diseases; Factor VII; Female; Fibrinogen; Humans; Male; Prospective Studies; Risk Factors; Thrombosis

1989
[Incidence of reduced fibrinolytic activity and fibrinogen increase in the pathogenesis of vascular risk in obese subjects. Study of fibrinolytic activity of plasma, fibrinogen, erythrocyte aggregation and plasma viscosity].
    Minerva cardioangiologica, 1988, Volume: 36, Issue:11

    Topics: Adult; Blood Viscosity; Cardiovascular Diseases; Erythrocyte Aggregation; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Obesity; Plasminogen; Risk Factors

1988
Cardiovascular risk factors in type I (insulin-dependent) diabetic patients with and without proteinuria.
    Acta medica Scandinavica, 1987, Volume: 222, Issue:5

    Topics: Adolescent; Adult; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 1; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Proteinuria; Risk Factors; Serum Albumin

1987
Skinfold thickness and cardiovascular risk factors.
    American journal of epidemiology, 1987, Volume: 126, Issue:1

    Topics: Adolescent; Adult; Blood Pressure; Cardiovascular Diseases; Cholesterol; Factor VII; Female; Fibrinogen; Humans; Male; Middle Aged; Obesity; Sex Factors; Skinfold Thickness

1987
Fibrinogen and risk of cardiovascular disease. The Framingham Study.
    JAMA, 1987, Sep-04, Volume: 258, Issue:9

    Topics: Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Female; Fibrinogen; Humans; Longitudinal Studies; Male; Massachusetts; Middle Aged; Risk; Sex Factors; Statistics as Topic

1987
Relationship between elevated fibrinopeptide A levels and alpha-2-antiplasmin.
    Haemostasis, 1987, Volume: 17, Issue:5

    Topics: Adolescent; Adult; Aged; alpha-2-Antiplasmin; Cardiovascular Diseases; Collagen Diseases; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged

1987
Abnormalities of blood coagulation tests in patients with cancer.
    American journal of clinical pathology, 1987, Volume: 88, Issue:5

    Topics: Blood Coagulation Tests; Cardiovascular Diseases; Fibrinogen; Fibrinopeptide A; Humans; Neoplasms; Platelet Count; Thrombin; Warfarin

1987
Plasma fibrinogen in a diabetic population.
    The Journal of the Royal College of General Practitioners, 1986, Volume: 36, Issue:285

    Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Male

1986
Fibrinogen as a risk factor in cardiovascular disease.
    The New England journal of medicine, 1985, Jan-10, Volume: 312, Issue:2

    Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Fibrinogen; Humans; Risk

1985
Mode of action of phenformin plus ethyloestrenol on fibrinolysis.
    Lancet (London, England), 1971, Apr-10, Volume: 1, Issue:7702

    Topics: Age Factors; Aged; Cardiovascular Diseases; Drug Synergism; Ethylestrenol; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Phenformin; Plasminogen; Thrombophlebitis; Vascular Diseases

1971
Roles for calcium and free fatty acids in cardiac function.
    Recent advances in studies on cardiac structure and metabolism, 1974, Volume: 4

    Topics: Animals; Blood Coagulation; Calcium; Cardiovascular Diseases; Fatty Acids, Nonesterified; Fibrinogen; Humans; Structure-Activity Relationship

1974
Influence of ABO blood groups and fibrinogen on thrombus formation and aggregation of red cells in cardiovascular and malignant diseases: new aspects of biorheological characterization of disease.
    Biorheology, 1973, Volume: 10, Issue:4

    Topics: ABO Blood-Group System; Blood Coagulation; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cell Aggregation; Diabetes Mellitus; Erythrocytes; Fibrinogen; Graft Rejection; Hematocrit; Hemophilia A; Humans; Hyperthyroidism; Kidney Failure, Chronic; Kidney Transplantation; Melanoma; Myocardial Infarction; Prognosis; Rheology; Serum Albumin; Thrombosis; Transplantation, Homologous

1973
[Diagnosis of pulmonary embolism. Value of lung scanning and of the measure of fibrinogen degradation products].
    La Nouvelle presse medicale, 1974, Feb-09, Volume: 3, Issue:6

    Topics: Adult; Aged; Cardiovascular Diseases; Diagnosis, Differential; Female; Fibrinogen; Fibrinolysis; Humans; Hypertension, Pulmonary; Male; Methods; Middle Aged; Pulmonary Circulation; Pulmonary Embolism; Radionuclide Imaging; Statistics as Topic

1974
[Microcirculation studies in a surgical clinic].
    Kardiologiia, 1971, Volume: 11, Issue:8

    Topics: Acid-Base Equilibrium; Blood Pressure; Blood Sedimentation; Capillaries; Cardiac Surgical Procedures; Cardiovascular Diseases; Cerebrovascular Circulation; Conjunctiva; Constriction; Erythrocyte Aggregation; Extracorporeal Circulation; Fibrinogen; Hematocrit; Humans; Kidney Failure, Chronic; Methods; Microcirculation; Photomicrography; Pulse; Stress, Physiological; Time Factors; Vascular Surgical Procedures; Vasomotor System

1971
[Biological half-life of fibrinogen labelled with radioactive iodine I-131 in coronary disease].
    Acta medica Iugoslavica, 1970, Volume: 24, Issue:1

    Topics: Adult; Aged; Blood Coagulation; Cardiovascular Diseases; Coronary Disease; Ethyl Biscoumacetate; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction

1970
[Blood coagulation in rheumatic heart disease according to the data of a thromboelastographic study].
    Kardiologiia, 1967, Volume: 7, Issue:12

    Topics: Blood Coagulation Disorders; Cardiovascular Diseases; Fibrinogen; Fibrinolysis; Heparin; Humans; Rheumatic Diseases; Rheumatic Heart Disease; Thrombelastography; Thrombosis

1967
Extrapulmonary effects of cancer of the lung and pleura. Endocrine, muscular, cutaneous, hematologic, and cardiovascular manifestations not due to metastases.
    The Journal of thoracic and cardiovascular surgery, 1971, Volume: 61, Issue:4

    Topics: Adult; Agammaglobulinemia; Aged; Anemia; Biopsy; Cardiovascular Diseases; Cerebellar Diseases; Connective Tissue; Dermatomyositis; Endocarditis; Endocrine System Diseases; Fibrinogen; Hematologic Diseases; Humans; Hyperparathyroidism; Lung Neoplasms; Male; Microscopy, Electron; Middle Aged; Mitral Valve; Neuromuscular Diseases; Photomicrography; Pleural Neoplasms; Polycythemia; Radiography; Skin Manifestations

1971
Metabolic aspects of imbalance in hemostasis: consumption of factors in disease. Discussion.
    Thrombosis et diathesis haemorrhagica. Supplementum, 1965, Volume: 17

    Topics: Blood Coagulation; Cardiovascular Diseases; Fibrinogen; Hematologic Diseases; Neoplasms

1965